US20030032874A1 - Sensor head for use with implantable devices - Google Patents

Sensor head for use with implantable devices Download PDF

Info

Publication number
US20030032874A1
US20030032874A1 US09/916,711 US91671101A US2003032874A1 US 20030032874 A1 US20030032874 A1 US 20030032874A1 US 91671101 A US91671101 A US 91671101A US 2003032874 A1 US2003032874 A1 US 2003032874A1
Authority
US
United States
Prior art keywords
domain
sensor head
region
head according
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/916,711
Inventor
Rathbun Rhodes
Mark Tapsak
James Brauker
Mark Shults
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dexcom Inc
Original Assignee
Dexcom Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexcom Inc filed Critical Dexcom Inc
Priority to US09/916,711 priority Critical patent/US20030032874A1/en
Assigned to DEXCOM, INC. reassignment DEXCOM, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRAUKER, JAMES H., TAPSAK, MARK A., RHODES, RATHBUN, SHULTS, MARK C.
Priority to AU2002317584A priority patent/AU2002317584A1/en
Priority to EP06112130A priority patent/EP1669022A3/en
Priority to DE60213096T priority patent/DE60213096D1/en
Priority to EP02748255A priority patent/EP1411823B1/en
Priority to PCT/US2002/023903 priority patent/WO2003011131A2/en
Priority to JP2003516370A priority patent/JP4295615B2/en
Priority to AT02748255T priority patent/ATE332666T1/en
Publication of US20030032874A1 publication Critical patent/US20030032874A1/en
Priority to US11/021,162 priority patent/US7471972B2/en
Priority to US12/260,017 priority patent/US8509871B2/en
Priority to US13/943,622 priority patent/US9328371B2/en
Priority to US15/059,086 priority patent/US9804114B2/en
Priority to US15/720,329 priority patent/US20180024086A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/002Electrode membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006Enzyme electrodes involving specific analytes or enzymes for glucose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48707Physical analysis of biological material of liquid biological material by electrical means
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48785Electrical and electronic details of measuring devices for physical analysis of liquid biological material not specific to a particular test method, e.g. user interface or power supply

Definitions

  • the present invention relates generally to novel sensor heads utilized with implantable devices, devices including these sensor heads and methods for determining analyte levels using these implantable devices. More particularly, the invention relates to sensor heads, implantable devices including these sensor heads and methods for monitoring glucose levels in a biological fluid using these devices.
  • Amperometric electrochemical sensors require a counter electrode to balance the current generated by the species being measured at the working electrode.
  • the species being measured at the working electrode is H 2 O 2 .
  • Glucose oxidase catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate according to the following reaction:
  • H 2 O 2 Because for each glucose molecule metabolized, there is a proportional change in the product H 2 O 2 , one can monitor the change in H 2 O 2 to determine glucose concentration. Oxidation of H 2 O 2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H 2 O 2 , or other reducible species at the counter electrode. In vivo glucose concentration may vary from about one hundred times or more that of the oxygen concentration. Consequently, oxygen becomes a limiting reactant in the electrochemical reaction and when insufficient oxygen is provided to the sensor, the sensor will be unable to accurately measure glucose concentration. Those skilled in the art have come to interpret oxygen limitations resulting in depressed function as being a problem of availability of oxygen to the enzyme.
  • the sensor head 10 includes a working electrode 21 (anode), counter electrode 22 (cathode), and reference electrode 20 which are affixed to the head by both brazing 26 the electrode metal to the ceramic and potting with epoxy 28 .
  • the working electrode 21 (anode) and counter-electrode 22 (cathode) of a glucose oxidase-based glucose sensor head 10 require oxygen in different capacities.
  • Prior art teaches an enzyme-containing membrane that resides above an amperometric electrochemical sensor.
  • region 32 includes an immobilized enzyme, i.e. glucose oxidase. Within the enzyme layer above the working electrode 21 , oxygen is required for the production of H 2 O 2 from glucose.
  • the H 2 O 2 produced from the glucose oxidase reaction further reacts at surface 21 a of working electrode 21 and produces two electrons.
  • the products of this reaction are two protons (2H + ), two electrons (2e ⁇ ), and one oxygen molecule (O 2 ) (Fraser, D. M. “An Introduction to In Vivo Biosensing: Progress and problems.” In “Biosensors and the Body,” D. M. Fraser, ed., 1997, pp. 1-56 John Wiley and Sons, New York).
  • the oxygen concentration near the working electrode 21, which is consumed during the glucose oxidase reaction is replenished by the second reaction at the working electrode. Therefore, the net consumption of oxygen is zero.
  • neither all of the H 2 O 2 produced by the enzyme diffuses to the working electrode surface nor does all of the oxygen produced at the electrode diffuse to the enzyme domain.
  • the counter electrode 22 utilizes oxygen as an electron acceptor.
  • the most likely reducible species for this system are oxygen or enzyme generated peroxide (Fraser, D. M. supra).
  • the two-electron pathway is shown in FIG. 1.
  • Oxygen is further consumed above the counter electrode by the glucose oxidase in region 32 . Due to the oxygen consumption by both the enzyme and the counter electrode, there is a net consumption of oxygen at the surface 22 a of the counter electrode.
  • loss of glucose oxidase sensor function may not be due to a limitation of oxygen in the enzyme layer near the working electrode, but may instead be due to a limitation of oxygen at the counter electrode.
  • a higher peroxide concentration results, thereby increasing the current at the working electrode.
  • the counter electrode limitation begins to manifest itself as this electrode moves to increasingly negative voltages in the search for reducible species.
  • the counter electrode voltage reaches a circuitry limit of ⁇ 0.6V resulting in compromised sensor function (see FIG. 3).
  • FIG. 3 shows simultaneous measurement of counter-electrode voltage and sensor output to glucose levels from a glucose sensor implanted subcutaneously in a canine host. It can be observed that as glucose levels increase, the counter electrode voltage decreases. When the counter electrode voltage reaches ⁇ 0.6V, the signal to noise ratio increases significantly. This reduces the accuracy of the device.
  • FIG. 4 shows a further example of another glucose sensor in which the counter-electrode reaches the circuitry limit. Again, once the counter electrode reaches ⁇ 0.6V, the sensitivity and/or signal to noise ratio of the device is compromised. In both of these examples, glucose levels reached nearly 300 mg/dl. However, in FIG. 3 the sensor showed a greater than three-fold higher current output than the sensor in FIG. 4.
  • FIG. 5 shows a glucose sensor in which the counter electrode voltage did not reach ⁇ 0.6V.
  • the sensor was able to maintain a current balance between the working and counter electrodes, thereby enabling accurate measurements throughout the course of the experiment.
  • the results shown in FIGS. 3, 4 and 5 led the present inventors to postulate that by keeping the counter electrode from reaching the circuitry limit, one could maintain sensitivity and accuracy of the device.
  • the first approach involves the widening of the potential range over which the counter electrode can move in the negative direction to avoid reaching circuitry limitations.
  • This approach increases undesirable products that are produced at lower potentials.
  • One such product, hydrogen may form at the counter electrode, which may then diffuse back to the working electrode. This may contribute to additional current resulting in erroneously high glucose concentration readings.
  • the probability of passivating or poisoning the counter electrode greatly increases. This effectively reduces the counter electrode surface area requiring a higher current density at the remaining area to maintain current balance.
  • increased current load increases the negative potentials eventually resulting in electrode failure.
  • the second approach is utilizing the metal case of the device as a counter electrode (see U.S. Pat. No. 4,671,288, Gough or U.S. Pat. No. 5,914,026, Blubaugh).
  • This provides an initial excess in surface area which is expected to serve the current balancing needs of the device over its lifetime.
  • the counter electrode reaction is a reduction reaction, as in Blubaugh, the normally present metal oxide layer will be reduced to bare metal over time leaving the surface subject to corrosion, poisoning, and eventual cascade failure. This problem is magnified when considering the various constituents of the body fluid that the metal casing is exposed to during in vivo use. To date, there has been no demonstration of long-term performance of such a device with this counter electrode geometry.
  • a sensor head for use in a device that measures the concentration of an analyte in a biological fluid
  • a sensor head for use in a device that measures the concentration of an analyte in a biological fluid
  • a sensor head for use in an implantable analyte measuring device which includes the same sensor head components as those described above.
  • the sensor heads of the present invention include a multi-region membrane that controls the number of species that are able to reach the surface of the electrodes.
  • a membrane allows the passage of desired substrate molecules (e.g. oxygen and glucose) and rejects other larger molecules that may interfere with accurate detection of an analyte.
  • desired substrate molecules e.g. oxygen and glucose
  • the sensor heads of the present invention also provide a larger counter electrode reactive surface that balances the current between the working and counter electrodes, thereby minimizing negative potential extremes that may interfere with accurate analyte detection.
  • an implantable device for measuring an analyte in a biological fluid including at least one of the sensor heads described above.
  • a method of monitoring glucose levels is disclosed which includes the steps of providing a host, and an implantable device as provided above and implanting the device in the host.
  • a method of measuring glucose in a biological fluid including the steps of providing a host and a implantable device described above, which includes a sensor head capable of accurate continuous glucose sensing; and implanting the device in the host.
  • the sensor head, membrane architectures, devices and methods of the present invention allow for the collection of continuous information regarding desired analyte levels (e.g. glucose). Such continuous information enables the determination of trends in glucose levels, which can be extremely important in the management of diabetic patients.
  • desired analyte levels e.g. glucose
  • the term “sensor head” refers to the region of a monitoring device responsible for the detection of a particular analyte.
  • the sensor head generally comprises a non-conductive body, a working electrode (anode), a reference electrode and a counter electrode (cathode) passing through and secured within the body forming an electrochemically reactive surface at one location on the body and an electronic connective means at another location on the body, and a multi-region membrane affixed to the body and covering the electrochemically reactive surface.
  • the counter electrode has a greater electrochemically reactive surface area than the working electrode.
  • a biological sample e.g., blood or interstitial fluid
  • an enzyme e.g., glucose oxidase
  • the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the analyte (e.g. glucose) level in the biological sample.
  • the multi-region membrane further comprises an enzyme domain, and an electrolyte phase (i.e., a free-flowing liquid phase comprising an electrolyte-containing fluid described further below).
  • analyte refers to a substance or chemical constituent in a biological fluid (e.g., blood, interstitial fluid, cerebral spinal fluid, lymph fluid or urine) that can be analyzed.
  • a preferred analyte for measurement by the sensor heads, devices and methods of the present invention is glucose.
  • electrochemically reactive surface refers to the surface of an electrode where an electrochemical reaction takes place.
  • the hydrogen peroxide produced by the enzyme catalyzed reaction of the analyte being detected reacts creating a measurable electronic current (e.g. detection of glucose analyte utilizing glucose oxidase produces H 2 O 2 peroxide as a by product, H 2 O 2 reacts with the surface of the working electrode producing two protons (2H + ), two electrons (2e ⁇ ) and one molecule of oxygen (O 2 ) which produces the electronic current being detected).
  • a reducible species e.g. O 2 is reduced at the electrode surface in order to balance the current being generated by the working electrode.
  • connection refers to any electronic connection known to those in the art that may be utilized to interface the sensor head electrodes with the electronic circuitry of a device such as mechanical (e.g., pin and socket) or soldered.
  • domain refers to regions of the membrane of the present invention that may be layers, uniform or non-uniform gradients (e.g. anisotropic) or provided as portions of the membrane.
  • multi-region membrane refers to a permeable membrane that may be comprised of two or more domains and constructed of biomaterials of a few microns thickness or more which are permeable to oxygen and may or may not be permeable to glucose.
  • One of the the membranes may be placed over the sensor body to keep host cells (e.g., macrophages) from gaining proximity to, and thereby damaging, the enzyme membrane or forming a barrier cell layer and interfering with the transport of analyte across the tissue-device interface.
  • a biological fluid measuring device comprises a multi-region membrane that may be comprised of a number of domains. If the electrodes of the sensor head are deemed to be the point of reference, and one of the multi-region membrane domains is positioned farther from the electrodes, than that domain is distant from the electrodes.
  • oxygen antenna domain refers to a domain composed of a material that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane.
  • the domain can then act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains.
  • this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function.
  • solid portions refer to a material having a structure that may or may not have an open-cell configuration but in either case prohibits whole cells from traveling through or residing within the material.
  • substantially number refers to the number of cavities or solid portions having a particular size within a domain in which greater than 50 percent of all cavities or solid portions are of the specified size, preferably greater than 75 percent and most preferably greater than 90 percent of the cavities or solid portions have the specified size.
  • co-continuous and the like refers to a solid portion wherein an unbroken curved line in three dimensions exists between any two points of the solid portion.
  • the term “host” refers to both humans and animals.
  • the term “accurately” means, for example, 90% of measured glucose values are within the “A” and “B” region of a standard Clarke error grid when the sensor measurements are compared to a standard reference measurement. It is understood that like any analytical device, calibration, calibration validation and recalibration are required for the most accurate operation of the device.
  • continuous glucose sensing refers to the period in which monitoring of plasma glucose concentration is continuously performed, for example, about every 10 minutes.
  • FIG. 1 Illustration of thermodynamically favored reactions at the working electrode and counter electrode at the desired voltage potentials.
  • FIG. 2A depicts a cross-sectional exploded view of a sensor head of the present invention wherein the multi-region membrane comprises three regions.
  • FIG. 2B depicts a cross-sectional exploded view of a sensor head of the present invention wherein a portion of the second membrane region does not cover the working electrode.
  • FIG. 2C depicts a cross-sectional exploded view of a sensor head of the present invention which includes two distinct regions, wherein the region adjacent the electrochemically reactive surfaces includes a portion positioned over the counter electrode which corresponds to a silicone domain.
  • FIG. 2D depicts a cross-sectional exploded view of a sensor head of the present invention wherein an active enzyme of the immobilized enzyme domain is positioned only over the working electrode.
  • FIG. 2E depicts a cross-sectional exploded view of a sensor head of the present invention wherein the enzyme positioned over the counter electrode has been inactivated.
  • FIG. 2F depicts a cross-sectional exploded view of a sensor head of the present invention wherein the membrane region containing immobilized enzyme is positioned only over the working electrode.
  • FIG. 3 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit at approximately 0.75 hours wherein the sensor current output reaches 2.50 nA.
  • FIG. 4 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit after 0.5 hours wherein the sensor current output reaches 0.50 nA.
  • FIG. 5 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage is maintained above the electronic circuitry limit.
  • FIG. 6A shows a schematic representation of a cylindrical analyte measuring device including a sensor head according to the present invention.
  • FIG. 6B is an exploded view of the sensor head of the device shown in FIG. 6A.
  • FIG. 7 Graphical representation of the function of a device of the present invention utilizing the multi-region membrane architecture of FIG. 2B in vitro at 400 mg/dL glucose.
  • FIG. 8 depicts a cross-sectional exploded view of the electrode and membrane regions of a prior sensor device where the electrochemical reactive surface of the counter electrode is substantially equal to the surface area of the working electrode.
  • FIG. 9 Graphical representation of the counter electrode voltage as a function of oxygen concentration at 400 mg/dL glucose for sensor devices including the membrane shown in FIG. 8.
  • the sensor heads, devices and methods of the present invention may be used to determine the level of glucose or other analytes in a host.
  • the level of glucose is a particularly important measurement for individuals having diabetes in that effective treatment depends on the accuracy of this measurement.
  • the present invention increases the effectiveness of counter electrode function by a method that does not depend on increasing the local concentration of oxygen.
  • the counter electrode has an electrochemical reactive surface area greater than twice the surface area of the working electrode thereby substantially increasing the electrodes ability to utilize oxygen as a substrate. Further enhancement of the counter electrode's activity may be achieved if the electrode were made of gold.
  • the counter electrode has a textured surface, with surface topography that increases the surface area of the electrode while the diameter of the electrode remains constant.
  • the proximity of the glucose oxidase enzyme to the counter electrode may be decreased. Since the enzyme depletes oxygen locally, the counter electrode would best be situated at a location distant from the enzyme.
  • the membrane could be covered with an additional domain where glucose is selectively blocked from the area over the counter electrode.
  • the present invention reduces the potential for electrode poisoning by positioning all electrodes underneath a multi-region membrane so that there is control of the species reaching the electrode surfaces. These membranes allow passage of dissolved oxygen to support the counter electrode reactions at reasonable negative potentials while rejecting larger molecules which when reduced would coat the surface of the counter electrode eventually leading to cascade failure.
  • the positioning of the counter electrode underneath the membrane assures that all currents are passing through the same conductive media, thereby reducing voltage losses due to membrane or solution resistance.
  • the counter electrode will be able to collect enough species for the balancing current while minimizing the need to move towards negative potential extremes.
  • the description that follows is primarily directed at glucose monitoring sensor heads, devices and methods for their use, the sensor heads, devices and methods of the present invention are not limited to glucose measurement. Rather, the devices and methods may be applied to detect and quantitate other analytes present in biological fluids (including, but not limited to, amino acids and lactate), especially those analytes that are substrates for oxidase enzymes [see, e.g., U.S. Pat. No. 4,703,756 to Gough et al., hereby incorporated by reference].
  • FBC foreign body capsule
  • the teachings of the present invention recognize that FBC formation is the dominant event surrounding long-term implantation of any sensor and must be managed to support, rather than hinder or block, sensor performance. It has been observed that during the early periods following implantation of an analyte sensing device, particularly a glucose sensing device, that glucose sensors function well. However, after a few days to two or more weeks of implantation, these device lose their function.
  • the present invention contemplates the use of particular biointerface membrane architectures that interfere with barrier cell layer formation on the membrane's surface.
  • the present invention also contemplates the use of these membranes with a variety of implantable devices (e.g. analyte measuring devices particularly glucose measuring devices).
  • the body is made of a non-conductive material such as ceramic, glass, or polymer.
  • the sensor head interface region may include several different layers and/or membranes that cover and protect the electrodes of an implantable analyte-measuring device.
  • the characteristics of these layers and/or membranes are now discussed in more detail.
  • the layers and/or membranes prevent direct contact of the biological fluid sample with the electrodes, while permitting selected substances (e.g., analytes) of the fluid to pass therethrough for reaction in an enzyme rich domain with subsequent electrochemical reaction of formed products at the electrodes.
  • the multi-region membrane is constructed of two or more regions.
  • the multi-region membrane may be provided in a number of different architectures.
  • the multi-region membrane includes a first region distant from the electrochemically reactive surfaces, a second region less distant from the electrochemically reactive surfaces and a third region adjacent to the electrochemically reactive surfaces.
  • the first region includes a cell disruptive domain distant from the electrochemically reactive surfaces and a cell impermeable domain less distant from the electrochemically reactive surfaces.
  • the second region is a glucose exclusion domain and the third region includes a resistance domain distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme domain and a hydrogel domain adjacent to the electrochemically reactive surfaces.
  • the multi-region membrane includes a first region distant from the electrochemically reactive surfaces and a further region less distant from the electrochemically reactive surfaces.
  • the first region includes a cell disruptive domain and a cell impermeable domain as described above.
  • the “further region” includes a resistance domain, immobilized enzyme domain, interference domain, and hydrogel domain and serves as the equivalent of the “third region” described above.
  • the multi-region membrane further includes an oxygen antenna domain. Each of these domains will now be described in further detail.
  • the domain of the multi-region membrane positioned most distal to the electrochemically reactive surfaces corresponds to the cell disruptive domain.
  • This domain includes a material that supports tissue in-growth and may be vascularized.
  • the cell disruptive domain prevents formation of the barrier cell layer on the surface of the membrane, which as described above, blocks the transport of glucose into the sensor device.
  • a useful cell disruptive domain is described in a U.S. application entitled “Membrane for use with Implantable Devices” which was filed on the same day as the present application.
  • the cell disruptive domain may be composed of an open-cell configuration having cavities and solid portions. Cells may enter into the cavities, however, they can not travel through or wholly exist within the solid portions. The cavities allow most substances to pass through, including, e.g., macrophages.
  • the open-cell configuration yields a co-continuous solid domain that contains greater than one cavity in three dimensions substantially throughout the entirety of the membrane.
  • the cavities and cavity interconnections may be formed in layers having different cavity dimensions.
  • a linear line can be used to define a dimension across a cavity or solid portion the length of which is the distance between two points lying at the interface of the cavity and solid portion.
  • a substantial number of the cavities are not less than 20 microns in the shortest dimension and not more than 1000 microns in the longest dimension.
  • a substantial number of the cavities are not less than 25 microns in the shortest dimension and not more than 500 microns in the longest dimension.
  • the solid portion has not less than 5 microns in a substantial number of the shortest dimensions and not more than 2000 microns in a substantial number of the longest dimensions.
  • the solid portion is not less than 10 microns in a substantial number of the shortest dimensions and not more than 1000 microns in a substantial number of the longest dimensions and most preferably, not less than 10 microns in a substantial number of the shortest dimensions and not more than 400 microns in a substantial number of the longest dimensions.
  • the solid portion may be made of polytetrafluoroethylene or polyethylene-cotetrafluoroethylene, for example.
  • the solid portion includes polyurethanes or block copolymers and, most preferably, includes silicone.
  • the non-woven fibers may be greater than 5 microns in the shortest dimension.
  • the non-woven fibers are about 10 microns in the shortest dimension and most preferably, the non-woven fibers are greater than or equal to 10 microns in the shortest dimension.
  • the non-woven fibers may be constructed of polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones, and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers (block copolymers are discussed in U.S. Pat. Nos. 4,803,243 and 4,686,044, hereby incorporated by reference).
  • the non-woven fibers are comprised of polyolefins or polyester or polycarbonates or polytetrafluoroethylene.
  • a subset of the cell disruptive domain is the oxygen antenna domain.
  • This domain can act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane.
  • This domain may be composed of a material such as silicone, that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains.
  • this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function.
  • this domain is composed of silicone and has a thickness of about 100 microns
  • the thickness of the cell disruptive domain is usually not less than about 20 microns and not more than about 2000 microns.
  • the cell impermeable of the first region is positioned less distal to the electrochemically reactive surfaces than the cell disruptive domain of the same region.
  • This domain is impermeable to host cells, such as macrophages.
  • Cell impermeable domains are described in U.S. Pat. No. 6,001,067, herein incorporated by reference, and in copending, commonly owned U.S. application entitled “Membrane for use with Implantable Devices”, Ser. No. ______, filed on even date herewith.
  • the inflammatory response that initiates and sustains a FBC is associated with disadvantages in the practice of sensing analytes. Inflammation is associated with invasion of inflammatory response cells (e.g.
  • tissue macrophages which have the ability to overgrow at the interface and form barrier cell layers, which may block transport of glucose across the biointerface membrane. These inflammatory cells may also biodegrade many artificial biomaterials (some of which were, until recently, considered nonbiodegradable).
  • tissue macrophages When activated by a foreign body, tissue macrophages degranulate, releasing from their cytoplasmic myeloperoxidase system hypochlorite (bleach) and other oxidative species. Hypochlorite and other oxidative species are known to break down a variety of polymers, including ether based polyurethanes, by a phenomenon referred to as environmental stress cracking.
  • polycarbonate based polyurethanes are believed to be resistant to environmental stress cracking and have been termed biodurable.
  • biodurable because hypochlorite and other oxidizing species are short-lived chemical species in vivo, biodegradation will not occur if macrophages are kept a sufficient distance from the enzyme active membrane.
  • the present invention contemplates the use of cell impermeable biomaterials of a few microns thickness or more (i.e., a cell impermeable domain) in most of its membrane architectures.
  • This domain of the biointerface membrane is permeable to oxygen and may or may not be permeable to glucose and is constructed of biodurable materials (e.g. for period of several years in vivo) that are impermeable by host cells (e.g. macrophages) such as for example polymer blends of polycarbonate based polyurethane and PVP.
  • the thickness of the cell impermeable domain is not less than about 10 microns and not more than about 100 microns.
  • the glucose exclusion domain includes a thin, hydrophobic membrane that is non-swellable and blocks diffusion of glucose while being permeable to oxygen.
  • the glucose exclusion domain serves to allow analytes and other substances that are to be measured or utilized by the sensor to pass through, while preventing passage of other substances.
  • the glucose exclusion domain is constructed of a material such as, for example, silicone.
  • the glucose exclusion domain has a preferred thickness not less than about 130 microns, more preferably not less than about 5 and not more than about 75 microns and most preferably not less than 15 microns and not more than about 50 microns.
  • the “third region” or “further region” of the multi-region membrane includes a resistance domain.
  • the resistance domain is located more distal to the electrochemically reactive surfaces relative to other domains in this region.
  • the resistance domain controls the flux of oxygen and glucose to the underlying enzyme domain.
  • glucose There is a molar excess of glucose relative to the amount of oxygen in samples of blood. Indeed, for every free oxygen molecule in extra-cellular fluid, there are typically more than 100 glucose molecules present [Updike et al., Diabetes Care 5:207-21(1982)].
  • an immobilized enzyme-based sensor using oxygen (O 2 ) as cofactor must be supplied with oxygen in non-rate-limiting excess in order to respond linearly to changes in glucose concentration, while not responding to changes in oxygen tension. More specifically, when a glucose-monitoring reaction is oxygen-limited, linearity is not achieved above minimal concentrations of glucose. Without a semipermeable membrane over the enzyme domain, linear response to glucose levels can be obtained only up to about 40 mg/dL; however, in a clinical setting, linear response to glucose levels are desirable up to at least about 500 mg/dL.
  • the resistance domain includes a semipermeable membrane that controls the flux of oxygen and glucose to the underlying enzyme domain (i.e., limits the flux of glucose), rendering the necessary supply of oxygen in non-rate-limiting excess.
  • the devices of the present invention contemplate resistance domains including polymer membranes with oxygen-to-glucose permeability ratios of approximately 200: 1; as a result, one-dimensional reactant diffusion is adequate to provide excess oxygen at all reasonable glucose and oxygen concentrations found in the subcutaneous matrix [Rhodes et al., Anal. Chem., 66:1520-1529 (1994)].
  • the resistance domain is constructed of a polyurethane urea/polyurethane-block-polyethylene glycol blend and has a thickness of not more than about 45 microns, more preferably not less than about 15 microns, and not more than about 40 microns and, most preferably, not less than about 20 microns, and not more than about 35 microns.
  • the resistance domain When the resistance domain is combined with the cell-impermeable domain, it is the immobilized enzyme domain which corresponds to the outermost domain of the “third region” or “further region”, i.e. it is located more distal to the electrochemically reactive surfaces as compared to the other domains in this region.
  • the enzyme domain includes glucose oxidase.
  • the present invention contemplates the use of a domain impregnated with other oxidases, e.g., galactose oxidase or uricase, For an enzyme-based electrochemical glucose sensor to perform well, the sensor's response must neither be limited by enzyme activity nor cofactor concentration. Because enzymes, including glucose oxidase, are subject to deactivation as a function of ambient conditions, this behavior needs to be accounted for in constructing sensors for long-term use.
  • the domain is constructed of aqueous dispersions of colloidal polyurethane polymers including the enzyme.
  • the coating has a thickness of not less than about 2.5 microns and not more than about 12.5 microns, preferably about 6.0 microns.
  • the interference domain in the “third region” or “further region” is located less distant from the electrochemically reactive surfaces than the immobilized enzyme domain in this same region. It includes a thin membrane that can limit diffusion of molecular weight species greater than 34 kD.
  • the interference domain serves to allow analytes and other substances that are to be measured by the electrodes to pass through, while preventing passage of other substances, including potentially interfering substances.
  • the interference domain is preferably constructed of a polyurethane.
  • the interference domain has a preferred thickness of not more than about 5 microns, more preferably not less than about 0.1 microns, and not more than about 5 microns and, most preferably, not less than about 0.5 microns, and not more than about 3 microns.
  • the hydrogel domain is located adjacent to the electrochemically reactive surfaces.
  • the hydrogel domain includes a semipermeable coating that maintains hydrophilicity at the electrode region of the sensor interface.
  • the hydrogel domain enhances the stability of the interference domain of the present invention by protecting and supporting the membrane that makes up the interference domain. Furthermore, the hydrogel domain assists in stabilizing operation of the device by overcoming electrode start-up problems and drifting problems caused by inadequate electrolyte.
  • the buffered electrolyte solution contained in the hydrogel domain also protects against pH-mediated damage that may result from the formation of a large pH gradient between the hydrophobic interference domain and the electrode (or electrodes) due to the electrochemical activity of the electrode(s).
  • the hydrogel domain includes a flexible, water-swellable, substantially solid gel-like film having a “dry film” thickness of not less than about 2.5 microns and not more than about 12.5 microns; preferably, the thickness is about 6.0 microns.
  • “Dry film” thickness refers to the thickness of a cured film cast from a coating formulation onto the surface of the membrane by standard coating techniques
  • Suitable hydrogel domains are formed of a curable copolymer of a urethane polymer and a hydrophilic film-forming polymer.
  • Particularly preferred coatings are formed of a polyurethane polymer having anionic carboxylate functional groups and non-ionic hydrophilic polyether segments, which is crosslinked in the present of polyvinylpyrrolidone and cured at a moderate temperature of about 50° C.
  • the electrolyte phase is a free-fluid phase including a solution containing at least one compound, usually a soluble chloride salt, that conducts electric current.
  • the electrolyte phase flows over the electrodes and is in contact with the hydrogel domain.
  • the devices of the present invention contemplate the use of any suitable electrolyte solution, including standard, commercially available solutions.
  • the electrolyte phase should have the same or less osmotic pressure than the sample being analyzed.
  • the electrolyte phase includes normal saline.
  • first region 33 is permeable to oxygen and glucose and includes a cell disruptive domain distant from the electrodes and a cell impermeable domain less distant from the electrodes.
  • the second region 31 is permeable to oxygen and includes a glucose exclusion domain and region three 32 includes a resistance domain, distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme and a hydrogel domain adjacent to the electrochemically reactive surfaces.
  • the multi-region membrane is positioned over the sensor interface 30 of the non-conductive body 10 , covering the working electrode 21 , the reference electrode 20 and the counter electrode 22 .
  • the electrodes are brazed to the sensor head and back filled with epoxy 28 .
  • the glucose exclusion domain has been positioned over the electrochemically reactive surfaces such that it does not cover the working electrode 21 .
  • a hole 35 has been created in the second region 31 and positioned directly above the working electrode 21 .
  • the glucose-blocking domain is made of a material that allows sufficient O 2 to pass to the counter electrode.
  • the glucose-blocking domain may be made of a variety of materials such as silicone or silicone containing copolymers.
  • the glucose-blocking domain is made of silicone.
  • the multi-region membrane is shown as being constructed of two regions: a first region 33 which includes a cell disruptive domain and a cell impermeable domain; and a further region 32 .
  • Region 32 is defined herein as including an enzyme immobilized domain, interference domain, and hydrogel domain and may also include a resistance domain.
  • Region 32 is referred to as the “third region” in embodiments where the multi-region membrane includes three regions.
  • a silicone domain plug 36 positioned over the counter electrode 22 in order to eliminate the consumption of O 2 above the counter electrode by the oxidation of glucose with glucose oxidase.
  • the enzyme immobilized domain can be fabricated as previously described, then a hole punched into the domain.
  • the silicone domain plug 36 may be cut to fit the hole, and then adhered into place, for example, with silicone adhesive (e.g., MED-1511, NuSil, Carpinteria, Calif.).
  • the immobilized enzyme domain of the multi-region membrane can be fabricated such that active enzyme 37 is positioned only above the working electrode 21 .
  • the immobilized enzyme domain may be prepared so that the glucose oxidase only exists above the working electrode 21 .
  • the immobilized enzyme domain coating solution can be applied as a circular region similar to the diameter of the working electrode.
  • This fabrication can be accomplished in a variety of ways such as screen printing or pad printing.
  • the enzyme domain is pad printed during the enzyme membrane fabrication with equipment as available from Pad Print Machinery of Vermont (Manchester, Vt.).
  • the immobilized enzyme of the multi-region membrane in region 32 may be deactivated 38 except for the area covering the working electrode 21 .
  • the glucose oxidase is distributed homogeneously throughout the immobilized enzyme domain.
  • the active enzyme need only reside above the working electrode. Therefore, the enzyme may be deactivated 38 above the counter 22 and reference 20 electrodes by irradiation.
  • a mask that covers the working electrode 21 such as those used for photolithography can be placed above the membrane. In this way, exposure of the masked membrane to ultraviolet light deactivates the glucose oxidase in all regions except that covered by the mask.
  • FIG. 2F shows an architecture in which the third region 32 which includes immobilized enzyme only resides over the working electrode 21 .
  • this architecture consumption of O 2 above the counter electrode 22 by the oxidation of glucose with glucose oxidase is eliminated.
  • the electrode assembly of this invention comprises a non-conductive body and three electrodes affixed within the body having electrochemically reactive surfaces at one location on the body and an electronic connection means at another location on the body and may be used in the manner commonly employed in the making of amperometric measurements.
  • a sample of the fluid being analyzed is placed in contact with a reference electrode, e.g., silver/silver-chloride, a working electrode which is preferably formed of platinum, and a counter electrode which is preferably formed of gold or platinum.
  • the electrodes are connected to a galvanometer or polarographic instrument and the current is read or recorded upon application of the desired D.C. bias voltage between the electrodes.
  • the present invention contemplates several structural architectures that effectively increase the electrochemically reactive surface of the counter electrode.
  • the diameter of wire used to create the counter electrode is at least twice the diameter of the working electrode.
  • the electrochemically reactive surface of the counter electrode be not less than about 2 and not more than about 100 times the surface area of the working electrode. More preferably, the electrochemically reactive surface of the counter electrode is not less than about 2 and not more than about 50, not less than about 2 and not more than about 25 or not less than about 2 and not more than about 10 times the surface area of the working electrode. In another embodiment, the electrochemically reactive surface is larger that the wire connecting this surface to the sensor head.
  • the electrode could have a cross-sectional view that resembles a “T”.
  • the present invention contemplates a variety of configurations of the electrode head that would provide a large reactive surface, while maintaining a relatively narrow connecting wire.
  • Such configurations could be prepared by micromachining with techniques such as reactive ion etching, wet chemical etching and focused ion beam machining as available from Norsam Technologies (Santa Fe, N. Mex.).
  • the diameter of the counter electrode is substantially similar to the working electrode; however, the surface of the counter electrode has been modified to increase the surface area such that it has at least twice the surface area of the working electrode. More specifically the counter electrodes surface may be textured, effectively increasing its surface area without significantly increasing its diameter. This may be accomplished by a variety of methods known to those skilled in the art including, such as acid etching.
  • the electrochemically reactive surface may be provided in a variety of shapes and sizes (e.g. round, triangular, square or free form) provided that it is at least twice the surface area of the working electrode.
  • the electrodes are prepared from a 0.020′′ diameter wire having the desired modified reactive surface.
  • the electrodes are secured inside the non-conductive body by brazing.
  • the counter electrode is preferably made of gold or platinum.
  • FIG. 6A A preferred embodiment of an analyte measuring device including a sensor head according to the present invention is shown in FIG. 6A.
  • a ceramic body 1 and ceramic head 10 houses the sensor electronics that include a circuit board 2 , a microprocessor 3 , a battery 4 , and an antenna 5 . Furthermore, the ceramic body 1 and head 10 possess a matching taper joint 6 that is sealed with epoxy. The electrodes are subsequently connected to the circuit board via a socket 8 .
  • three electrodes protrude through the ceramic head 10 , a platinum working electrode 21 , a platinum counter electrode 22 and a silver/silver chloride reference electrode 20 .
  • Each of these is hermetically brazed 26 to the ceramic head 10 and further secured with epoxy 28 .
  • the sensing region 24 is covered with a multi-region membrane described above and the ceramic head 10 contains a groove 29 so that the membrane may be affixed into place with an o-ring.
  • Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) ⁇ M (micromolar); N (Normal); mol (moles); mmol (millimoles); ⁇ mol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); ⁇ g (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); ⁇ L (microliters); cm (centimeters); mm (millimeters); um (micrometers); nm (nanometers); h and hr (hours); min.
  • the cell disruptive domain may be an ePTFE filtration membrane and the cell impermeable domain may then be coated on this domain layer.
  • the cell impermeable domain was prepared by placing approximately 706 gm of dimethylacetamide (DMAC) into a 3L stainless steel bowl to which a polycarbonateurethane solution (1325 g, Chronoflex AR 25% solids in DMAC and 5100 cp) and polyvinylpyrrolidone (125 g, Plasdone K-90D) are added. The bowl was then fitted to a planetary mixer with a paddle type blade and the contents were stirred for 1 hour at room temperature. This solution was then coated on the cell disruptive domain by knife edge drawn at a gap of 0.006′′ and dried at 60° C. for 24 hours.
  • DMAC dimethylacetamide
  • the polyurethane polyvinylpyrrolidone solution prepared above can be coated onto a PET release liner using a knife over roll coating machine. This material is then dried at 305° F. for approximately 2 minutes.
  • the ePTFE membrane is immersed in 50:50 (w/v) mixture of THF/DMAC and then placed atop the coated polyurethane polyvinylpyrrolidone material. Light pressure atop the assembly intimately embeds the ePTFE into the polyurethane polyvinylpyrrolidone. The membrane is then dried at 60° C. for 24 hours.
  • the “third region” or “further region” includes a resistance domain, an immobilized enzyme domain, an interference domain and an hydrogel domain.
  • the resistance domain was prepared by placing approximately 281 gm of dimethylacetamide into a 3 L stainless steel bowl to which a solution of polyetherurethaneurea (344 gm of Chronothane H, 29,750 cp at 25% solids in DMAC). To this mixture was added another polyetherurethaneurea (312 gm, Chronothane 1020, 6275 cp at 25% solids in DMAC.) The bowl was fitted to a planetary mixer with a paddle type blade and the contents were stirred for 30 minutes at room temperature.
  • the resistance domain coating solutions produced is coated onto a PET release liner (Douglas Hansen Co., Inc. Minneapolis, Minn.) using a knife over roll set at a 0.012′′ gap. This film is then dried at 305° F. The final film is approximately 0.0015′′ thick.
  • the immobilized enzyme domain was prepared by placing 304 gm polyurethane latex (Bayhydrol 140AQ, Bayer, Pittsburgh, Pa.) into a 3 L stainless steel bowl to which 51 gm of pyrogen free water and 5.85 gm of glucose oxidase (Sigma type VII from Aspergillus niger ) is added. The bowl was then fitted to a planetary mixer with a whisk type blade and the mixture was stirred for 15 minutes. Approximately 24 hr prior to coating a solution of glutaraldehyde (15.4 mL of a 2.5% solution in pyrogen free water) and 14 mL of pyrogen free water was added to the mixture. The solution was mixed by inverting a capped glass bottle by hand for about 3 minutes at room temperature. This mixture was then coated over the resistance domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C.
  • the interference domain was prepared by placing 187 gm of tetrahydrofuran into a 500 mL glass bottle to which an 18.7 gm aliphatic polyetherurethane (Tecoflex SG-85A, Thermedics Inc., Woburn, Mass.) was added. The bottle was placed onto a roller at approximately 3 rpm within an oven set at 37° C. The mixture was allowed to roll for 24 hr. This mixture was coated over the dried enzyme domain using a flexible knife and dried above room temperature preferably at about 50° C.
  • the hydrogel domain was prepared by placing 388 gm of polyurethane latex (Bayhydrol 123, Bayer, Pittsburgh, Pa. in a 3 L stainless steel bowl to which 125 gm of pyrogen free water and 12.5 gm polyvinylpyrrolidone (Plasdone K-90D) was added. The bowl was then fitted to a planetary mixer with a paddle type blade and stirred for 1 hr at room temperature. Within 30 minutes of coating approximately 13.1 mL of carbodiimide (UCARLNK) was added and the solution was mixed by inverting a capped polyethylene jar by hand for about 3 min at room temperature. This mixture was coated over the dried interference domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C.
  • UARLNK carbodiimide
  • a glucose solution (9.4 ml of 100 mg/ml glucose in buffer) was added in order to raise the glucose concentration to 400 mg/dl within the container.
  • the sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. In this way, the sensitivity of the sensor to glucose is given as the slope of sensor output versus glucose concentration.
  • the container was then fitted with an O 2 meter (WTW, model Oxi-340) and a gas purge. A mixture of compressed air and nitrogen was used to decrease the O 2 concentration.
  • Sensor output was recorded at an ambient O 2 level, then sensor output was recorded for the following O 2 concentrations; 1 mg/L, 0.85 to 0.75 mg/L, 0.65 to 0.55 mg/L and 0.40 to 0.30 mg/L. In this way, the function of the sensor could be compared to its function at ambient O 2 .
  • region 31 shown in FIG. 2B which includes a glucose blocking domain, above all areas other than above the working electrode 21 , oxygen consumption in areas other than working electrode areas is limited. In contrast, by eliminating region 31 in the control devices, less overall oxygen becomes available to electrode surfaces due to the increased availability of glucose.
  • the devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12 ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A glucose value was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L.
  • FIG. 7 graphically represents the formation of a device of the present invention utilizing the multi-region membrane architecture in FIG. 2B in vitro.
  • the data is expressed in percent Device Function at 400 mg/dL glucose vs. oxygen concentration.
  • the percent function of the device is simply the device output at any given oxygen concentration divided by that device's output at ambient oxygen.
  • inventive sensor devices containing the silicone membrane have better function at lower oxygen concentrations relative to both the control devices and the devices containing the polyurethane membrane. For example, at an oxygen concentration of about 0.5 mg/L, devices containing the silicone membrane are providing 100% output as compared to 80% output for the control devices.
  • FIG. 8 An in vitro testing procedure used in this example was similar to that described in Example 2.
  • Six devices similar to the one shown in FIGS. 6A and 6B were fitted with the multi-region membrane described herein. Two of these tested devices were comparative devices that possessed Pt counter electrodes having a 0.020′′ diameter; this diameter provided for an electrochemically reactive surface of the counter electrode which was substantially equal to the surface area of the working electrode, as schematically shown in FIG. 8.
  • the electrode-membrane region includes two distinct regions, the compositions and functions of which have already been described.
  • Region 32 includes an immobilized enzyme.
  • Region 33 includes a cell disruptive domain and a cell impermeable domain.
  • Electrodes 21 (working), 20 (reference) and 22 (counter) are in contact with an electrolyte phase 30 , a free-flowing phase.
  • Two other tested devices possessed Pt counter electrodes having a 0.060′′ diameter.
  • two additional devices possessed Au counter electrodes having a 0.060′′ diameter.
  • the 0.006′′ diameter devices provided for an electrochemically reactive surface of the counter electrode which was approximately six times the surface area of the working electrode.
  • Each of the devices including counter electrodes of 0.060′′ diameter include a multi-region membrane above the electrode region which is similar to that shown in FIG. 8.
  • the devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A counter electrode voltage was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L.
  • FIG. 9 graphically presents the counter electrode voltage as a function of oxygen concentration and 400 mg/dL glucose. This figure demonstrates that both the large Pt and Au counter electrode devices do not begin to reach the circuitry limits at low oxygen concentrations. Therefore, increased performance and accuracy can be obtained from a counter electrode that has an electrochemical reactive surface greater than the surface area of the working electrode.

Abstract

The present invention provides a sensor head for use in an implantable device that measures the concentration of an analyte in a biological fluid which includes: a non-conductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode. In addition, the present invention provides an implantable device including at least one of the sensor heads of the invention and methods of monitoring glucose levels in a host utilizing the implantable device of the invention.

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to novel sensor heads utilized with implantable devices, devices including these sensor heads and methods for determining analyte levels using these implantable devices. More particularly, the invention relates to sensor heads, implantable devices including these sensor heads and methods for monitoring glucose levels in a biological fluid using these devices. [0001]
  • BACKGROUND OF THE INVENTION
  • Amperometric electrochemical sensors require a counter electrode to balance the current generated by the species being measured at the working electrode. In the case of a glucose oxidase based glucose sensor, the species being measured at the working electrode is H[0002] 2O2. Glucose oxidase catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate according to the following reaction:
  • Glucose+O2→Gluconate+H2O2
  • Because for each glucose molecule metabolized, there is a proportional change in the product H[0003] 2O2, one can monitor the change in H2O2 to determine glucose concentration. Oxidation of H2O2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H2O2, or other reducible species at the counter electrode. In vivo glucose concentration may vary from about one hundred times or more that of the oxygen concentration. Consequently, oxygen becomes a limiting reactant in the electrochemical reaction and when insufficient oxygen is provided to the sensor, the sensor will be unable to accurately measure glucose concentration. Those skilled in the art have come to interpret oxygen limitations resulting in depressed function as being a problem of availability of oxygen to the enzyme.
  • As shown in FIG. 1, the [0004] sensor head 10 includes a working electrode 21 (anode), counter electrode 22 (cathode), and reference electrode 20 which are affixed to the head by both brazing 26 the electrode metal to the ceramic and potting with epoxy 28. The working electrode 21 (anode) and counter-electrode 22 (cathode) of a glucose oxidase-based glucose sensor head 10 require oxygen in different capacities. Prior art teaches an enzyme-containing membrane that resides above an amperometric electrochemical sensor. In FIG. 1, region 32 includes an immobilized enzyme, i.e. glucose oxidase. Within the enzyme layer above the working electrode 21, oxygen is required for the production of H2O2 from glucose. The H2O2 produced from the glucose oxidase reaction further reacts at surface 21 a of working electrode 21 and produces two electrons. The products of this reaction are two protons (2H+), two electrons (2e), and one oxygen molecule (O2) (Fraser, D. M. “An Introduction to In Vivo Biosensing: Progress and problems.” In “Biosensors and the Body,” D. M. Fraser, ed., 1997, pp. 1-56 John Wiley and Sons, New York). In theory, the oxygen concentration near the working electrode 21, which is consumed during the glucose oxidase reaction, is replenished by the second reaction at the working electrode. Therefore, the net consumption of oxygen is zero. In practice, neither all of the H2O2 produced by the enzyme diffuses to the working electrode surface nor does all of the oxygen produced at the electrode diffuse to the enzyme domain.
  • With further reference to FIG. 1, the [0005] counter electrode 22 utilizes oxygen as an electron acceptor. The most likely reducible species for this system are oxygen or enzyme generated peroxide (Fraser, D. M. supra). There are two main pathways by which oxygen may be consumed at the counter electrode 22. These are a four-electron pathway to produce hydroxide and a two-electron pathway to produce hydrogen peroxide. The two-electron pathway is shown in FIG. 1. Oxygen is further consumed above the counter electrode by the glucose oxidase in region 32. Due to the oxygen consumption by both the enzyme and the counter electrode, there is a net consumption of oxygen at the surface 22 a of the counter electrode. Theoretically, in the domain of the working electrode there is significantly less net loss of oxygen than in the region of the counter electrode. In addition, there is a close correlation between the ability of the counter electrode to maintain current balance and sensor function. Taken together, it appears that counter electrode function becomes limited before the enzyme reaction becomes limited when oxygen concentration is lowered.
  • Those practicing in the field of implantable glucose oxidase sensors have focused on improving sensor function by increasing the local concentration of oxygen in the region of the working electrode. (Fraser, D. M. supra). [0006]
  • We have observed that in some cases, loss of glucose oxidase sensor function may not be due to a limitation of oxygen in the enzyme layer near the working electrode, but may instead be due to a limitation of oxygen at the counter electrode. In the presence of increasing glucose concentrations, a higher peroxide concentration results, thereby increasing the current at the working electrode. When this occurs, the counter electrode limitation begins to manifest itself as this electrode moves to increasingly negative voltages in the search for reducible species. When a sufficient supply of reducible species, such as oxygen, are not available, the counter electrode voltage reaches a circuitry limit of −0.6V resulting in compromised sensor function (see FIG. 3). [0007]
  • FIG. 3 shows simultaneous measurement of counter-electrode voltage and sensor output to glucose levels from a glucose sensor implanted subcutaneously in a canine host. It can be observed that as glucose levels increase, the counter electrode voltage decreases. When the counter electrode voltage reaches −0.6V, the signal to noise ratio increases significantly. This reduces the accuracy of the device. FIG. 4 shows a further example of another glucose sensor in which the counter-electrode reaches the circuitry limit. Again, once the counter electrode reaches −0.6V, the sensitivity and/or signal to noise ratio of the device is compromised. In both of these examples, glucose levels reached nearly 300 mg/dl. However, in FIG. 3 the sensor showed a greater than three-fold higher current output than the sensor in FIG. 4. These data suggest that there may be a limitation of reducible species at the counter electrode, which may limit the sensitivity of the device as the glucose levels increase. In contrast, FIG. 5 shows a glucose sensor in which the counter electrode voltage did not reach −0.6V. In FIG. 5 it can be observed that the sensor was able to maintain a current balance between the working and counter electrodes, thereby enabling accurate measurements throughout the course of the experiment. The results shown in FIGS. 3, 4 and [0008] 5 led the present inventors to postulate that by keeping the counter electrode from reaching the circuitry limit, one could maintain sensitivity and accuracy of the device.
  • Two approaches have been utilized by others to relieve the counter electrode limitation described above. The first approach involves the widening of the potential range over which the counter electrode can move in the negative direction to avoid reaching circuitry limitations. Unfortunately, this approach increases undesirable products that are produced at lower potentials. One such product, hydrogen, may form at the counter electrode, which may then diffuse back to the working electrode. This may contribute to additional current resulting in erroneously high glucose concentration readings. Additionally, at these increasingly negative potentials, the probability of passivating or poisoning the counter electrode greatly increases. This effectively reduces the counter electrode surface area requiring a higher current density at the remaining area to maintain current balance. Furthermore, increased current load increases the negative potentials eventually resulting in electrode failure. [0009]
  • The second approach is utilizing the metal case of the device as a counter electrode (see U.S. Pat. No. 4,671,288, Gough or U.S. Pat. No. 5,914,026, Blubaugh). This provides an initial excess in surface area which is expected to serve the current balancing needs of the device over its lifetime. However, when the counter electrode reaction is a reduction reaction, as in Blubaugh, the normally present metal oxide layer will be reduced to bare metal over time leaving the surface subject to corrosion, poisoning, and eventual cascade failure. This problem is magnified when considering the various constituents of the body fluid that the metal casing is exposed to during in vivo use. To date, there has been no demonstration of long-term performance of such a device with this counter electrode geometry. [0010]
  • Consequently, there is a need for a sensor that will provide accurate analyte measurements, that reduces the potential for cascade failure due to increasing negative potentials, corrosion and poisoning, and that will function effectively and efficiently in low oxygen concentration environments. [0011]
  • SUMMARY OF THE INVENTION
  • In one aspect of the present invention, a sensor head for use in a device that measures the concentration of an analyte in a biological fluid is provided that includes a nonconductive body; a working electrode, a reference electrode and a counter electrode, wherein the electrodes pass through the non-conductive body forming an electrochemically reactive surface at one location on the body and forming an electronic connection at another location on the body, and further wherein the electrochemically reactive surface of the counter electrode is greater than the surface area of the working electrode; and a multi-region membrane affixed to the nonconductive body and covering the working electrode, reference electrode and counter electrode. [0012]
  • In another aspect of the present invention, a sensor head for use in an implantable analyte measuring device is provided which includes the same sensor head components as those described above. [0013]
  • The sensor heads of the present invention include a multi-region membrane that controls the number of species that are able to reach the surface of the electrodes. In particular, such a membrane allows the passage of desired substrate molecules (e.g. oxygen and glucose) and rejects other larger molecules that may interfere with accurate detection of an analyte. The sensor heads of the present invention also provide a larger counter electrode reactive surface that balances the current between the working and counter electrodes, thereby minimizing negative potential extremes that may interfere with accurate analyte detection. [0014]
  • In another aspect of the present invention, an implantable device for measuring an analyte in a biological fluid is provided including at least one of the sensor heads described above. In still another aspect of the present invention, a method of monitoring glucose levels is disclosed which includes the steps of providing a host, and an implantable device as provided above and implanting the device in the host. [0015]
  • Further encompassed by the invention is a method of measuring glucose in a biological fluid including the steps of providing a host and a implantable device described above, which includes a sensor head capable of accurate continuous glucose sensing; and implanting the device in the host. [0016]
  • The sensor head, membrane architectures, devices and methods of the present invention allow for the collection of continuous information regarding desired analyte levels (e.g. glucose). Such continuous information enables the determination of trends in glucose levels, which can be extremely important in the management of diabetic patients. [0017]
  • Definitions [0018]
  • In order to facilitate an understanding of the present invention, a number of terms are defined below. [0019]
  • The term “sensor head” refers to the region of a monitoring device responsible for the detection of a particular analyte. The sensor head generally comprises a non-conductive body, a working electrode (anode), a reference electrode and a counter electrode (cathode) passing through and secured within the body forming an electrochemically reactive surface at one location on the body and an electronic connective means at another location on the body, and a multi-region membrane affixed to the body and covering the electrochemically reactive surface. The counter electrode has a greater electrochemically reactive surface area than the working electrode. During general operation of the sensor a biological sample (e.g., blood or interstitial fluid) or a portion thereof contacts (directly or after passage through one or more membranes or domains) an enzyme (e.g., glucose oxidase); the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the analyte (e.g. glucose) level in the biological sample. In preferred embodiments of the present invention, the multi-region membrane further comprises an enzyme domain, and an electrolyte phase (i.e., a free-flowing liquid phase comprising an electrolyte-containing fluid described further below). [0020]
  • The term “analyte” refers to a substance or chemical constituent in a biological fluid (e.g., blood, interstitial fluid, cerebral spinal fluid, lymph fluid or urine) that can be analyzed. A preferred analyte for measurement by the sensor heads, devices and methods of the present invention is glucose. [0021]
  • The term “electrochemically reactive surface” refers to the surface of an electrode where an electrochemical reaction takes place. In the case of the working electrode, the hydrogen peroxide produced by the enzyme catalyzed reaction of the analyte being detected reacts creating a measurable electronic current (e.g. detection of glucose analyte utilizing glucose oxidase produces H[0022] 2O2 peroxide as a by product, H2O2 reacts with the surface of the working electrode producing two protons (2H+), two electrons (2e) and one molecule of oxygen (O2) which produces the electronic current being detected). In the case of the counter electrode, a reducible species, e.g. O2 is reduced at the electrode surface in order to balance the current being generated by the working electrode.
  • The term “electronic connection” refers to any electronic connection known to those in the art that may be utilized to interface the sensor head electrodes with the electronic circuitry of a device such as mechanical (e.g., pin and socket) or soldered. [0023]
  • The term “domain” refers to regions of the membrane of the present invention that may be layers, uniform or non-uniform gradients (e.g. anisotropic) or provided as portions of the membrane. [0024]
  • The term “multi-region membrane” refers to a permeable membrane that may be comprised of two or more domains and constructed of biomaterials of a few microns thickness or more which are permeable to oxygen and may or may not be permeable to glucose. One of the the membranes may be placed over the sensor body to keep host cells (e.g., macrophages) from gaining proximity to, and thereby damaging, the enzyme membrane or forming a barrier cell layer and interfering with the transport of analyte across the tissue-device interface. [0025]
  • The phrase “distant from” refers to the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a biological fluid measuring device comprise a multi-region membrane that may be comprised of a number of domains. If the electrodes of the sensor head are deemed to be the point of reference, and one of the multi-region membrane domains is positioned farther from the electrodes, than that domain is distant from the electrodes. [0026]
  • The term “oxygen antenna domain” and the like refers to a domain composed of a material that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane. The domain can then act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains. Thus, this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function. [0027]
  • The term “solid portions” and the like refer to a material having a structure that may or may not have an open-cell configuration but in either case prohibits whole cells from traveling through or residing within the material. [0028]
  • The term “substantial number” refers to the number of cavities or solid portions having a particular size within a domain in which greater than 50 percent of all cavities or solid portions are of the specified size, preferably greater than 75 percent and most preferably greater than 90 percent of the cavities or solid portions have the specified size. [0029]
  • The term “co-continuous” and the like refers to a solid portion wherein an unbroken curved line in three dimensions exists between any two points of the solid portion. [0030]
  • The term “host” refers to both humans and animals. [0031]
  • The term “accurately” means, for example, 90% of measured glucose values are within the “A” and “B” region of a standard Clarke error grid when the sensor measurements are compared to a standard reference measurement. It is understood that like any analytical device, calibration, calibration validation and recalibration are required for the most accurate operation of the device. [0032]
  • The phrase “continuous glucose sensing” refers to the period in which monitoring of plasma glucose concentration is continuously performed, for example, about every 10 minutes. [0033]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 Illustration of thermodynamically favored reactions at the working electrode and counter electrode at the desired voltage potentials. [0034]
  • FIG. 2A depicts a cross-sectional exploded view of a sensor head of the present invention wherein the multi-region membrane comprises three regions. [0035]
  • FIG. 2B depicts a cross-sectional exploded view of a sensor head of the present invention wherein a portion of the second membrane region does not cover the working electrode. [0036]
  • FIG. 2C depicts a cross-sectional exploded view of a sensor head of the present invention which includes two distinct regions, wherein the region adjacent the electrochemically reactive surfaces includes a portion positioned over the counter electrode which corresponds to a silicone domain. [0037]
  • FIG. 2D depicts a cross-sectional exploded view of a sensor head of the present invention wherein an active enzyme of the immobilized enzyme domain is positioned only over the working electrode. [0038]
  • FIG. 2E depicts a cross-sectional exploded view of a sensor head of the present invention wherein the enzyme positioned over the counter electrode has been inactivated. [0039]
  • FIG. 2F depicts a cross-sectional exploded view of a sensor head of the present invention wherein the membrane region containing immobilized enzyme is positioned only over the working electrode. [0040]
  • FIG. 3 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit at approximately 0.75 hours wherein the sensor current output reaches 2.50 nA. [0041]
  • FIG. 4 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage drops to the electronic circuitry limit after 0.5 hours wherein the sensor current output reaches 0.50 nA. [0042]
  • FIG. 5 Illustration of an implantable glucose sensor's ability to measure glucose concentration during an infusion study in a canine when the counter electrode voltage is maintained above the electronic circuitry limit. [0043]
  • FIG. 6A shows a schematic representation of a cylindrical analyte measuring device including a sensor head according to the present invention. [0044]
  • FIG. 6B is an exploded view of the sensor head of the device shown in FIG. 6A. [0045]
  • FIG. 7 Graphical representation of the function of a device of the present invention utilizing the multi-region membrane architecture of FIG. 2B in vitro at 400 mg/dL glucose. [0046]
  • FIG. 8 depicts a cross-sectional exploded view of the electrode and membrane regions of a prior sensor device where the electrochemical reactive surface of the counter electrode is substantially equal to the surface area of the working electrode. [0047]
  • FIG. 9 Graphical representation of the counter electrode voltage as a function of oxygen concentration at 400 mg/dL glucose for sensor devices including the membrane shown in FIG. 8.[0048]
  • DETILED DESCRIPTION OF THE INVENTION
  • In a preferred embodiment, the sensor heads, devices and methods of the present invention may be used to determine the level of glucose or other analytes in a host. The level of glucose is a particularly important measurement for individuals having diabetes in that effective treatment depends on the accuracy of this measurement. [0049]
  • The present invention increases the effectiveness of counter electrode function by a method that does not depend on increasing the local concentration of oxygen. In a preferred embodiment, the counter electrode has an electrochemical reactive surface area greater than twice the surface area of the working electrode thereby substantially increasing the electrodes ability to utilize oxygen as a substrate. Further enhancement of the counter electrode's activity may be achieved if the electrode were made of gold. In a second preferred embodiment, the counter electrode has a textured surface, with surface topography that increases the surface area of the electrode while the diameter of the electrode remains constant. In a third preferred embodiment, the proximity of the glucose oxidase enzyme to the counter electrode may be decreased. Since the enzyme depletes oxygen locally, the counter electrode would best be situated at a location distant from the enzyme. This could be achieved by depleting the enzyme from or inactivating the enzyme located in the region near and over the counter electrode by methods known to those skilled in the art such as laser ablation, or chemical ablation. Alternatively, the membrane could be covered with an additional domain where glucose is selectively blocked from the area over the counter electrode. [0050]
  • In particular, the present invention reduces the potential for electrode poisoning by positioning all electrodes underneath a multi-region membrane so that there is control of the species reaching the electrode surfaces. These membranes allow passage of dissolved oxygen to support the counter electrode reactions at reasonable negative potentials while rejecting larger molecules which when reduced would coat the surface of the counter electrode eventually leading to cascade failure. The positioning of the counter electrode underneath the membrane assures that all currents are passing through the same conductive media, thereby reducing voltage losses due to membrane or solution resistance. In addition, the counter electrode will be able to collect enough species for the balancing current while minimizing the need to move towards negative potential extremes. [0051]
  • Although the description that follows is primarily directed at glucose monitoring sensor heads, devices and methods for their use, the sensor heads, devices and methods of the present invention are not limited to glucose measurement. Rather, the devices and methods may be applied to detect and quantitate other analytes present in biological fluids (including, but not limited to, amino acids and lactate), especially those analytes that are substrates for oxidase enzymes [see, e.g., U.S. Pat. No. 4,703,756 to Gough et al., hereby incorporated by reference]. [0052]
  • I. Nature of the Foreign Body Capsule [0053]
  • Devices and probes that are implanted into subcutaneous tissue will almost always elicit a foreign body capsule (FBC) as part of the body's response to the introduction of a foreign material. Therefore, implantation of a glucose sensor results in an acute inflammatory reaction followed by building of fibrotic tissue. Ultimately, a mature FBC comprising primarily a vascular fibrous tissue forms around the device (Shanker and Greisler, Inflammation and Biomaterials in Greco R S, ed. Implantation Biology: The Host Response and Biomedical Devices, pp68-80, CRC Press (1994)). [0054]
  • In general, the formation of a FBC has precluded the collection of reliable, continuous information, reportedly because of poor vascularization (Updike, S. J. et al., “Principles of Long-term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from inside a Subcutaneous Foreign Body Capsule (FBC)” in “Biosensors and the Body,” D. M. Fraser, ed., 1997, pp. 117-38, John Wiley and Sons, New York). Thus, those skilled in the art have previously attempted to minimize FBC formation by, for example, using a short-lived needle geometry or sensor coatings to minimize the foreign body. [0055]
  • In contrast to the prior art, the teachings of the present invention recognize that FBC formation is the dominant event surrounding long-term implantation of any sensor and must be managed to support, rather than hinder or block, sensor performance. It has been observed that during the early periods following implantation of an analyte sensing device, particularly a glucose sensing device, that glucose sensors function well. However, after a few days to two or more weeks of implantation, these device lose their function. [0056]
  • We have observed that this lack of sensor function is most likely due to cells (barrier cells) that associate with the outer surface of the device and physically block the transport of glucose into the device (i.e. form a a barrier cell layer). Increased vascularization would not be expected to overcome this blockage. The present invention contemplates the use of particular biointerface membrane architectures that interfere with barrier cell layer formation on the membrane's surface. The present invention also contemplates the use of these membranes with a variety of implantable devices (e.g. analyte measuring devices particularly glucose measuring devices). [0057]
  • II. The Sensor Head [0058]
  • In one embodiment of the sensor head of the invention, the body is made of a non-conductive material such as ceramic, glass, or polymer. [0059]
  • In a preferred embodiment, the sensor head interface region may include several different layers and/or membranes that cover and protect the electrodes of an implantable analyte-measuring device. The characteristics of these layers and/or membranes are now discussed in more detail. The layers and/or membranes prevent direct contact of the biological fluid sample with the electrodes, while permitting selected substances (e.g., analytes) of the fluid to pass therethrough for reaction in an enzyme rich domain with subsequent electrochemical reaction of formed products at the electrodes. [0060]
  • It is well known in the art that electrode surfaces exposed to a wide range of biological molecules may suffer poisoning of catalytic activity and possible corrosion that could result in failure. However, utilizing the unique multi-region membrane architectures of the present invention, the active electrochemical surfaces of the sensor electrodes are preserved, retaining activity for extended periods of time in vivo. By limiting access to the electrochemically reactive surface of the electrodes to a small number of molecular species such as, for example, molecules having a molecular weight of about 34 Daltons (the molecular weight of peroxide) or less, only a small subset of the many molecular species present in biological fluids are permitted to contact the sensor. Use of such membranes has enabled sustained function of devices for over one year in vivo. [0061]
  • A. Multi-Region Membrane [0062]
  • The multi-region membrane is constructed of two or more regions. The multi-region membrane may be provided in a number of different architectures. In one architecture, the multi-region membrane includes a first region distant from the electrochemically reactive surfaces, a second region less distant from the electrochemically reactive surfaces and a third region adjacent to the electrochemically reactive surfaces. The first region includes a cell disruptive domain distant from the electrochemically reactive surfaces and a cell impermeable domain less distant from the electrochemically reactive surfaces. The second region is a glucose exclusion domain and the third region includes a resistance domain distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme domain and a hydrogel domain adjacent to the electrochemically reactive surfaces. [0063]
  • In another architecture, the multi-region membrane includes a first region distant from the electrochemically reactive surfaces and a further region less distant from the electrochemically reactive surfaces. The first region includes a cell disruptive domain and a cell impermeable domain as described above. The “further region” includes a resistance domain, immobilized enzyme domain, interference domain, and hydrogel domain and serves as the equivalent of the “third region” described above. In certain embodiments of the sensor head, the multi-region membrane further includes an oxygen antenna domain. Each of these domains will now be described in further detail. [0064]
  • i. Cell Disruptive Domain [0065]
  • The domain of the multi-region membrane positioned most distal to the electrochemically reactive surfaces corresponds to the cell disruptive domain. This domain includes a material that supports tissue in-growth and may be vascularized. The cell disruptive domain prevents formation of the barrier cell layer on the surface of the membrane, which as described above, blocks the transport of glucose into the sensor device. A useful cell disruptive domain is described in a U.S. application entitled “Membrane for use with Implantable Devices” which was filed on the same day as the present application. The cell disruptive domain may be composed of an open-cell configuration having cavities and solid portions. Cells may enter into the cavities, however, they can not travel through or wholly exist within the solid portions. The cavities allow most substances to pass through, including, e.g., macrophages. [0066]
  • The open-cell configuration yields a co-continuous solid domain that contains greater than one cavity in three dimensions substantially throughout the entirety of the membrane. In addition, the cavities and cavity interconnections may be formed in layers having different cavity dimensions. [0067]
  • A linear line can be used to define a dimension across a cavity or solid portion the length of which is the distance between two points lying at the interface of the cavity and solid portion. In this way, a substantial number of the cavities are not less than 20 microns in the shortest dimension and not more than 1000 microns in the longest dimension. Preferably, a substantial number of the cavities are not less than 25 microns in the shortest dimension and not more than 500 microns in the longest dimension. [0068]
  • Furthermore, the solid portion has not less than 5 microns in a substantial number of the shortest dimensions and not more than 2000 microns in a substantial number of the longest dimensions. Preferably, the solid portion is not less than 10 microns in a substantial number of the shortest dimensions and not more than 1000 microns in a substantial number of the longest dimensions and most preferably, not less than 10 microns in a substantial number of the shortest dimensions and not more than 400 microns in a substantial number of the longest dimensions. [0069]
  • The solid portion may be made of polytetrafluoroethylene or polyethylene-cotetrafluoroethylene, for example. Preferably, the solid portion includes polyurethanes or block copolymers and, most preferably, includes silicone. [0070]
  • When non-woven fibers are utilized as the solid portion of the present invention, the non-woven fibers may be greater than 5 microns in the shortest dimension. Preferably, the non-woven fibers are about 10 microns in the shortest dimension and most preferably, the non-woven fibers are greater than or equal to 10 microns in the shortest dimension. [0071]
  • The non-woven fibers may be constructed of polypropylene (PP), polyvinylchloride (PVC), polyvinylidene fluoride (PVDF), polybutylene terephthalate (PBT), polymethylmethacrylate (PMMA), polyether ether ketone (PEEK), polyurethanes, cellulosic polymers, polysulfones, and block copolymers thereof including, for example, di-block, tri-block, alternating, random and graft copolymers (block copolymers are discussed in U.S. Pat. Nos. 4,803,243 and 4,686,044, hereby incorporated by reference). Preferably, the non-woven fibers are comprised of polyolefins or polyester or polycarbonates or polytetrafluoroethylene. [0072]
  • A subset of the cell disruptive domain is the oxygen antenna domain. This domain can act as an oxygen reservoir during times of minimal oxygen need and has the capacity to provide on demand a higher oxygen gradient to facilitate oxygen transport across the membrane. This domain may be composed of a material such as silicone, that has higher oxygen solubility than aqueous media so that it concentrates oxygen from the biological fluid surrounding the biointerface membrane. This enhances function in the enzyme reaction domain and at the counter electrode surface when glucose conversion to hydrogen peroxide in the enzyme domain consumes oxygen from the surrounding domains. Thus, this ability of the oxygen antenna domain to apply a higher flux of oxygen to critical domains when needed improves overall sensor function. Preferably, this domain is composed of silicone and has a thickness of about 100 microns [0073]
  • The thickness of the cell disruptive domain is usually not less than about 20 microns and not more than about 2000 microns. [0074]
  • ii. Cell Impermeable Domain [0075]
  • The cell impermeable of the first region is positioned less distal to the electrochemically reactive surfaces than the cell disruptive domain of the same region. This domain is impermeable to host cells, such as macrophages. Cell impermeable domains are described in U.S. Pat. No. 6,001,067, herein incorporated by reference, and in copending, commonly owned U.S. application entitled “Membrane for use with Implantable Devices”, Ser. No. ______, filed on even date herewith. The inflammatory response that initiates and sustains a FBC is associated with disadvantages in the practice of sensing analytes. Inflammation is associated with invasion of inflammatory response cells (e.g. macrophages) which have the ability to overgrow at the interface and form barrier cell layers, which may block transport of glucose across the biointerface membrane. These inflammatory cells may also biodegrade many artificial biomaterials (some of which were, until recently, considered nonbiodegradable). When activated by a foreign body, tissue macrophages degranulate, releasing from their cytoplasmic myeloperoxidase system hypochlorite (bleach) and other oxidative species. Hypochlorite and other oxidative species are known to break down a variety of polymers, including ether based polyurethanes, by a phenomenon referred to as environmental stress cracking. Alternatively, polycarbonate based polyurethanes are believed to be resistant to environmental stress cracking and have been termed biodurable. In addition, because hypochlorite and other oxidizing species are short-lived chemical species in vivo, biodegradation will not occur if macrophages are kept a sufficient distance from the enzyme active membrane. [0076]
  • The present invention contemplates the use of cell impermeable biomaterials of a few microns thickness or more (i.e., a cell impermeable domain) in most of its membrane architectures. This domain of the biointerface membrane is permeable to oxygen and may or may not be permeable to glucose and is constructed of biodurable materials (e.g. for period of several years in vivo) that are impermeable by host cells (e.g. macrophages) such as for example polymer blends of polycarbonate based polyurethane and PVP. [0077]
  • The thickness of the cell impermeable domain is not less than about 10 microns and not more than about 100 microns. [0078]
  • iii. Glucose Exclusion Domain [0079]
  • The glucose exclusion domain includes a thin, hydrophobic membrane that is non-swellable and blocks diffusion of glucose while being permeable to oxygen. The glucose exclusion domain serves to allow analytes and other substances that are to be measured or utilized by the sensor to pass through, while preventing passage of other substances. Preferably, the glucose exclusion domain is constructed of a material such as, for example, silicone. [0080]
  • The glucose exclusion domain has a preferred thickness not less than about 130 microns, more preferably not less than about 5 and not more than about 75 microns and most preferably not less than 15 microns and not more than about 50 microns. [0081]
  • iv. Resistance Domain [0082]
  • In one embodiment of the sensor head the “third region” or “further region” of the multi-region membrane includes a resistance domain. When present, the resistance domain is located more distal to the electrochemically reactive surfaces relative to other domains in this region. As described in further detail below, the resistance domain controls the flux of oxygen and glucose to the underlying enzyme domain. There is a molar excess of glucose relative to the amount of oxygen in samples of blood. Indeed, for every free oxygen molecule in extra-cellular fluid, there are typically more than 100 glucose molecules present [Updike et al., Diabetes Care 5:207-21(1982)]. However, an immobilized enzyme-based sensor using oxygen (O[0083] 2) as cofactor must be supplied with oxygen in non-rate-limiting excess in order to respond linearly to changes in glucose concentration, while not responding to changes in oxygen tension. More specifically, when a glucose-monitoring reaction is oxygen-limited, linearity is not achieved above minimal concentrations of glucose. Without a semipermeable membrane over the enzyme domain, linear response to glucose levels can be obtained only up to about 40 mg/dL; however, in a clinical setting, linear response to glucose levels are desirable up to at least about 500 mg/dL.
  • The resistance domain includes a semipermeable membrane that controls the flux of oxygen and glucose to the underlying enzyme domain (i.e., limits the flux of glucose), rendering the necessary supply of oxygen in non-rate-limiting excess. As a result, the upper limit of linearity of glucose measurement is extended to a much higher value than that which could be achieved without the resistance domain. The devices of the present invention contemplate resistance domains including polymer membranes with oxygen-to-glucose permeability ratios of approximately 200: 1; as a result, one-dimensional reactant diffusion is adequate to provide excess oxygen at all reasonable glucose and oxygen concentrations found in the subcutaneous matrix [Rhodes et al., Anal. Chem., 66:1520-1529 (1994)]. [0084]
  • In preferred embodiments, the resistance domain is constructed of a polyurethane urea/polyurethane-block-polyethylene glycol blend and has a thickness of not more than about 45 microns, more preferably not less than about 15 microns, and not more than about 40 microns and, most preferably, not less than about 20 microns, and not more than about 35 microns. [0085]
  • v. Immobilized Enzyme Domain [0086]
  • When the resistance domain is combined with the cell-impermeable domain, it is the immobilized enzyme domain which corresponds to the outermost domain of the “third region” or “further region”, i.e. it is located more distal to the electrochemically reactive surfaces as compared to the other domains in this region. In one embodiment, the enzyme domain includes glucose oxidase. In addition to glucose oxidase, the present invention contemplates the use of a domain impregnated with other oxidases, e.g., galactose oxidase or uricase, For an enzyme-based electrochemical glucose sensor to perform well, the sensor's response must neither be limited by enzyme activity nor cofactor concentration. Because enzymes, including glucose oxidase, are subject to deactivation as a function of ambient conditions, this behavior needs to be accounted for in constructing sensors for long-term use. [0087]
  • Preferably, the domain is constructed of aqueous dispersions of colloidal polyurethane polymers including the enzyme. Preferably, the coating has a thickness of not less than about 2.5 microns and not more than about 12.5 microns, preferably about 6.0 microns. [0088]
  • vi. Interference Domain [0089]
  • The interference domain in the “third region” or “further region” is located less distant from the electrochemically reactive surfaces than the immobilized enzyme domain in this same region. It includes a thin membrane that can limit diffusion of molecular weight species greater than 34 kD. The interference domain serves to allow analytes and other substances that are to be measured by the electrodes to pass through, while preventing passage of other substances, including potentially interfering substances. The interference domain is preferably constructed of a polyurethane. [0090]
  • The interference domain has a preferred thickness of not more than about 5 microns, more preferably not less than about 0.1 microns, and not more than about 5 microns and, most preferably, not less than about 0.5 microns, and not more than about 3 microns. [0091]
  • vii. Hydrogel Domain [0092]
  • The hydrogel domain is located adjacent to the electrochemically reactive surfaces. To ensure electrochemical reaction, the hydrogel domain includes a semipermeable coating that maintains hydrophilicity at the electrode region of the sensor interface. The hydrogel domain enhances the stability of the interference domain of the present invention by protecting and supporting the membrane that makes up the interference domain. Furthermore, the hydrogel domain assists in stabilizing operation of the device by overcoming electrode start-up problems and drifting problems caused by inadequate electrolyte. The buffered electrolyte solution contained in the hydrogel domain also protects against pH-mediated damage that may result from the formation of a large pH gradient between the hydrophobic interference domain and the electrode (or electrodes) due to the electrochemical activity of the electrode(s). [0093]
  • Preferably, the hydrogel domain includes a flexible, water-swellable, substantially solid gel-like film having a “dry film” thickness of not less than about 2.5 microns and not more than about 12.5 microns; preferably, the thickness is about 6.0 microns. “Dry film” thickness refers to the thickness of a cured film cast from a coating formulation onto the surface of the membrane by standard coating techniques [0094]
  • Suitable hydrogel domains are formed of a curable copolymer of a urethane polymer and a hydrophilic film-forming polymer. Particularly preferred coatings are formed of a polyurethane polymer having anionic carboxylate functional groups and non-ionic hydrophilic polyether segments, which is crosslinked in the present of polyvinylpyrrolidone and cured at a moderate temperature of about 50° C. [0095]
  • B. Electrolyte Phase [0096]
  • The electrolyte phase is a free-fluid phase including a solution containing at least one compound, usually a soluble chloride salt, that conducts electric current. The electrolyte phase flows over the electrodes and is in contact with the hydrogel domain. The devices of the present invention contemplate the use of any suitable electrolyte solution, including standard, commercially available solutions. [0097]
  • Generally speaking, the electrolyte phase should have the same or less osmotic pressure than the sample being analyzed. In preferred embodiments of the present invention, the electrolyte phase includes normal saline. [0098]
  • C. Membrane Architectures [0099]
  • Prior art teaches that an enzyme containing membrane that resides above an amperometric electrochemical sensor can possess the same architecture throughout the electrode surfaces. However, the function of converting glucose into hydrogen peroxide by glucose oxidase may only by necessary above the working electrode. In fact, it may be beneficial to limit the conversion of glucose into hydrogen peroxide above the counter electrode. Therefore, the present invention contemplates a number of membrane architectures that include a multi-region membrane wherein the regions include at least one domain. [0100]
  • Referring now to FIG. 2A, which shows one desired embodiment of the general architecture of a three region membrane, [0101] first region 33 is permeable to oxygen and glucose and includes a cell disruptive domain distant from the electrodes and a cell impermeable domain less distant from the electrodes. The second region 31 is permeable to oxygen and includes a glucose exclusion domain and region three 32 includes a resistance domain, distant from the electrochemically reactive surfaces, an immobilized enzyme domain less distant from the electrochemically reactive surfaces, an interference domain less distant from the electrochemically reactive surfaces than the immobilized enzyme and a hydrogel domain adjacent to the electrochemically reactive surfaces. The multi-region membrane is positioned over the sensor interface 30 of the non-conductive body 10, covering the working electrode 21, the reference electrode 20 and the counter electrode 22. The electrodes are brazed to the sensor head and back filled with epoxy 28.
  • In FIG. 2B, the glucose exclusion domain has been positioned over the electrochemically reactive surfaces such that it does not cover the working [0102] electrode 21. To illustrate this, a hole 35 has been created in the second region 31 and positioned directly above the working electrode 21. In this way, glucose is blocked from entering the underlying enzyme membrane above the counter electrode 22 and O2 is conserved above the counter electrode because it is not being consumed by the glucose oxidation reaction. The glucose-blocking domain is made of a material that allows sufficient O2 to pass to the counter electrode. The glucose-blocking domain may be made of a variety of materials such as silicone or silicone containing copolymers. Preferably, the glucose-blocking domain is made of silicone.
  • In FIG. 2C, the multi-region membrane is shown as being constructed of two regions: a [0103] first region 33 which includes a cell disruptive domain and a cell impermeable domain; and a further region 32. Region 32 is defined herein as including an enzyme immobilized domain, interference domain, and hydrogel domain and may also include a resistance domain. Region 32 is referred to as the “third region” in embodiments where the multi-region membrane includes three regions. In the embodiment shown, a silicone domain plug 36 positioned over the counter electrode 22 in order to eliminate the consumption of O2 above the counter electrode by the oxidation of glucose with glucose oxidase. The enzyme immobilized domain can be fabricated as previously described, then a hole punched into the domain. The silicone domain plug 36 may be cut to fit the hole, and then adhered into place, for example, with silicone adhesive (e.g., MED-1511, NuSil, Carpinteria, Calif.).
  • In FIG. 2D, the immobilized enzyme domain of the multi-region membrane can be fabricated such that [0104] active enzyme 37 is positioned only above the working electrode 21. In this architecture, the immobilized enzyme domain may be prepared so that the glucose oxidase only exists above the working electrode 21. During the preparation of the multi-region membrane, the immobilized enzyme domain coating solution can be applied as a circular region similar to the diameter of the working electrode. This fabrication can be accomplished in a variety of ways such as screen printing or pad printing. Preferably, the enzyme domain is pad printed during the enzyme membrane fabrication with equipment as available from Pad Print Machinery of Vermont (Manchester, Vt.). These architectures eliminate the consumption of O2 above the counter electrode 22 by the oxidation of glucose with glucose oxidase.
  • In FIG. 2E, the immobilized enzyme of the multi-region membrane in [0105] region 32 may be deactivated 38 except for the area covering the working electrode 21. In some of the previous membrane architectures, the glucose oxidase is distributed homogeneously throughout the immobilized enzyme domain. However, the active enzyme need only reside above the working electrode. Therefore, the enzyme may be deactivated 38 above the counter 22 and reference 20 electrodes by irradiation. A mask that covers the working electrode 21, such as those used for photolithography can be placed above the membrane. In this way, exposure of the masked membrane to ultraviolet light deactivates the glucose oxidase in all regions except that covered by the mask.
  • FIG. 2F shows an architecture in which the [0106] third region 32 which includes immobilized enzyme only resides over the working electrode 21. In this architecture, consumption of O2 above the counter electrode 22 by the oxidation of glucose with glucose oxidase is eliminated.
  • D. The Electrode Assembly [0107]
  • The electrode assembly of this invention comprises a non-conductive body and three electrodes affixed within the body having electrochemically reactive surfaces at one location on the body and an electronic connection means at another location on the body and may be used in the manner commonly employed in the making of amperometric measurements. A sample of the fluid being analyzed is placed in contact with a reference electrode, e.g., silver/silver-chloride, a working electrode which is preferably formed of platinum, and a counter electrode which is preferably formed of gold or platinum. The electrodes are connected to a galvanometer or polarographic instrument and the current is read or recorded upon application of the desired D.C. bias voltage between the electrodes. [0108]
  • The ability of the present device electrode assembly to accurately measure the concentration of substances such as glucose over a broad range of concentrations in fluids including undiluted whole blood samples enables the rapid and accurate determination of the concentration of those substances. That information can be employed in the study and control of metabolic disorders including diabetes. [0109]
  • The present invention contemplates several structural architectures that effectively increase the electrochemically reactive surface of the counter electrode. In one embodiment, the diameter of wire used to create the counter electrode is at least twice the diameter of the working electrode. In this architecture, it is preferable that the electrochemically reactive surface of the counter electrode be not less than about 2 and not more than about 100 times the surface area of the working electrode. More preferably, the electrochemically reactive surface of the counter electrode is not less than about 2 and not more than about 50, not less than about 2 and not more than about 25 or not less than about 2 and not more than about 10 times the surface area of the working electrode. In another embodiment, the electrochemically reactive surface is larger that the wire connecting this surface to the sensor head. In this architecture, the electrode could have a cross-sectional view that resembles a “T”. The present invention contemplates a variety of configurations of the electrode head that would provide a large reactive surface, while maintaining a relatively narrow connecting wire. Such configurations could be prepared by micromachining with techniques such as reactive ion etching, wet chemical etching and focused ion beam machining as available from Norsam Technologies (Santa Fe, N. Mex.). [0110]
  • In another embodiment, the diameter of the counter electrode is substantially similar to the working electrode; however, the surface of the counter electrode has been modified to increase the surface area such that it has at least twice the surface area of the working electrode. More specifically the counter electrodes surface may be textured, effectively increasing its surface area without significantly increasing its diameter. This may be accomplished by a variety of methods known to those skilled in the art including, such as acid etching. The electrochemically reactive surface may be provided in a variety of shapes and sizes (e.g. round, triangular, square or free form) provided that it is at least twice the surface area of the working electrode. [0111]
  • In all of the architectures described, the electrodes are prepared from a 0.020″ diameter wire having the desired modified reactive surface. The electrodes are secured inside the non-conductive body by brazing. The counter electrode is preferably made of gold or platinum. [0112]
  • III. Analyte Measuring Device [0113]
  • A preferred embodiment of an analyte measuring device including a sensor head according to the present invention is shown in FIG. 6A. In this embodiment, a [0114] ceramic body 1 and ceramic head 10 houses the sensor electronics that include a circuit board 2, a microprocessor 3, a battery 4, and an antenna 5. Furthermore, the ceramic body 1 and head 10 possess a matching taper joint 6 that is sealed with epoxy. The electrodes are subsequently connected to the circuit board via a socket 8.
  • As indicated in detail in FIG. 6B, three electrodes protrude through the [0115] ceramic head 10, a platinum working electrode 21, a platinum counter electrode 22 and a silver/silver chloride reference electrode 20. Each of these is hermetically brazed 26 to the ceramic head 10 and further secured with epoxy 28. The sensing region 24 is covered with a multi-region membrane described above and the ceramic head 10 contains a groove 29 so that the membrane may be affixed into place with an o-ring.
  • IV. Experimental [0116]
  • The following examples serve to illustrate certain preferred embodiments and aspects of the present invention and are not to be construed as limiting the scope thereof [0117]
  • In the preceding description and the experimental disclosure which follows, the following abbreviations apply: Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) μM (micromolar); N (Normal); mol (moles); mmol (millimoles); μmol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); μg (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); μL (microliters); cm (centimeters); mm (millimeters); um (micrometers); nm (nanometers); h and hr (hours); min. (minutes); s and sec. (seconds); ° C. (degrees Centigrade); Astor Wax (Titusville, Pa.); BASF Wyandotte Corporation (Parsippany, N.J.); Data Sciences, Inc. (St. Paul, Minn.); DuPont (DuPont Co., Wilmington, Del.); Exxon Chemical (Houston, Tex.); GAF Corporation (New York, N.Y.); Markwell Medical (Racine, Wis.); Meadox Medical, Inc. (Oakland, N.J.); Mobay (Mobay Corporation, Pittsburgh, Pa.); NuSil Technologies (Carpenteria, Calif.) Sandoz (East Hanover, N.J.); and Union Carbide (Union Carbide Corporation; Chicago, Ill.). [0118]
  • EXAMPLE 1
  • Preparation of the Multi-region Membrane [0119]
  • A. Preparation of the First Region [0120]
  • The cell disruptive domain may be an ePTFE filtration membrane and the cell impermeable domain may then be coated on this domain layer. The cell impermeable domain was prepared by placing approximately 706 gm of dimethylacetamide (DMAC) into a 3L stainless steel bowl to which a polycarbonateurethane solution (1325 g, Chronoflex AR 25% solids in DMAC and 5100 cp) and polyvinylpyrrolidone (125 g, Plasdone K-90D) are added. The bowl was then fitted to a planetary mixer with a paddle type blade and the contents were stirred for 1 hour at room temperature. This solution was then coated on the cell disruptive domain by knife edge drawn at a gap of 0.006″ and dried at 60° C. for 24 hours. [0121]
  • Alternatively, the polyurethane polyvinylpyrrolidone solution prepared above can be coated onto a PET release liner using a knife over roll coating machine. This material is then dried at 305° F. for approximately 2 minutes. Next the ePTFE membrane is immersed in 50:50 (w/v) mixture of THF/DMAC and then placed atop the coated polyurethane polyvinylpyrrolidone material. Light pressure atop the assembly intimately embeds the ePTFE into the polyurethane polyvinylpyrrolidone. The membrane is then dried at 60° C. for 24 hours. [0122]
  • B. Preparation of the Glucose Exclusion Domain [0123]
  • An oxime cured silicone dispersion (NuSil Technologies, MED-6607) was cast onto a polypropylene sheet and cured at 40° C. for three days. [0124]
  • C. Preparation of the Third Region [0125]
  • The “third region” or “further region” includes a resistance domain, an immobilized enzyme domain, an interference domain and an hydrogel domain. The resistance domain was prepared by placing approximately 281 gm of dimethylacetamide into a 3 L stainless steel bowl to which a solution of polyetherurethaneurea (344 gm of Chronothane H, 29,750 cp at 25% solids in DMAC). To this mixture was added another polyetherurethaneurea (312 gm, Chronothane 1020, 6275 cp at 25% solids in DMAC.) The bowl was fitted to a planetary mixer with a paddle type blade and the contents were stirred for 30 minutes at room temperature. The resistance domain coating solutions produced is coated onto a PET release liner (Douglas Hansen Co., Inc. Minneapolis, Minn.) using a knife over roll set at a 0.012″ gap. This film is then dried at 305° F. The final film is approximately 0.0015″ thick. [0126]
  • The immobilized enzyme domain was prepared by placing 304 gm polyurethane latex (Bayhydrol 140AQ, Bayer, Pittsburgh, Pa.) into a 3 L stainless steel bowl to which 51 gm of pyrogen free water and 5.85 gm of glucose oxidase (Sigma type VII from [0127] Aspergillus niger) is added. The bowl was then fitted to a planetary mixer with a whisk type blade and the mixture was stirred for 15 minutes. Approximately 24 hr prior to coating a solution of glutaraldehyde (15.4 mL of a 2.5% solution in pyrogen free water) and 14 mL of pyrogen free water was added to the mixture. The solution was mixed by inverting a capped glass bottle by hand for about 3 minutes at room temperature. This mixture was then coated over the resistance domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C.
  • The interference domain was prepared by placing 187 gm of tetrahydrofuran into a 500 mL glass bottle to which an 18.7 gm aliphatic polyetherurethane (Tecoflex SG-85A, Thermedics Inc., Woburn, Mass.) was added. The bottle was placed onto a roller at approximately 3 rpm within an oven set at 37° C. The mixture was allowed to roll for 24 hr. This mixture was coated over the dried enzyme domain using a flexible knife and dried above room temperature preferably at about 50° C. [0128]
  • The hydrogel domain was prepared by placing 388 gm of polyurethane latex (Bayhydrol 123, Bayer, Pittsburgh, Pa. in a 3 L stainless steel bowl to which 125 gm of pyrogen free water and 12.5 gm polyvinylpyrrolidone (Plasdone K-90D) was added. The bowl was then fitted to a planetary mixer with a paddle type blade and stirred for 1 hr at room temperature. Within 30 minutes of coating approximately 13.1 mL of carbodiimide (UCARLNK) was added and the solution was mixed by inverting a capped polyethylene jar by hand for about 3 min at room temperature. This mixture was coated over the dried interference domain with a #10 Mayer rod and dried above room temperature preferably at about 50° C. [0129]
  • In order to affix this multi-region membrane to a sensor head, it is first placed into buffer for about 2 minutes. It is then stretched over the nonconductive body of sensor head and affixed into place with an o-ring. [0130]
  • EXAMPLE 2
  • In vitro Evaluation of Sensor Devices [0131]
  • This example describes experiments directed at sensor function of several sensor devices contemplated by the present invention. [0132]
  • In vitro testing of the sensor devices was accomplished in a manner similar to that previously described. [Gilligan et al., Diabetes Care 17:882-887 (1994)]. Briefly, devices were powered on and placed into a polyethylene container containing phosphate buffer (450 ml, pH 7.30) at 37° C. The container was placed onto a shaker (Lab Line Rotator, model 1314) set to [0133] speed 2. The sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. After this time, a glucose solution (9.2 ml of 100 mg/ml glucose in buffer) was added in order to raise the glucose concentration to 200 mg/dl within the container. The sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. Again, a glucose solution (9.4 ml of 100 mg/ml glucose in buffer) was added in order to raise the glucose concentration to 400 mg/dl within the container. The sensors were allowed to equilibrate for at least 30 minutes and their output value recorded. In this way, the sensitivity of the sensor to glucose is given as the slope of sensor output versus glucose concentration. The container was then fitted with an O2 meter (WTW, model Oxi-340) and a gas purge. A mixture of compressed air and nitrogen was used to decrease the O2 concentration. Sensor output was recorded at an ambient O2 level, then sensor output was recorded for the following O2 concentrations; 1 mg/L, 0.85 to 0.75 mg/L, 0.65 to 0.55 mg/L and 0.40 to 0.30 mg/L. In this way, the function of the sensor could be compared to its function at ambient O2.
  • Sensor devices like the one shown in FIGS. 6A and 6B, which included inventive sensor heads having a multi-region membrane with the architecture shown in FIG. 2B, were tested in vitro. Eight of these devices were fitted with membranes that possessed a 0.020″ diameter hole, four with a 0.0015″ thick polyurethane (Chronoflex AR, CardioTech International Inc.) and four with a 0.032″ thick silicone (MED-1511, NuSil Technologies Inc.). The hole was positioned above the working electrode and both membranes were secured to the device with an o-ring. Four control devices were also tested which were fitted with a multi-region membrane which lacked [0134] region 31 shown in FIB. 2B.
  • As discussed above, for oxygen to be consumed in the [0135] sensing region 32 above the electrodes, glucose is required. By placing region 31 shown in FIG. 2B, which includes a glucose blocking domain, above all areas other than above the working electrode 21, oxygen consumption in areas other than working electrode areas is limited. In contrast, by eliminating region 31 in the control devices, less overall oxygen becomes available to electrode surfaces due to the increased availability of glucose.
  • The devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12 ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A glucose value was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L. [0136]
  • FIG. 7 graphically represents the formation of a device of the present invention utilizing the multi-region membrane architecture in FIG. 2B in vitro. The data is expressed in percent Device Function at 400 mg/dL glucose vs. oxygen concentration. The percent function of the device is simply the device output at any given oxygen concentration divided by that device's output at ambient oxygen. The results from FIG. 7 indicate that inventive sensor devices containing the silicone membrane have better function at lower oxygen concentrations relative to both the control devices and the devices containing the polyurethane membrane. For example, at an oxygen concentration of about 0.5 mg/L, devices containing the silicone membrane are providing 100% output as compared to 80% output for the control devices. [0137]
  • EXAMPLE 3
  • The Effect of Varying the Size and Material of the Counter Electrode on Sensor Response and Accuracy [0138]
  • An in vitro testing procedure used in this example was similar to that described in Example 2. Six devices similar to the one shown in FIGS. 6A and 6B were fitted with the multi-region membrane described herein. Two of these tested devices were comparative devices that possessed Pt counter electrodes having a 0.020″ diameter; this diameter provided for an electrochemically reactive surface of the counter electrode which was substantially equal to the surface area of the working electrode, as schematically shown in FIG. 8. In FIG. 8, the electrode-membrane region includes two distinct regions, the compositions and functions of which have already been described. [0139] Region 32 includes an immobilized enzyme. Region 33 includes a cell disruptive domain and a cell impermeable domain. The top ends of electrodes 21 (working), 20 (reference) and 22 (counter) are in contact with an electrolyte phase 30, a free-flowing phase. Two other tested devices possessed Pt counter electrodes having a 0.060″ diameter. Finally, two additional devices possessed Au counter electrodes having a 0.060″ diameter. The 0.006″ diameter devices provided for an electrochemically reactive surface of the counter electrode which was approximately six times the surface area of the working electrode. Each of the devices including counter electrodes of 0.060″ diameter include a multi-region membrane above the electrode region which is similar to that shown in FIG. 8.
  • The devices were activated, placed into a 500 ml-polyethylene container with sodium phosphate buffered solution (300 ml, pH 7.3) and allowed to equilibrate. Each device's baseline value was recorded. Then 12ml of glucose solution (100 mg/ml in sodium phosphate buffer) was added to the container so that the total glucose concentration became 400 mg/dL. After this, the container was covered and fitted with an oxygen sensor and a source of nitrogen and compressed air. In this way, the oxygen concentration was controlled with a gas sparge. A counter electrode voltage was recorded for each device at decreasing oxygen concentrations from ambient to approximately 0.1 mg/L. [0140]
  • FIG. 9 graphically presents the counter electrode voltage as a function of oxygen concentration and 400 mg/dL glucose. This figure demonstrates that both the large Pt and Au counter electrode devices do not begin to reach the circuitry limits at low oxygen concentrations. Therefore, increased performance and accuracy can be obtained from a counter electrode that has an electrochemical reactive surface greater than the surface area of the working electrode. [0141]
  • The description and experimental materials presented above are intended to be illustrative of the present invention while not limiting the scope thereof. It will be apparent to those skilled in the art that variations and modifications can be made without departing from the spirit and scope of the present invention. [0142]

Claims (33)

What is claimed is:
1. A sensor head for use in an analyte measuring device comprising:
a) a non-conductive body;
b) a working electrode, a reference electrode and a counter electrode, wherein said electrodes pass through said non-conductive body forming an electrochemically reactive surface at one location on said body and an electronic connection at another location on said body, further wherein said electrochemical reactive surface of said counter electrode is greater than the surface area of said working electrode; and
c) a multi-region membrane affixed over said non-conductive body and covering said working electrode, reference electrode and counter electrode.
2. A sensor head for use in an implantable analyte measuring device comprising:
a) a non-conductive body;
b) a working electrode, a reference electrode and a counter electrode, wherein said electrodes pass through said non-conductive body forming an electrochemically reactive surface at one location on said body and an electronic connection at another location on said body, further wherein said electrochemical reactive surface of said counter electrode is greater than the surface area of said working electrode; and
c) a multi-region membrane affixed over said non-conductive body and covering said working electrode, reference electrode and counter electrode.
3. A sensor head according to claim 1 wherein said multi-region membrane comprises an oxygen antenna domain.
4. A sensor head according to claim 2 wherein said multi-region membrane comprises an oxygen antenna domain.
5. A sensor head according to claim 2 wherein said multi-region membrane comprises a first region distant from said electrochemically reactive surfaces, a second region less distant from said electrochemically reactive surfaces and a third region adjacent to said electrochemically reactive surfaces.
6. A sensor head according to claim 5 wherein said first region comprises a cell disruptive domain distant from said electrochemically reactive surfaces and a cell impermeable domain less distant from said electrochemically reactive surfaces.
7. A sensor head according to claim 5 wherein said second region is a glucose exclusion domain.
8. A sensor head according to claim 5 wherein said third region comprises an immobilized enzyme domain distant from said electrochemically reactive surfaces, an interference domain less distant from said electrochemically reactive surfaces than said immobilized enzyme domain and a hydrogel domain adjacent to said electrochemically reactive surfaces.
9. A sensor head according to claim 8 wherein said third region further comprises a resistance domain more distant from said electrochemically reactive surfaces than said immobilized enzyme domain.
10. A sensor head according to claim 5 wherein said first region is permeable to oxygen and glucose.
11. A sensor head according to claim 5 wherein said second region is permeable to oxygen and interferes with glucose transport across said membrane, further wherein said second region does not cover the working electrode.
12. A sensor head according to claim 2 wherein said multi-region membrane comprises a first region distant from said electrochemically reactive surfaces and a further region adjacent to said electrochemically reactive surfaces.
13. A sensor head according to claim 12 wherein said first region comprises a cell disruptive domain distant from said electrochemically reactive surfaces and a cell impermeable domain less distant from said electrochemically reactive surfaces.
14. A sensor head according to claim 12 wherein said further region comprises an immobilized enzyme domain distant from said electrochemically reactive surfaces, an interference domain less distant from said electrochemically reactive surfaces than said immobilized enzyme domain and a hydrogel domain adjacent to said electrochemically reactive surfaces.
15. A sensor head according to claim 14 wherein said further region further comprises a resistance domain more distant from said electrochemically reactive surfaces than said immobilized enzyme domain.
16. A sensor head according to claim 12 wherein said further region comprises a portion positioned over only said counter electrode that reduces the consumption of oxygen above said counter electrode.
17. A sensor head according to claim 16 wherein said portion of said further region comprises silicone.
18. A sensor head according to claim 14 wherein an active enzyme of the immobilized enzyme domain of said further region is positioned only over the working electrode.
19. A sensor head according to claim 14 wherein an inactive enzyme of the immobilized enzyme domain of said further region is positioned only over the reference electrode and the counter electrode.
20. A sensor head according to claim 14 wherein said further region is positioned only over said working electrode.
21. A sensor head according to claim 2 wherein said non-conductive body is made of ceramic or glass.
22. A sensor head according to claim 2 wherein said non-conductive body is made of plastic or polymer.
23. A sensor head according to claim 2 wherein said working electrode is made of platinum.
24. A sensor head according to claim 2 wherein said counter electrode is made of platinum or gold.
25. A sensor head according to claim 2 wherein said electrochemically reactive surface of said counter electrode is greater than or equal to about two times the surface area of the working electrode and is less than or equal to about 100 times the surface area of the working electrode.
26. A sensor head according to claim 2 wherein said electrode is greater than or equal to about two times the surface area of the working electrode and is less than or equal to about 50 times the surface area of the working electrode.
27. A sensor head according to claim 2 wherein said electrochemically reactive surface of said counter electrode is greater than or equal to about two times the surface area of the working electrode and is less than or equal to about 25 times the surface area of the working electrode.
28. A sensor head according to claim 2 wherein said electrochemically reactive surface of said counter electrode is greater than or equal to about two times the surface area of the working electrode and is less than or equal to about 10 times the surface area of the working electrode.
29. An implantable device for measuring an analyte in a biological fluid comprising at least one sensor head according to claim 2.
30. A method of monitoring glucose levels, comprising:
a) providing i) a host, and ii) an implantable device according to claim 29; and
b) implanting said device in said host.
31. A method according to claim 30 wherein said implanting is subcutaneous.
32. A method of measuring glucose in a biological fluid, comprising;
a) providing i) a host, and ii) an implantable device according to claim 29, said sensor head being capable of accurate continuous glucose sensing; and
b) implanting said device in said host.
33. A method according to claim 32, wherein said implanting is subcutaneous.
US09/916,711 2001-07-27 2001-07-27 Sensor head for use with implantable devices Abandoned US20030032874A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
US09/916,711 US20030032874A1 (en) 2001-07-27 2001-07-27 Sensor head for use with implantable devices
AT02748255T ATE332666T1 (en) 2001-07-27 2002-07-26 GLUCOSE MONITORING HEAD APPLICABLE IN IMPLANTABLE DEVICES
PCT/US2002/023903 WO2003011131A2 (en) 2001-07-27 2002-07-26 Sensor head for monitoring glucose for use with implantable devices
JP2003516370A JP4295615B2 (en) 2001-07-27 2002-07-26 Sensor head for use with implantable devices
EP06112130A EP1669022A3 (en) 2001-07-27 2002-07-26 Sensor head for monitoring glucose for use with implantable devices
DE60213096T DE60213096D1 (en) 2001-07-27 2002-07-26 MEASURING HEAD FOR GLUCOSE MONITORING, APPLICABLE IN IMPLANTABLE DEVICES
EP02748255A EP1411823B1 (en) 2001-07-27 2002-07-26 Sensor head for monitoring glucose for use with implantable devices
AU2002317584A AU2002317584A1 (en) 2001-07-27 2002-07-26 Sensor head for monitoring glucose for use with implantable devices
US11/021,162 US7471972B2 (en) 2001-07-27 2004-12-22 Sensor head for use with implantable devices
US12/260,017 US8509871B2 (en) 2001-07-27 2008-10-28 Sensor head for use with implantable devices
US13/943,622 US9328371B2 (en) 2001-07-27 2013-07-16 Sensor head for use with implantable devices
US15/059,086 US9804114B2 (en) 2001-07-27 2016-03-02 Sensor head for use with implantable devices
US15/720,329 US20180024086A1 (en) 2001-07-27 2017-09-29 Sensor head for use with implantable devices

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/916,711 US20030032874A1 (en) 2001-07-27 2001-07-27 Sensor head for use with implantable devices

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/021,162 Continuation US7471972B2 (en) 2001-07-27 2004-12-22 Sensor head for use with implantable devices

Publications (1)

Publication Number Publication Date
US20030032874A1 true US20030032874A1 (en) 2003-02-13

Family

ID=25437709

Family Applications (6)

Application Number Title Priority Date Filing Date
US09/916,711 Abandoned US20030032874A1 (en) 2001-07-27 2001-07-27 Sensor head for use with implantable devices
US11/021,162 Expired - Lifetime US7471972B2 (en) 2001-07-27 2004-12-22 Sensor head for use with implantable devices
US12/260,017 Active 2025-02-15 US8509871B2 (en) 2001-07-27 2008-10-28 Sensor head for use with implantable devices
US13/943,622 Expired - Lifetime US9328371B2 (en) 2001-07-27 2013-07-16 Sensor head for use with implantable devices
US15/059,086 Expired - Lifetime US9804114B2 (en) 2001-07-27 2016-03-02 Sensor head for use with implantable devices
US15/720,329 Abandoned US20180024086A1 (en) 2001-07-27 2017-09-29 Sensor head for use with implantable devices

Family Applications After (5)

Application Number Title Priority Date Filing Date
US11/021,162 Expired - Lifetime US7471972B2 (en) 2001-07-27 2004-12-22 Sensor head for use with implantable devices
US12/260,017 Active 2025-02-15 US8509871B2 (en) 2001-07-27 2008-10-28 Sensor head for use with implantable devices
US13/943,622 Expired - Lifetime US9328371B2 (en) 2001-07-27 2013-07-16 Sensor head for use with implantable devices
US15/059,086 Expired - Lifetime US9804114B2 (en) 2001-07-27 2016-03-02 Sensor head for use with implantable devices
US15/720,329 Abandoned US20180024086A1 (en) 2001-07-27 2017-09-29 Sensor head for use with implantable devices

Country Status (7)

Country Link
US (6) US20030032874A1 (en)
EP (2) EP1669022A3 (en)
JP (1) JP4295615B2 (en)
AT (1) ATE332666T1 (en)
AU (1) AU2002317584A1 (en)
DE (1) DE60213096D1 (en)
WO (1) WO2003011131A2 (en)

Cited By (339)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030217966A1 (en) * 2002-05-22 2003-11-27 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US20040186362A1 (en) * 2001-07-27 2004-09-23 Dexcom, Inc. Membrane for use with implantable devices
US20040199059A1 (en) * 2003-04-04 2004-10-07 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
US20040254434A1 (en) * 2003-06-10 2004-12-16 Goodnow Timothy T. Glucose measuring module and insulin pump combination
US20050009126A1 (en) * 2003-06-12 2005-01-13 Therasense, Inc. Method and apparatus for providing power management in data communication systems
US20050013684A1 (en) * 2003-07-14 2005-01-20 Wu Kung Chris Single reticle transfer system
US20050027181A1 (en) * 2003-08-01 2005-02-03 Goode Paul V. System and methods for processing analyte sensor data
US20050051440A1 (en) * 2003-07-25 2005-03-10 Simpson Peter C. Electrochemical sensors including electrode systems with increased oxygen generation
US20050051427A1 (en) * 2003-07-23 2005-03-10 Brauker James H. Rolled electrode array and its method for manufacture
US20050054909A1 (en) * 2003-07-25 2005-03-10 James Petisce Oxygen enhancing membrane systems for implantable devices
US20050056552A1 (en) * 2003-07-25 2005-03-17 Simpson Peter C. Increasing bias for oxygen production in an electrode system
US20050090607A1 (en) * 2003-10-28 2005-04-28 Dexcom, Inc. Silicone composition for biocompatible membrane
US20050103625A1 (en) * 2001-07-27 2005-05-19 Rathbun Rhodes Sensor head for use with implantable devices
US20050112169A1 (en) * 2003-05-21 2005-05-26 Dexcom, Inc. Porous membranes for use with implantable devices
US20050115832A1 (en) * 2003-07-25 2005-06-02 Simpson Peter C. Electrode systems for electrochemical sensors
WO2005057173A2 (en) 2003-12-08 2005-06-23 Dexcom, Inc. Systems and methods for improving electrochemical analyte sensors
US20050143635A1 (en) * 2003-12-05 2005-06-30 Kamath Apurv U. Calibration techniques for a continuous analyte sensor
US20050176136A1 (en) * 2003-11-19 2005-08-11 Dexcom, Inc. Afinity domain for analyte sensor
US20050177036A1 (en) * 1997-03-04 2005-08-11 Shults Mark C. Device and method for determining analyte levels
US20050182451A1 (en) * 2004-01-12 2005-08-18 Adam Griffin Implantable device with improved radio frequency capabilities
US20050197554A1 (en) * 2004-02-26 2005-09-08 Michael Polcha Composite thin-film glucose sensor
US20050203360A1 (en) * 2003-12-09 2005-09-15 Brauker James H. Signal processing for continuous analyte sensor
US20050239154A1 (en) * 2003-10-31 2005-10-27 Feldman Benjamin J A method of calibrating an analyte-measurement device, and associated methods, devices and systems
US20050238503A1 (en) * 2002-10-09 2005-10-27 Rush Benjamin M Variable volume, shape memory actuated insulin dispensing pump
US20050235732A1 (en) * 2002-10-09 2005-10-27 Rush Benjamin M Fluid delivery device with autocalibration
US20050242479A1 (en) * 2004-05-03 2005-11-03 Petisce James R Implantable analyte sensor
US20050245795A1 (en) * 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
US20050245799A1 (en) * 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
US20050251083A1 (en) * 2004-02-12 2005-11-10 Victoria Carr-Brendel Biointerface with macro-and micro-architecture
US20050287620A1 (en) * 1991-03-04 2005-12-29 Therasense, Inc. Method of determining analyte level using subcutaneous electrode
US20060015024A1 (en) * 2004-07-13 2006-01-19 Mark Brister Transcutaneous medical device with variable stiffness
US20060015020A1 (en) * 2004-07-06 2006-01-19 Dexcom, Inc. Systems and methods for manufacture of an analyte-measuring device including a membrane system
US20060020192A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060016700A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20060118415A1 (en) * 1998-03-04 2006-06-08 Abbott Diabetes Care Inc. Electrochemical Analyte Sensor
US20060142651A1 (en) * 2004-07-13 2006-06-29 Mark Brister Analyte sensor
US20060198864A1 (en) * 2003-05-21 2006-09-07 Mark Shults Biointerface membranes incorporating bioactive agents
EP1701654A2 (en) * 2003-12-18 2006-09-20 Subq LLC Implantable biosensor and methods of use thereof
US20060224141A1 (en) * 2005-03-21 2006-10-05 Abbott Diabetes Care, Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US20060253012A1 (en) * 2005-05-05 2006-11-09 Petisce James R Cellulosic-based resistance domain for an analyte sensor
US20060249381A1 (en) * 2005-05-05 2006-11-09 Petisce James R Cellulosic-based resistance domain for an analyte sensor
US20060258761A1 (en) * 2002-05-22 2006-11-16 Robert Boock Silicone based membranes for use in implantable glucose sensors
US20060257996A1 (en) * 2005-04-15 2006-11-16 Simpson Peter C Analyte sensing biointerface
US20060270923A1 (en) * 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20070027385A1 (en) * 2003-12-05 2007-02-01 Mark Brister Dual electrode system for a continuous analyte sensor
US20070027384A1 (en) * 2003-12-05 2007-02-01 Mark Brister Dual electrode system for a continuous analyte sensor
US20070027381A1 (en) * 2005-07-29 2007-02-01 Therasense, Inc. Inserter and methods of use
US20070032717A1 (en) * 2003-12-05 2007-02-08 Mark Brister Dual electrode system for a continuous analyte sensor
US20070060814A1 (en) * 2005-08-30 2007-03-15 Abbott Diabetes Care, Inc. Analyte sensor introducer and methods of use
US20070093704A1 (en) * 2003-12-05 2007-04-26 Mark Brister Dual electrode system for a continuous analyte sensor
US20070173709A1 (en) * 2005-04-08 2007-07-26 Petisce James R Membranes for an analyte sensor
US20070176867A1 (en) * 2006-01-31 2007-08-02 Abbott Diabetes Care, Inc. Method and system for providing a fault tolerant display unit in an electronic device
US20070179568A1 (en) * 2006-01-31 2007-08-02 Sdgi Holdings, Inc. Methods for detecting osteolytic conditions in the body
US20070197890A1 (en) * 2003-07-25 2007-08-23 Robert Boock Analyte sensor
US20070203966A1 (en) * 2003-08-01 2007-08-30 Dexcom, Inc. Transcutaneous analyte sensor
US20070203407A1 (en) * 2006-02-28 2007-08-30 Abbott Diabetes Care, Inc. Analyte sensors and methods of use
US20070213611A1 (en) * 2003-07-25 2007-09-13 Simpson Peter C Dual electrode system for a continuous analyte sensor
US20070238998A1 (en) * 2006-04-11 2007-10-11 Sdgi Holdings, Inc. Volumetric measurement and visual feedback of tissues
US20070235331A1 (en) * 2003-07-25 2007-10-11 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20070244379A1 (en) * 2002-05-22 2007-10-18 Robert Boock Silicone based membranes for use in implantable glucose sensors
US20070249922A1 (en) * 2005-12-28 2007-10-25 Abbott Diabetes Care, Inc. Medical Device Insertion
US20080004601A1 (en) * 2006-06-28 2008-01-03 Abbott Diabetes Care, Inc. Analyte Monitoring and Therapy Management System and Methods Therefor
US20080027287A1 (en) * 2002-04-22 2008-01-31 Rajiv Shah Methods and materials for stabilizing analyte sensors
US20080033254A1 (en) * 2003-07-25 2008-02-07 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US20080033268A1 (en) * 2005-12-28 2008-02-07 Abbott Diabetes Care, Inc. Method and Apparatus for Providing Analyte Sensor Insertion
US20080039702A1 (en) * 2006-08-09 2008-02-14 Abbott Diabetes Care, Inc. Method and System for Providing Calibration of an Analyte Sensor in an Analyte Monitoring System
US20080060955A1 (en) * 2003-07-15 2008-03-13 Therasense, Inc. Glucose measuring device integrated into a holster for a personal area network device
US20080071157A1 (en) * 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
WO2008041984A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080083617A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080097246A1 (en) * 2006-09-10 2008-04-24 Abbott Diabetes Care, Inc Method and System for Providing An Integrated Analyte Sensor Insertion Device and Data Processing Unit
US20080119710A1 (en) * 2006-10-31 2008-05-22 Abbott Diabetes Care, Inc. Medical devices and methods of using the same
US20080172205A1 (en) * 2006-10-26 2008-07-17 Abbott Diabetes Care, Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US20080201169A1 (en) * 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US20080199894A1 (en) * 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US20080214918A1 (en) * 2006-10-04 2008-09-04 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080255437A1 (en) * 2007-04-14 2008-10-16 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
US20080256048A1 (en) * 2007-04-14 2008-10-16 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
US20080288180A1 (en) * 2007-05-14 2008-11-20 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080287762A1 (en) * 2007-05-14 2008-11-20 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080287764A1 (en) * 2003-11-19 2008-11-20 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20080287763A1 (en) * 2007-05-14 2008-11-20 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080296155A1 (en) * 1997-03-04 2008-12-04 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20080300476A1 (en) * 2007-05-31 2008-12-04 Abbott Diabetes Care, Inc. Insertion devices and methods
US20080306435A1 (en) * 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20080312841A1 (en) * 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080312845A1 (en) * 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080312842A1 (en) * 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080319294A1 (en) * 2007-06-21 2008-12-25 Abbott Diabetes Care, Inc. Health management devices and methods
US20090006034A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090005665A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090002179A1 (en) * 2007-06-28 2009-01-01 Abbott Diabetes Care, Inc. Signal converting cradle for medical condition monitoring and management system
US20090012377A1 (en) * 2007-06-27 2009-01-08 Abbott Diabetes Care, Inc. Method and structure for securing a monitoring device element
US20090033482A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090036760A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090054750A1 (en) * 2006-08-07 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Integrated Analyte Monitoring and Infusion System Therapy Management
US20090054745A1 (en) * 2006-08-07 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Data Management in Integrated Analyte Monitoring and Infusion System
US20090054746A1 (en) * 2005-09-30 2009-02-26 Abbott Diabetes Care, Inc. Device for channeling fluid and methods of use
US20090055149A1 (en) * 2007-05-14 2009-02-26 Abbott Diabetes Care, Inc. Method and system for determining analyte levels
US20090069649A1 (en) * 2006-10-25 2009-03-12 Abbott Diabetes Care, Inc. Method and System for Providing Analyte Monitoring
US20090068954A1 (en) * 2005-10-31 2009-03-12 Abbott Diabetes Care, Inc. Method and apparatus for providing data communication in data monitoring and management systems
US20090076358A1 (en) * 2005-05-17 2009-03-19 Abbott Diabetes Care, Inc. Method and System for Providing Data Management in Data Monitoring System
US20090076359A1 (en) * 2006-03-31 2009-03-19 Abbott Diabetes Care, Inc. Analyte monitoring and management system and methods therefor
US20090083003A1 (en) * 2003-04-28 2009-03-26 Reggiardo Christopher V Method and apparatus for providing peak detection circuitry for data communication systems
US20090088614A1 (en) * 2006-01-30 2009-04-02 Abbott Diabetes Care, Inc. On-body medical device securement
US20090105658A1 (en) * 2005-12-28 2009-04-23 Abbott Diabetes Care, Inc. Infusion sets for the delivery of a therapeutic substance to a patient
US20090105569A1 (en) * 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US20090105571A1 (en) * 2006-06-30 2009-04-23 Abbott Diabetes Care, Inc. Method and System for Providing Data Communication in Data Management Systems
US20090105568A1 (en) * 2007-10-23 2009-04-23 Abbott Diabetes Care, Inc. Assessing Measures Of Glycemic Variability
US20090102678A1 (en) * 2006-02-28 2009-04-23 Abbott Diabetes Care, Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US20090124877A1 (en) * 2003-08-22 2009-05-14 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20090124879A1 (en) * 2004-07-13 2009-05-14 Dexcom, Inc. Transcutaneous analyte sensor
US20090143661A1 (en) * 2007-06-29 2009-06-04 Abbott Diabetes Care, Inc Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US20090143659A1 (en) * 2003-08-01 2009-06-04 Dexcom, Inc. Analyte sensor
US20090164190A1 (en) * 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Physiological condition simulation device and method
US20090164239A1 (en) * 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US20090171269A1 (en) * 2006-06-29 2009-07-02 Abbott Diabetes Care, Inc. Infusion Device and Methods Therefor
US20090192745A1 (en) * 2003-08-01 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20090192380A1 (en) * 2003-07-25 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20090198118A1 (en) * 2008-01-31 2009-08-06 Abbott Diabetes Care, Inc. Analyte Sensor with Time Lag Compensation
US20090240120A1 (en) * 2008-02-21 2009-09-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US20090247857A1 (en) * 2008-03-28 2009-10-01 Abbott Diabetes Care, Inc. Analyte Sensor Calibration Management
US20090247855A1 (en) * 2008-03-28 2009-10-01 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US20090257911A1 (en) * 2008-04-10 2009-10-15 Abbott Diabetes Care Inc. Method and System for Sterilizing an Analyte Sensor
US20090259118A1 (en) * 2008-03-31 2009-10-15 Abbott Diabetes Care Inc. Shallow Implantable Analyte Sensor with Rapid Physiological Response
US20090300616A1 (en) * 2008-05-30 2009-12-03 Abbott Diabetes Care, Inc. Automated task execution for an analyte monitoring system
US20090299151A1 (en) * 2008-05-30 2009-12-03 Abbott Diabetes Care Inc. Method and Apparatus for Providing Glycemic Control
US20090320978A1 (en) * 2008-06-27 2009-12-31 Martinez Johnny C Sound-emitting wallet
US7651596B2 (en) 2005-04-08 2010-01-26 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
US20100027169A1 (en) * 2008-07-30 2010-02-04 Arnold Knott Power distribution arrangement
US20100049024A1 (en) * 2004-01-12 2010-02-25 Dexcom, Inc. Composite material for implantable device
US20100057040A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US20100057041A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Closed Loop Control With Reference Measurement And Methods Thereof
US20100057057A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Closed Loop Control And Signal Attenuation Detection
US20100076288A1 (en) * 2003-04-04 2010-03-25 Brian Edmond Connolly Method and System for Transferring Analyte Test Data
US20100076293A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Monitor
US20100076283A1 (en) * 2008-09-19 2010-03-25 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US20100081909A1 (en) * 2008-09-30 2010-04-01 Abbott Diabetes Care, Inc. Optimizing Analyte Sensor Calibration
US20100082364A1 (en) * 2008-09-30 2010-04-01 Abbott Diabetes Care, Inc. Medical Information Management
US20100121167A1 (en) * 2008-11-10 2010-05-13 Abbott Diabetes Care Inc. Alarm Characterization for Analyte Monitoring Devices and Systems
US20100168543A1 (en) * 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20100168545A1 (en) * 2005-03-10 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7756561B2 (en) 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US20100179406A1 (en) * 2003-08-01 2010-07-15 DesCom, Inc. System and methods for processing analyte sensor data
US20100179409A1 (en) * 2002-02-12 2010-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100191085A1 (en) * 2009-01-29 2010-07-29 Abbott Diabetes Care, Inc. Method and Device for Providing Offset Model Based Calibration for Analyte Sensor
US7768387B2 (en) 2007-04-14 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
EP2223710A1 (en) 2004-02-26 2010-09-01 DexCom, Inc. Integrated delivery device for continuous glucose sensor
US20100230285A1 (en) * 2009-02-26 2010-09-16 Abbott Diabetes Care Inc. Analyte Sensors and Methods of Making and Using the Same
US20100247775A1 (en) * 2009-03-31 2010-09-30 Abbott Diabetes Care Inc. Precise Fluid Dispensing Method and Device
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US20100265073A1 (en) * 2009-04-15 2010-10-21 Abbott Diabetes Care Inc. Analyte Monitoring System Having An Alert
US20100274107A1 (en) * 2008-03-28 2010-10-28 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US20100274515A1 (en) * 2009-04-28 2010-10-28 Abbott Diabetes Care Inc. Dynamic Analyte Sensor Calibration Based On Sensor Stability Profile
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860545B2 (en) 1997-03-04 2010-12-28 Dexcom, Inc. Analyte measuring device
US20110029269A1 (en) * 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and Apparatus for Providing Analyte Monitoring System Calibration Accuracy
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
EP2329770A1 (en) 2004-07-13 2011-06-08 DexCom, Inc. Transcutaneous analyte sensor
US20110144465A1 (en) * 1997-03-04 2011-06-16 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US7981034B2 (en) 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US20110184258A1 (en) * 2010-01-28 2011-07-28 Abbott Diabetes Care Inc. Balloon Catheter Analyte Measurement Sensors and Methods for Using the Same
US20110191044A1 (en) * 2009-09-30 2011-08-04 Stafford Gary A Interconnect for on-body analyte monitoring device
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20110193704A1 (en) * 2009-08-31 2011-08-11 Abbott Diabetes Care Inc. Displays for a medical device
US20110213230A1 (en) * 2008-07-02 2011-09-01 Stefan Lindgren On-Line Measuring System of Body Substances
US8047811B2 (en) 2002-10-09 2011-11-01 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
EP2407095A1 (en) 2006-02-22 2012-01-18 DexCom, Inc. Analyte sensor
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8112138B2 (en) 2005-06-03 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US8115635B2 (en) 2005-02-08 2012-02-14 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US8140142B2 (en) 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8155723B2 (en) 1997-03-04 2012-04-10 Dexcom, Inc. Device and method for determining analyte levels
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US8160670B2 (en) 2005-12-28 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US8185181B2 (en) 2009-10-30 2012-05-22 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US20120209097A1 (en) * 2003-09-30 2012-08-16 Andre Mang Sensor with increased biocompatibility
CN102725629A (en) * 2009-10-01 2012-10-10 美敦力迷你迈德公司 Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US20130053666A1 (en) * 2011-08-26 2013-02-28 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US8515517B2 (en) 2006-10-02 2013-08-20 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8512244B2 (en) 2006-06-30 2013-08-20 Abbott Diabetes Care Inc. Integrated analyte sensor and infusion device and methods therefor
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8515518B2 (en) 2005-12-28 2013-08-20 Abbott Diabetes Care Inc. Analyte monitoring
US8527026B2 (en) 1997-03-04 2013-09-03 Dexcom, Inc. Device and method for determining analyte levels
US8548553B2 (en) 2003-08-01 2013-10-01 Dexcom, Inc. System and methods for processing analyte sensor data
WO2013152090A2 (en) 2012-04-04 2013-10-10 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US8583205B2 (en) 2008-03-28 2013-11-12 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
WO2013184566A2 (en) 2012-06-05 2013-12-12 Dexcom, Inc. Systems and methods for processing analyte data and generating reports
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
WO2014004460A1 (en) 2012-06-29 2014-01-03 Dexcom, Inc. Use of sensor redundancy to detect sensor failures
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
WO2014011488A2 (en) 2012-07-09 2014-01-16 Dexcom, Inc. Systems and methods for leveraging smartphone features in continuous glucose monitoring
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
WO2014052080A1 (en) 2012-09-28 2014-04-03 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US20140194713A1 (en) * 2012-08-06 2014-07-10 Google Inc. Contact lenses having two-electrode electrochemical sensors
US8777853B2 (en) 2003-08-22 2014-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8798934B2 (en) 2009-07-23 2014-08-05 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
WO2014158405A2 (en) 2013-03-14 2014-10-02 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
WO2014158327A2 (en) 2013-03-14 2014-10-02 Dexcom, Inc. Advanced calibration for analyte sensors
EP2796090A1 (en) 2006-10-04 2014-10-29 DexCom, Inc. Analyte sensor
EP2796093A1 (en) 2007-03-26 2014-10-29 DexCom, Inc. Analyte sensor
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
WO2015156966A1 (en) 2014-04-10 2015-10-15 Dexcom, Inc. Sensors for continuous analyte monitoring, and related methods
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US20160077036A1 (en) * 2010-03-11 2016-03-17 Roche Diabetes Care, Inc. Method and fuel cell for electrochemical measurement of analyte concentration in vivo
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
US9451908B2 (en) 2006-10-04 2016-09-27 Dexcom, Inc. Analyte sensor
US9451910B2 (en) 2007-09-13 2016-09-27 Dexcom, Inc. Transcutaneous analyte sensor
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
EP3092949A1 (en) 2011-09-23 2016-11-16 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US9795326B2 (en) 2009-07-23 2017-10-24 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9980670B2 (en) 2002-11-05 2018-05-29 Abbott Diabetes Care Inc. Sensor inserter assembly
EP3366201A1 (en) 2006-01-17 2018-08-29 DexCom, Inc. Low oxygen in vivo analyte sensor
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US20190090797A1 (en) * 2017-09-28 2019-03-28 California Institute Of Technology Switchable low voltage electrochemical sensing for interfering species rejection
EP3536241A1 (en) 2011-04-08 2019-09-11 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US10555695B2 (en) 2011-04-15 2020-02-11 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10561349B2 (en) 2016-03-31 2020-02-18 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10653835B2 (en) 2007-10-09 2020-05-19 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
EP3654348A1 (en) 2012-11-07 2020-05-20 Dexcom, Inc. Systems and methods for managing glycemic variability
CN111278356A (en) * 2017-06-23 2020-06-12 博卡赛恩斯公司 Analyte sensor
US10791928B2 (en) 2007-05-18 2020-10-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US10856736B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
US10860687B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
CN112294323A (en) * 2019-08-02 2021-02-02 华广生技股份有限公司 Miniature biosensor and measuring method thereof
US10932672B2 (en) 2015-12-28 2021-03-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US10963417B2 (en) 2004-06-04 2021-03-30 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US10966609B2 (en) 2004-02-26 2021-04-06 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US10985804B2 (en) 2013-03-14 2021-04-20 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US11112377B2 (en) 2015-12-30 2021-09-07 Dexcom, Inc. Enzyme immobilized adhesive layer for analyte sensors
EP3925522A1 (en) 2017-06-23 2021-12-22 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11213226B2 (en) 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
EP4046571A1 (en) 2015-10-21 2022-08-24 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11439351B2 (en) 2015-09-02 2022-09-13 Metronom Health, Inc. Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US11559260B2 (en) 2003-08-22 2023-01-24 Dexcom, Inc. Systems and methods for processing analyte sensor data
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
USD980986S1 (en) 2015-05-14 2023-03-14 Abbott Diabetes Care Inc. Analyte sensor inserter
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP4218548A1 (en) 2006-03-09 2023-08-02 Dexcom, Inc. Systems and methods for processing analyte sensor data
US11717225B2 (en) 2014-03-30 2023-08-08 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
EP4250312A2 (en) 2007-10-25 2023-09-27 DexCom, Inc. Systems and methods for processing sensor data
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
US11892426B2 (en) 2012-06-29 2024-02-06 Dexcom, Inc. Devices, systems, and methods to compensate for effects of temperature on implantable sensors
US11918354B2 (en) 2019-12-31 2024-03-05 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070227907A1 (en) * 2006-04-04 2007-10-04 Rajiv Shah Methods and materials for controlling the electrochemistry of analyte sensors
US20080242961A1 (en) * 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US20090082693A1 (en) * 2004-12-29 2009-03-26 Therasense, Inc. Method and apparatus for providing temperature sensor module in a data communication system
CA2620586A1 (en) 2005-08-31 2007-03-08 Boris P. Kovatchev Improving the accuracy of continuous glucose sensors
EP1785085A1 (en) * 2005-11-12 2007-05-16 Roche Diagnostics GmbH Implantable electrode system, method and device for measuring the concentration of an analyte in a human or animal body
WO2007147475A1 (en) * 2006-06-19 2007-12-27 Roche Diagnostics Gmbh Amperometric sensor and method for its manufacturing
US9700252B2 (en) 2006-06-19 2017-07-11 Roche Diabetes Care, Inc. Amperometric sensor and method for its manufacturing
US20080161666A1 (en) * 2006-12-29 2008-07-03 Abbott Diabetes Care, Inc. Analyte devices and methods
US7751864B2 (en) * 2007-03-01 2010-07-06 Roche Diagnostics Operations, Inc. System and method for operating an electrochemical analyte sensor
DK1972275T3 (en) * 2007-03-20 2016-02-08 Hoffmann La Roche A system for in-vivo measurement of an analyte concentration
US8700114B2 (en) 2008-07-31 2014-04-15 Medtronic Minmed, Inc. Analyte sensor apparatuses comprising multiple implantable sensor elements and methods for making and using them
US20100025238A1 (en) * 2008-07-31 2010-02-04 Medtronic Minimed, Inc. Analyte sensor apparatuses having improved electrode configurations and methods for making and using them
JP5470010B2 (en) * 2008-12-22 2014-04-16 シスメックス株式会社 In vivo component measuring method and in vivo component measuring apparatus
US20100198033A1 (en) * 2009-02-05 2010-08-05 Peter Krulevitch Flexible indwelling biosensor, flexible indwelling biosensor insertion device, and related methods
US9357951B2 (en) 2009-09-30 2016-06-07 Dexcom, Inc. Transcutaneous analyte sensor
JP5785937B2 (en) 2010-04-16 2015-09-30 アークレイ株式会社 Sensor and interfering substance removal method
JP5819183B2 (en) * 2011-02-03 2015-11-18 アークレイ株式会社 Analysis device, sensor inspection device, inspection method, and inspection program
CA2843008A1 (en) 2011-07-26 2013-01-31 Glysens Incorporated Tissue implantable sensor with hermetically sealed housing
US10561353B2 (en) 2016-06-01 2020-02-18 Glysens Incorporated Biocompatible implantable sensor apparatus and methods
US10660550B2 (en) 2015-12-29 2020-05-26 Glysens Incorporated Implantable sensor apparatus and methods
WO2014110492A2 (en) * 2013-01-11 2014-07-17 Northeastern University Saliva glucose monitoring system
JP2014178143A (en) * 2013-03-13 2014-09-25 Dainippon Printing Co Ltd Concentration measurement sensor, concentration measurement sensor sheet, and manufacturing method thereof
US9761874B2 (en) 2013-12-30 2017-09-12 Verily Life Sciences Llc Fabrication methods for batteries
US10765863B2 (en) 2015-02-24 2020-09-08 Elira, Inc. Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
US10864367B2 (en) 2015-02-24 2020-12-15 Elira, Inc. Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions
US10335302B2 (en) 2015-02-24 2019-07-02 Elira, Inc. Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions
US10118035B2 (en) 2015-02-24 2018-11-06 Elira, Inc. Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch
US10376145B2 (en) 2015-02-24 2019-08-13 Elira, Inc. Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
US9956393B2 (en) 2015-02-24 2018-05-01 Elira, Inc. Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch
US10674944B2 (en) 2015-05-14 2020-06-09 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
WO2016196516A1 (en) 2015-06-03 2016-12-08 William Kenneth Ward Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives
US10638962B2 (en) 2016-06-29 2020-05-05 Glysens Incorporated Bio-adaptable implantable sensor apparatus and methods
WO2018136898A1 (en) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US10638979B2 (en) 2017-07-10 2020-05-05 Glysens Incorporated Analyte sensor data evaluation and error reduction apparatus and methods
US11278668B2 (en) 2017-12-22 2022-03-22 Glysens Incorporated Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods
US11255839B2 (en) 2018-01-04 2022-02-22 Glysens Incorporated Apparatus and methods for analyte sensor mismatch correction
GB2608290B (en) 2020-07-29 2023-07-26 Biolinq Incorporated Continuous analyte monitoring system with microneedle array
JP7341583B6 (en) 2021-05-08 2023-09-29 バイオリンク インコーポレイテッド Fault detection for microneedle array-based continuous analyte monitoring devices

Citations (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4436094A (en) * 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
US4453537A (en) * 1981-08-04 1984-06-12 Spitzer Daniel E Apparatus for powering a body implant device
US4484987A (en) * 1983-05-19 1984-11-27 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4686044A (en) * 1979-08-13 1987-08-11 Akzo Nv Polycarbonate-polyether-copolymer membrane
US4703756A (en) * 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4757022A (en) * 1986-04-15 1988-07-12 Markwell Medical Institute, Inc. Biological fluid measuring device
US4759828A (en) * 1987-04-09 1988-07-26 Nova Biomedical Corporation Glucose electrode and method of determining glucose
US4787398A (en) * 1985-04-08 1988-11-29 Garid, Inc. Glucose medical monitoring system
US4803243A (en) * 1986-03-26 1989-02-07 Shin-Etsu Chemical Co., Ltd. Block-graft copolymer
US4823808A (en) * 1987-07-06 1989-04-25 Clegg Charles T Method for control of obesity, overweight and eating disorders
US4871440A (en) * 1987-07-06 1989-10-03 Daiken Industries, Ltd. Biosensor
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4902294A (en) * 1986-12-03 1990-02-20 Olivier Gosserez Implantable mammary prosthesis adapted to combat the formation of a retractile shell
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5171689A (en) * 1984-11-08 1992-12-15 Matsushita Electric Industrial Co., Ltd. Solid state bio-sensor
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
US5321414A (en) * 1990-03-01 1994-06-14 Her Majesty In Right Of Canada As Represented By The Minister Of Communications Dual polarization dipole array antenna
US5322063A (en) * 1991-10-04 1994-06-21 Eli Lilly And Company Hydrophilic polyurethane membranes for electrochemical glucose sensors
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US5380536A (en) * 1990-10-15 1995-01-10 The Board Of Regents, The University Of Texas System Biocompatible microcapsules
US5384028A (en) * 1992-08-28 1995-01-24 Nec Corporation Biosensor with a data memory
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5417395A (en) * 1993-06-30 1995-05-23 Medex, Inc. Modular interconnecting component support plate
US5421923A (en) * 1993-12-03 1995-06-06 Baxter International, Inc. Ultrasonic welding horn with sonics dampening insert
US5431160A (en) * 1989-07-19 1995-07-11 University Of New Mexico Miniature implantable refillable glucose sensor and material therefor
US5453278A (en) * 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
US5462064A (en) * 1993-12-22 1995-10-31 International Medical Associates, Inc. Integrated system for biological fluid constituent analysis
US5469846A (en) * 1992-10-19 1995-11-28 Duquesne University Of The Holy Ghost Implantable non-enzymatic electrochemical glucose sensor
US5476094A (en) * 1992-02-11 1995-12-19 Eli Lilly And Company Acrylic copolymer membranes for biosensors
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5538511A (en) * 1994-04-01 1996-07-23 Minimed Inc. Indwelling catheter with stable enzyme coating
US5545223A (en) * 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5549675A (en) * 1994-01-11 1996-08-27 Baxter International, Inc. Method for implanting tissue in a host
US5569186A (en) * 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5569462A (en) * 1993-09-24 1996-10-29 Baxter International Inc. Methods for enhancing vascularization of implant devices
US5575930A (en) * 1992-10-07 1996-11-19 Tietje-Girault; Jordis Method of making gas permeable membranes for amperometric gas electrodes
US5578463A (en) * 1985-08-29 1996-11-26 Genencor International, Inc. Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
US5628890A (en) * 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
US5683562A (en) * 1994-09-14 1997-11-04 Avl Medical Instruments Ag Planar sensor for determining a chemical parameter of a sample
US5713888A (en) * 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
US5741330A (en) * 1990-10-31 1998-04-21 Baxter International, Inc. Close vascularization implant material
US5777060A (en) * 1995-03-27 1998-07-07 Minimed, Inc. Silicon-containing biocompatible membranes
US5791344A (en) * 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5807406A (en) * 1994-10-07 1998-09-15 Baxter International Inc. Porous microfabricated polymer membrane structures
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US5985129A (en) * 1989-12-14 1999-11-16 The Regents Of The University Of California Method for increasing the service life of an implantable sensor
US6001067A (en) * 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6119028A (en) * 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
US6122536A (en) * 1995-07-06 2000-09-19 Animas Corporation Implantable sensor and system for measurement and control of blood constituent levels
US6144869A (en) * 1998-05-13 2000-11-07 Cygnus, Inc. Monitoring of physiological analytes
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6180416B1 (en) * 1998-09-30 2001-01-30 Cygnus, Inc. Method and device for predicting physiological values
US6201980B1 (en) * 1998-10-05 2001-03-13 The Regents Of The University Of California Implantable medical sensor system
US6200772B1 (en) * 1997-08-23 2001-03-13 Sensalyse Holdings Limited Modified polyurethane membrane sensors and analytical methods
US6208894B1 (en) * 1997-02-26 2001-03-27 Alfred E. Mann Foundation For Scientific Research And Advanced Bionics System of implantable devices for monitoring and/or affecting body parameters
US6212416B1 (en) * 1995-11-22 2001-04-03 Good Samaritan Hospital And Medical Center Device for monitoring changes in analyte concentration
US6223080B1 (en) * 1998-04-29 2001-04-24 Medtronic, Inc. Power consumption reduction in medical devices employing multiple digital signal processors and different supply voltages
US6223083B1 (en) * 1999-04-16 2001-04-24 Medtronic, Inc. Receiver employing digital filtering for use with an implantable medical device
US6230059B1 (en) * 1999-03-17 2001-05-08 Medtronic, Inc. Implantable monitor
US6233471B1 (en) * 1998-05-13 2001-05-15 Cygnus, Inc. Signal processing for measurement of physiological analysis
US6254586B1 (en) * 1998-09-25 2001-07-03 Minimed Inc. Method and kit for supplying a fluid to a subcutaneous placement site
US6256522B1 (en) * 1992-11-23 2001-07-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Sensors for continuous monitoring of biochemicals and related method
US6259937B1 (en) * 1997-09-12 2001-07-10 Alfred E. Mann Foundation Implantable substrate sensor
US6272382B1 (en) * 1998-07-31 2001-08-07 Advanced Bionics Corporation Fully implantable cochlear implant system
US6272364B1 (en) * 1998-05-13 2001-08-07 Cygnus, Inc. Method and device for predicting physiological values
US6299578B1 (en) * 1995-12-28 2001-10-09 Cygnus, Inc. Methods for monitoring a physiological analyte
US6326160B1 (en) * 1998-09-30 2001-12-04 Cygnus, Inc. Microprocessors for use in a device for predicting physiological values
US6329161B1 (en) * 1993-12-02 2001-12-11 Therasense, Inc. Subcutaneous glucose electrode
US6360888B1 (en) * 1999-02-25 2002-03-26 Minimed Inc. Glucose sensor package system

Family Cites Families (838)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852258A1 (en) 1998-11-11 2000-05-18 Agfa Gevaert Ag Radiation-sensitive recording material for the production of waterless offset printing plates
US1564641A (en) 1922-04-10 1925-12-08 Chicago Miniature Lamp Works Detector for wireless systems
US2402306A (en) 1943-10-07 1946-06-18 Turkel Henry Retaining guard guide for needles
US2719797A (en) 1950-05-23 1955-10-04 Baker & Co Inc Platinizing tantalum
US2830020A (en) * 1956-10-01 1958-04-08 American Cyanamid Co Lubricating oils thickened with metal salts of cyanuric acid
US3220960A (en) 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
US3210578A (en) 1962-01-12 1965-10-05 Westinghouse Electric Corp Multispeed motor connector
US3381371A (en) 1965-09-27 1968-05-07 Sanders Associates Inc Method of constructing lightweight antenna
US3562352A (en) * 1968-09-06 1971-02-09 Avco Corp Polysiloxane-polyurethane block copolymers
US3607329A (en) 1969-04-22 1971-09-21 Us Interior Cellulose acetate butyrate semipermeable membranes and their production
JPS4810633B1 (en) * 1969-04-25 1973-04-05
USRE31916E (en) 1970-11-10 1985-06-18 Becton Dickinson & Company Electrochemical detection cell
US3933593A (en) 1971-02-22 1976-01-20 Beckman Instruments, Inc. Rate sensing batch analysis method
US3746588A (en) 1971-03-29 1973-07-17 Aerojet General Co Sterilization of nitroparaffin-amine explosives
US3791871A (en) 1971-04-14 1974-02-12 Lockheed Aircraft Corp Electrochemical cell
CH559912A5 (en) 1971-09-09 1975-03-14 Hoffmann La Roche
GB1412983A (en) 1971-11-30 1975-11-05 Debell & Richardson Method of producing porous plastic materials
US3943918A (en) 1971-12-02 1976-03-16 Tel-Pac, Inc. Disposable physiological telemetric device
US3775182A (en) 1972-02-25 1973-11-27 Du Pont Tubular electrochemical cell with coiled electrodes and compressed central spindle
GB1442303A (en) 1972-09-08 1976-07-14 Radiometer As Cell for electro-chemical analysis
CS164231B2 (en) 1972-09-28 1975-11-07
US3929971A (en) 1973-03-30 1975-12-30 Research Corp Porous biomaterials and method of making same
US3826244A (en) 1973-07-20 1974-07-30 Us Health Education & Welfare Thumbtack microelectrode and method of making same
US4267145A (en) 1974-01-03 1981-05-12 E. I. Du Pont De Nemours And Company Process for preparing cold water-soluble films from PVA by melt extrusion
US3898984A (en) 1974-02-04 1975-08-12 Us Navy Ambulatory patient monitoring system
US4067322A (en) 1974-07-19 1978-01-10 Johnson Joseph H Disposable, pre-gel body electrodes
US3966580A (en) 1974-09-16 1976-06-29 The University Of Utah Novel protein-immobilizing hydrophobic polymeric membrane, process for producing same and apparatus employing same
US3957613A (en) 1974-11-01 1976-05-18 General Electric Company Miniature probe having multifunctional electrodes for sensing ions and gases
US3982530A (en) 1975-04-22 1976-09-28 Egon Storch Penial appliance
US4052754A (en) 1975-08-14 1977-10-11 Homsy Charles A Implantable structure
US3979274A (en) 1975-09-24 1976-09-07 The Yellow Springs Instrument Company, Inc. Membrane for enzyme electrodes
CH591237A5 (en) 1975-11-06 1977-09-15 Bbc Brown Boveri & Cie
US4040908A (en) 1976-03-12 1977-08-09 Children's Hospital Medical Center Polarographic analysis of cholesterol and other macromolecular substances
US4037563A (en) 1976-03-29 1977-07-26 John M. Pflueger Aquarium viewing window
US4024312A (en) 1976-06-23 1977-05-17 Johnson & Johnson Pressure-sensitive adhesive tape having extensible and elastic backing composed of a block copolymer
US4136250A (en) * 1977-07-20 1979-01-23 Ciba-Geigy Corporation Polysiloxane hydrogels
JPS5921500B2 (en) 1978-01-28 1984-05-21 東洋紡績株式会社 Enzyme membrane for oxygen electrode
NL7801867A (en) 1978-02-20 1979-08-22 Philips Nv DEVICE FOR THE TRANSCUTANEOUS MEASUREMENT OF THE PARTIAL OXYGEN PRESSURE IN BLOOD.
US4172770A (en) 1978-03-27 1979-10-30 Technicon Instruments Corporation Flow-through electrochemical system analytical method
DE2820474C2 (en) * 1978-05-10 1983-11-10 Fresenius AG, 6380 Bad Homburg Electrochemical probe
US4259540A (en) 1978-05-30 1981-03-31 Bell Telephone Laboratories, Incorporated Filled cables
US4215703A (en) 1978-08-29 1980-08-05 Willson James K V Variable stiffness guide wire
US4255500A (en) 1979-03-29 1981-03-10 General Electric Company Vibration resistant electrochemical cell having deformed casing and method of making same
US4292423A (en) 1979-04-19 1981-09-29 Wacker-Chemie Gmbh Process for the preparation of organopolysiloxanes
US4253469A (en) 1979-04-20 1981-03-03 The Narda Microwave Corporation Implantable temperature probe
JPS5627643A (en) 1979-08-14 1981-03-18 Toshiba Corp Electrochemical measuring device
US4260725A (en) * 1979-12-10 1981-04-07 Bausch & Lomb Incorporated Hydrophilic contact lens made from polysiloxanes which are thermally bonded to polymerizable groups and which contain hydrophilic sidechains
US4403984A (en) 1979-12-28 1983-09-13 Biotek, Inc. System for demand-based adminstration of insulin
US4861830A (en) 1980-02-29 1989-08-29 Th. Goldschmidt Ag Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming
US5120813A (en) 1980-02-29 1992-06-09 Th. Goldschmidt Ag Moisture vapor permeable materials
US4686137A (en) 1980-02-29 1987-08-11 Thoratec Laboratories Corp. Moisture vapor permeable materials
SE419903B (en) 1980-03-05 1981-08-31 Enfors Sven Olof enzyme electrode
DE3173564D1 (en) 1980-09-02 1986-03-06 Medtronic Inc Subcutaneously implantable lead with drug dispenser means
IE51643B1 (en) 1980-10-15 1987-01-21 Smith & Nephew Ass Coated articles and materials suitable for coating
JPS5929693Y2 (en) 1980-12-25 1984-08-25 オリンパス光学工業株式会社 Cell collection device for endoscope
JPS57118152A (en) 1981-01-14 1982-07-22 Matsushita Electric Ind Co Ltd Enzyme electrode
JPS57156004A (en) 1981-03-20 1982-09-27 Nitto Electric Ind Co Ltd Gas separating membrane
JPS57156005A (en) 1981-03-20 1982-09-27 Nitto Electric Ind Co Ltd Selective permeable membrane
JPS57156005U (en) 1981-03-26 1982-09-30
JPS57156004U (en) 1981-03-26 1982-09-30
US4442841A (en) 1981-04-30 1984-04-17 Mitsubishi Rayon Company Limited Electrode for living bodies
US4378016A (en) 1981-07-15 1983-03-29 Biotek, Inc. Artificial endocrine gland containing hormone-producing cells
US4402694A (en) 1981-07-16 1983-09-06 Biotek, Inc. Body cavity access device containing a hormone source
US4419535A (en) 1981-07-31 1983-12-06 Hara Robert J O Multi-cable conduit for floors and walls
DE3278334D1 (en) 1981-10-23 1988-05-19 Genetics Int Inc Sensor for components of a liquid mixture
US4418148A (en) 1981-11-05 1983-11-29 Miles Laboratories, Inc. Multilayer enzyme electrode membrane
US4415666A (en) 1981-11-05 1983-11-15 Miles Laboratories, Inc. Enzyme electrode membrane
NL193256C (en) 1981-11-10 1999-04-02 Cordis Europ Sensor system.
US4454295A (en) 1981-11-16 1984-06-12 Uco Optics, Inc. Cured cellulose ester, method of curing same, and use thereof
JPS5886172A (en) 1981-11-18 1983-05-23 テルモ株式会社 Medical substance moving apparatus
US4494950A (en) 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
JPS58137840U (en) 1982-03-12 1983-09-16 三菱自動車工業株式会社 Injection timing control device
US4482666A (en) 1982-03-12 1984-11-13 Apace Research Limited Emulsions of liquid hydrocarbons with water and/or alcohols
JPS58163402A (en) 1982-03-20 1983-09-28 Nitto Electric Ind Co Ltd Gas separation membrane
JPS58163403A (en) 1982-03-23 1983-09-28 Nitto Electric Ind Co Ltd Gas separation membrane
US4403847A (en) 1982-03-29 1983-09-13 Eastman Kodak Company Electrographic transfer apparatus
US4493714A (en) * 1982-05-06 1985-01-15 Teijin Limited Ultrathin film, process for production thereof, and use thereof for concentrating a specified gas in a gaseous mixture
JPS58217605A (en) * 1982-06-08 1983-12-17 Natl Aerospace Lab Manufacture of combustor for rocket
EP0098592A3 (en) 1982-07-06 1985-08-21 Fujisawa Pharmaceutical Co., Ltd. Portable artificial pancreas
DE3228551A1 (en) 1982-07-30 1984-02-02 Siemens AG, 1000 Berlin und 8000 München METHOD FOR DETERMINING SUGAR CONCENTRATION
JPS5929693A (en) 1982-08-10 1984-02-16 Asahi Glass Co Ltd Fluorine-containing diisocyanate containing siloxane bond
US4571292A (en) 1982-08-12 1986-02-18 Case Western Reserve University Apparatus for electrochemical measurements
JPS5949803A (en) 1982-09-17 1984-03-22 Teijin Ltd Permselective membrane for separation of gas
JPS5949805A (en) 1982-09-17 1984-03-22 Teijin Ltd Permselective membrane for separation of gas
JPS5949803U (en) 1982-09-27 1984-04-02 リンナイ株式会社 Oven cooking device operating device
JPS5949805U (en) 1982-09-27 1984-04-02 株式会社東芝 High frequency heating cooking device
JPS5959221A (en) 1982-09-29 1984-04-05 Teijin Ltd Prearation of composite perrmeable membrane for separating gas
JPS5959221U (en) 1982-10-12 1984-04-18 和光産業株式会社 Plate fixing device in multi-blade fan assembly machine
DE3379589D1 (en) 1982-10-25 1989-05-18 Hellgren Lars G I Enzyme composition for cleaning, the use thereof and preparation of the composition
JPS591929Y2 (en) 1982-10-25 1984-01-19 ロ−レルバンクマシン株式会社 Cumulative coin support rod of coin wrapping machine
JPS5987004A (en) 1982-11-08 1984-05-19 Nitto Electric Ind Co Ltd Gas separation membrane
JPS58163403U (en) 1982-11-27 1983-10-31 ナイガイ株式会社 Single drive source packaging machine
JPS5987004U (en) 1982-12-01 1984-06-12 古河電気工業株式会社 Airtight penetration for optical transmission line
US5059654A (en) 1983-02-14 1991-10-22 Cuno Inc. Affinity matrices of modified polysaccharide supports
JPS59128406U (en) 1983-02-19 1984-08-29 倉敷化工株式会社 Suspension rubber bushing for automobiles
US4506680A (en) 1983-03-17 1985-03-26 Medtronic, Inc. Drug dispensing body implantable lead
US5682884A (en) 1983-05-05 1997-11-04 Medisense, Inc. Strip electrode with screen printing
CA1219040A (en) 1983-05-05 1987-03-10 Elliot V. Plotkin Measurement of enzyme-catalysed reactions
CA1226036A (en) 1983-05-05 1987-08-25 Irving J. Higgins Analytical equipment and sensor electrodes therefor
JPS59209609A (en) 1983-05-12 1984-11-28 Teijin Ltd Permselective membrane
JPS59209610A (en) 1983-05-12 1984-11-28 Teijin Ltd Permselective membrane
JPS59209608A (en) 1983-05-12 1984-11-28 Teijin Ltd Permselective membrane
JPS59211459A (en) 1983-05-17 1984-11-30 帝人株式会社 Pasturization of blood treating device
US4650547A (en) 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
JPH0693160B2 (en) * 1983-05-31 1994-11-16 シャープ株式会社 LCD drive circuit
WO1985000463A1 (en) 1983-07-05 1985-01-31 Matsushita Electric Industrial Co., Ltd. Aluminum electrolytic capacitor and method of manufacture thereof
US4655880A (en) 1983-08-01 1987-04-07 Case Western Reserve University Apparatus and method for sensing species, substances and substrates using oxidase
US4578215A (en) 1983-08-12 1986-03-25 Micro-Circuits Company Electrical conductivity-enhancing and protecting material
US4554927A (en) 1983-08-30 1985-11-26 Thermometrics Inc. Pressure and temperature sensor
GB2149918A (en) 1983-11-03 1985-06-19 John Anderson Sudden infant death syndrome monitor
JPS60146219A (en) 1984-01-11 1985-08-01 Toray Ind Inc Contact lens
US4739380A (en) 1984-01-19 1988-04-19 Integrated Ionics, Inc. Integrated ambient sensing devices and methods of manufacture
JPS60136214U (en) 1984-02-23 1985-09-10 いすゞ自動車株式会社 Height adjustment device for vehicles with air spring suspension
US4527999A (en) 1984-03-23 1985-07-09 Abcor, Inc. Separation membrane and method of preparing and using same
US4753652A (en) 1984-05-04 1988-06-28 Children's Medical Center Corporation Biomaterial implants which resist calcification
US4883057A (en) 1984-05-09 1989-11-28 Research Foundation, The City University Of New York Cathodic electrochemical current arrangement with telemetric application
JPS60245623A (en) 1984-05-18 1985-12-05 Nippon Yunikaa Kk Production of flexible polyether-urethane foam of low gas permeability
US4583976A (en) * 1984-05-31 1986-04-22 E. R. Squibb & Sons, Inc. Catheter support
US4644046A (en) * 1984-06-20 1987-02-17 Teijin Limited Ultrathin film, process for production thereof, and use thereof for concentrating a specific gas from a gas mixture
CA1258496A (en) 1984-07-30 1989-08-15 Teruyoshi Uchida Insulated noble metal wire and porous membrane as po.sub.2 bioelectrode
US4602922A (en) 1984-11-09 1986-07-29 Research Foundation Of State University Of New York Method of making membranes for gas separation and the composite membranes
US4702732A (en) 1984-12-24 1987-10-27 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands
US5235003A (en) 1985-01-04 1993-08-10 Thoratec Laboratories Corporation Polysiloxane-polylactone block copolymers
US4963595A (en) 1985-01-04 1990-10-16 Thoratec Laboratories Corporation Polysiloxane-polylactone block copolymers
US4577642A (en) 1985-02-27 1986-03-25 Medtronic, Inc. Drug dispensing body implantable lead employing molecular sieves and methods of fabrication
US4958148A (en) 1985-03-22 1990-09-18 Elmwood Sensors, Inc. Contrast enhancing transparent touch panel device
JPS61238319A (en) 1985-04-17 1986-10-23 Dainippon Ink & Chem Inc Selective gas permeable membrane
US4781798A (en) 1985-04-19 1988-11-01 The Regents Of The University Of California Transparent multi-oxygen sensor array and method of using same
GB8514176D0 (en) 1985-06-05 1985-07-10 Ici Plc Membrane
US4671288A (en) 1985-06-13 1987-06-09 The Regents Of The University Of California Electrochemical cell sensor for continuous short-term use in tissues and blood
US4938860A (en) 1985-06-28 1990-07-03 Miles Inc. Electrode for electrochemical sensors
US4805624A (en) * 1985-09-09 1989-02-21 The Montefiore Hospital Association Of Western Pa Low-potential electrochemical redox sensors
US4680268A (en) 1985-09-18 1987-07-14 Children's Hospital Medical Center Implantable gas-containing biosensor and method for measuring an analyte such as glucose
JPS6274406A (en) 1985-09-30 1987-04-06 Teijin Ltd Separating membrane
US4689309A (en) 1985-09-30 1987-08-25 Miles Laboratories, Inc. Test device, method of manufacturing same and method of determining a component in a sample
JPS6283849A (en) 1985-10-04 1987-04-17 Reiji Yoshinaka Method of purifying collagen
JPS6283649A (en) 1985-10-08 1987-04-17 Matsushita Electric Ind Co Ltd Blood-sugar measuring device
JPS6274406U (en) 1985-10-29 1987-05-13
JPS62102815A (en) 1985-10-30 1987-05-13 Agency Of Ind Science & Technol Gas permselective membrane
US4647643A (en) * 1985-11-08 1987-03-03 Becton, Dickinson And Company Soft non-blocking polyurethanes
JPS6283849U (en) 1985-11-12 1987-05-28
JPS6283649U (en) 1985-11-14 1987-05-28
JPH0341047Y2 (en) 1985-12-19 1991-08-29
JPS62174260A (en) * 1986-01-20 1987-07-31 Shin Etsu Chem Co Ltd Fluorosilicone rubber composition
US4684538A (en) 1986-02-21 1987-08-04 Loctite Corporation Polysiloxane urethane compounds and adhesive compositions, and method of making and using the same
US4776944A (en) 1986-03-20 1988-10-11 Jiri Janata Chemical selective sensors utilizing admittance modulated membranes
JPH0696106B2 (en) 1986-03-31 1994-11-30 帝人株式会社 Gas separation membrane
US4685463A (en) 1986-04-03 1987-08-11 Williams R Bruce Device for continuous in vivo measurement of blood glucose concentrations
US4795542A (en) * 1986-04-24 1989-01-03 St. Jude Medical, Inc. Electrochemical concentration detector device
US4909908A (en) * 1986-04-24 1990-03-20 Pepi Ross Electrochemical cncentration detector method
EP0265519B1 (en) 1986-04-30 1995-09-13 IGEN, INC. (a California corporation) Electrochemiluminescent assays
US4731726A (en) 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
GB8612861D0 (en) 1986-05-27 1986-07-02 Cambridge Life Sciences Immobilised enzyme biosensors
US4726381A (en) 1986-06-04 1988-02-23 Solutech, Inc. Dialysis system and method
US4763658A (en) 1986-06-04 1988-08-16 Solutech, Inc. Dialysis system 2nd method
US4750496A (en) 1987-01-28 1988-06-14 Xienta, Inc. Method and apparatus for measuring blood glucose concentration
US4781733A (en) 1986-07-23 1988-11-01 Bend Research, Inc. Semipermeable thin-film membranes comprising siloxane, alkoxysilyl and aryloxysilyl oligomers and copolymers
US4935346A (en) 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5002572A (en) 1986-09-11 1991-03-26 Picha George J Biological implant with textured surface
US5007929B1 (en) 1986-11-04 1994-08-30 Medical Products Dev Open-cell silicone-elastomer medical implant
AU617667B2 (en) 1986-11-04 1991-12-05 Allergan, Inc. Open-cell, silicone-elastomer medical implant and method for making
JPS63130661A (en) 1986-11-20 1988-06-02 Toppan Printing Co Ltd Non-porous moisture-permeable waterproof film
US4954381A (en) 1986-12-30 1990-09-04 The Research Foundation Of The State University Of New York Preparation of porous substrates having well defined morphology
DE3700119A1 (en) 1987-01-03 1988-07-14 Inst Diabetestechnologie Gemei IMPLANTABLE ELECTROCHEMICAL SENSOR
AT391063B (en) 1987-01-08 1990-08-10 Blum Gmbh Julius CONNECTING FITTING FOR FASTENING THE RAILING OF A DRAWER
JPS63130661U (en) 1987-02-18 1988-08-26
EP0284518B1 (en) 1987-03-27 1992-10-07 Isao Karube Miniaturized oxygen electrode and miniaturized biosensor and production process thereof
US4935345A (en) 1987-04-07 1990-06-19 Arizona Board Of Regents Implantable microelectronic biochemical sensor incorporating thin film thermopile
US4832034A (en) 1987-04-09 1989-05-23 Pizziconi Vincent B Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids
US5352348A (en) 1987-04-09 1994-10-04 Nova Biomedical Corporation Method of using enzyme electrode
US4961954A (en) 1987-04-10 1990-10-09 University Of Florida Surface modified surgical instruments, devices, implants, contact lenses and the like
US5094876A (en) * 1987-04-10 1992-03-10 University Of Florida Surface modified surgical instruments, devices, implants, contact lenses and the like
US6387379B1 (en) 1987-04-10 2002-05-14 University Of Florida Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like
US5100689A (en) * 1987-04-10 1992-03-31 University Of Florida Surface modified surgical instruments, devices, implants, contact lenses and the like
IT1215491B (en) 1987-05-15 1990-02-14 Enricerche Spa BIOSENSOR WITH ENZYMATIC MEMBRANE CHEMICALLY CONNECTED TO A SEMICONDUCTIVE DEVICE.
US4880883A (en) 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US5286364A (en) * 1987-06-08 1994-02-15 Rutgers University Surface-modified electochemical biosensor
US5540828A (en) 1987-06-08 1996-07-30 Yacynych; Alexander Method for making electrochemical sensors and biosensors having a polymer modified surface
US4810470A (en) 1987-06-19 1989-03-07 Miles Inc. Volume independent diagnostic device
US4786657A (en) 1987-07-02 1988-11-22 Minnesota Mining And Manufacturing Company Polyurethanes and polyurethane/polyureas crosslinked using 2-glyceryl acrylate or 2-glyceryl methacrylate
US4805625A (en) 1987-07-08 1989-02-21 Ad-Tech Medical Instrument Corporation Sphenoidal electrode and insertion method
JPH0824830B2 (en) 1987-07-13 1996-03-13 帝人株式会社 Separation membrane
JPH07114937B2 (en) 1987-07-13 1995-12-13 帝人株式会社 Separation membrane
FI77569C (en) 1987-07-13 1989-04-10 Huhtamaeki Oy ANORDINATION FOR THE PURPOSE OF THE OPERATIONS AND THE OPERATIONS OF ELLER EN VAEVNAD.
DE3725728A1 (en) 1987-08-04 1989-02-16 Freudenberg Carl Fa MEDICAL DEVICE AND METHOD FOR THE PRODUCTION THEREOF
US5221724A (en) 1987-08-12 1993-06-22 Wisconsin Alumni Research Foundation Polysiloxane polyurea urethanes
GB2209836A (en) 1987-09-16 1989-05-24 Cambridge Life Sciences Multilayer enzyme electrode membrane and method of making same
US4974929A (en) 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
NL8702370A (en) 1987-10-05 1989-05-01 Groningen Science Park METHOD AND SYSTEM FOR GLUCOSE DETERMINATION AND USEABLE MEASURING CELL ASSEMBLY.
DE3736652A1 (en) 1987-10-29 1989-05-11 Bayer Ag PROCESS FOR PREPARING COATINGS
US5242835A (en) 1987-11-03 1993-09-07 Radiometer A/S Method and apparatus for determining the concentration of oxygen
GB8725936D0 (en) 1987-11-05 1987-12-09 Genetics Int Inc Sensing system
US5128408A (en) 1987-11-16 1992-07-07 Toyo Boseki Kabushiki Kaisha Gas-permeable material with excellent compatibility with blood
US4852573A (en) 1987-12-04 1989-08-01 Kennedy Philip R Implantable neural electrode
US4813424A (en) 1987-12-23 1989-03-21 University Of New Mexico Long-life membrane electrode for non-ionic species
US4890621A (en) 1988-01-19 1990-01-02 Northstar Research Institute, Ltd. Continuous glucose monitoring and a system utilized therefor
US5070169A (en) 1988-02-26 1991-12-03 Ciba-Geigy Corporation Wettable, flexible, oxygen permeable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units and use thereof
US4822336A (en) * 1988-03-04 1989-04-18 Ditraglia John Blood glucose level sensing
US4955861A (en) 1988-04-21 1990-09-11 Therex Corp. Dual access infusion and monitoring system
US4793555A (en) 1988-04-22 1988-12-27 Dow Corning Corporation Container, method and composition for controlling the release of a volatile liquid from an aqueous mixture
US4951657A (en) 1988-04-22 1990-08-28 Dow Corning Corporation Heat sealable membrane for transdermal drug release
US4908208A (en) * 1988-04-22 1990-03-13 Dow Corning Corporation Matrix for release of active ingredients
US4952618A (en) 1988-05-03 1990-08-28 Minnesota Mining And Manufacturing Company Hydrocolloid/adhesive composition
US5034112A (en) 1988-05-19 1991-07-23 Nissan Motor Company, Ltd. Device for measuring concentration of nitrogen oxide in combustion gas
US5342693A (en) 1988-06-08 1994-08-30 Cardiopulmonics, Inc. Multifunctional thrombo-resistant coating and methods of manufacture
JPH022913A (en) 1988-06-16 1990-01-08 Bridgestone Corp Modified electrode
CA1299653C (en) 1988-07-07 1992-04-28 Markwell Medical Institute, Inc. Biological fluid measuring device
GB8817997D0 (en) 1988-07-28 1988-09-01 Cambridge Life Sciences Enzyme electrodes & improvements in manufacture thereof
EP0353328A1 (en) 1988-08-03 1990-02-07 Dräger Nederland B.V. A polarographic-amperometric three-electrode sensor
US5438984A (en) 1988-09-08 1995-08-08 Sudor Partners Apparatus and method for the collection of analytes on a dermal patch
US4960594A (en) 1988-09-22 1990-10-02 Derma-Lock Medical Corporation Polyurethane foam dressing
US4983702A (en) 1988-09-28 1991-01-08 Ciba-Geigy Corporation Crosslinked siloxane-urethane polymer contact lens
NL8802481A (en) * 1988-10-10 1990-05-01 Texas Instruments Holland TRANSPONDER AND METHOD FOR MAKING THE SAME
US6306594B1 (en) 1988-11-14 2001-10-23 I-Stat Corporation Methods for microdispensing patterened layers
US5063081A (en) 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
US5200051A (en) 1988-11-14 1993-04-06 I-Stat Corporation Wholly microfabricated biosensors and process for the manufacture and use thereof
US5212050A (en) 1988-11-14 1993-05-18 Mier Randall M Method of forming a permselective layer
WO1990007575A1 (en) 1988-12-30 1990-07-12 Anderson David M Stabilized microporous materials and hydrogel materials
US5269891A (en) 1989-03-09 1993-12-14 Novo Nordisk A/S Method and apparatus for determination of a constituent in a fluid
JPH02298855A (en) 1989-03-20 1990-12-11 Assoc Univ Inc Electrochemical biosensor using immobilized enzyme and redox polymer
US5089112A (en) 1989-03-20 1992-02-18 Associated Universities, Inc. Electrochemical biosensor based on immobilized enzymes and redox polymers
US4986671A (en) 1989-04-12 1991-01-22 Luxtron Corporation Three-parameter optical fiber sensor and system
US4953552A (en) 1989-04-21 1990-09-04 Demarzo Arthur P Blood glucose monitoring system
EP0396788A1 (en) 1989-05-08 1990-11-14 Dräger Nederland B.V. Process and sensor for measuring the glucose content of glucosecontaining fluids
US4907145A (en) * 1989-05-11 1990-03-06 Belmont Instrument Corporation Sine wave inverter
US4988341A (en) * 1989-06-05 1991-01-29 Eastman Kodak Company Sterilizing dressing device and method for skin puncture
US5034461A (en) 1989-06-07 1991-07-23 Bausch & Lomb Incorporated Novel prepolymers useful in biomedical devices
US5045601A (en) 1989-06-13 1991-09-03 Biointerface Technologies, Inc. Pressure-sensitive adhesive compositions suitable for medical uses
US4927407A (en) 1989-06-19 1990-05-22 Regents Of The University Of Minnesota Cardiac assist pump with steady rate supply of fluid lubricant
US5334681A (en) 1989-06-20 1994-08-02 Ciba-Geigy Corporation Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymer hydrogels and contact lenses thereof
US5115056A (en) 1989-06-20 1992-05-19 Ciba-Geigy Corporation Fluorine and/or silicone containing poly(alkylene-oxide)-block copolymers and contact lenses thereof
CH677149A5 (en) 1989-07-07 1991-04-15 Disetronic Ag
US5264104A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
FR2650756B1 (en) 1989-08-11 1991-10-31 Inst Francais Du Petrole GAS SEPARATION MEMBRANE
US5101814A (en) 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5050612A (en) 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5002590A (en) * 1989-09-19 1991-03-26 Bend Research, Inc. Countercurrent dehydration by hollow fibers
FR2652736A1 (en) 1989-10-06 1991-04-12 Neftel Frederic IMPLANTABLE DEVICE FOR EVALUATING THE RATE OF GLUCOSE.
JPH03133440A (en) 1989-10-18 1991-06-06 Nishitomo:Kk Clinical thermometer for ladies
US5010141A (en) * 1989-10-25 1991-04-23 Ciba-Geigy Corporation Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof
US5067491A (en) 1989-12-08 1991-11-26 Becton, Dickinson And Company Barrier coating on blood contacting devices
CA2071829C (en) 1989-12-14 2001-11-13 David A. Gough Method for increasing the service life of an implantable sensor
FR2656423A1 (en) 1989-12-22 1991-06-28 Rhone Poulenc Chimie Electrochemical biosensor
US5243696A (en) 1989-12-29 1993-09-07 General Signal Corporation Programmable electronic display for a chart recorder
US5183549A (en) * 1990-01-26 1993-02-02 Commtech International Management Corporation Multi-analyte sensing electrolytic cell
US5108819A (en) * 1990-02-14 1992-04-28 Eli Lilly And Company Thin film electrical component
US5031618A (en) 1990-03-07 1991-07-16 Medtronic, Inc. Position-responsive neuro stimulator
US5316008A (en) 1990-04-06 1994-05-31 Casio Computer Co., Ltd. Measurement of electrocardiographic wave and sphygmus
JPH07101215B2 (en) 1990-04-11 1995-11-01 国立身体障害者リハビリテーションセンター総長 Analytical method using biofunctional substance-immobilized electrode
GB9009409D0 (en) 1990-04-26 1990-06-20 Dow Corning Film-forming copolymers and their use in water vapour permeable coatings
US5331555A (en) 1990-05-11 1994-07-19 Sharp Kabushiki Kaisha Electronic apparatus
IT1248934B (en) 1990-06-01 1995-02-11 Fidia Spa BIOCOMPATIBLE PERFORATED MEMBRANES, PROCESSES FOR THEIR PREPARATION, THEIR USE AS A SUPPORT FOR THE IN VITRO GROWTH OF EPITHELIAL CELLS, ARTIFICIAL LEATHER THUS OBTAINED AND THEIR USE IN LEATHER TRANSPLANTS
US5147725A (en) 1990-07-03 1992-09-15 Corvita Corporation Method for bonding silicone rubber and polyurethane materials and articles manufactured thereby
US5202261A (en) 1990-07-19 1993-04-13 Miles Inc. Conductive sensors and their use in diagnostic assays
US5250439A (en) 1990-07-19 1993-10-05 Miles Inc. Use of conductive sensors in diagnostic assays
JPH0820412B2 (en) 1990-07-20 1996-03-04 松下電器産業株式会社 Quantitative analysis method and device using disposable sensor
US5746898A (en) 1990-08-10 1998-05-05 Siemens Aktiengesellschaft Electrochemical-enzymatic sensor
WO1992003107A1 (en) 1990-08-28 1992-03-05 Meadox Medicals, Inc. Self-supporting woven vascular graft
KR960012335B1 (en) 1990-09-17 1996-09-18 후지쓰 가부시끼가이샤 Oxygen electrode
WO1992007464A1 (en) 1990-10-24 1992-05-14 University Of Florida Combined plasma and gamma radiation polymerization method for modifying surfaces
US5219965A (en) 1990-11-27 1993-06-15 Bausch & Lomb Incorporated Surface modification of polymer objects
US5135297A (en) 1990-11-27 1992-08-04 Bausch & Lomb Incorporated Surface coating of polymer objects
US5354449A (en) 1991-01-10 1994-10-11 Band David M pH electrode
DE69228957T2 (en) 1991-01-16 1999-10-07 Toyo Boseki Blood compatible material
AU1356792A (en) 1991-01-25 1992-08-27 Markwell Medical Institute, Inc. Implantable biological fluid measuring device
US5348788A (en) 1991-01-30 1994-09-20 Interpore Orthopaedics, Inc. Mesh sheet with microscopic projections and holes
JPH04278450A (en) 1991-03-04 1992-10-05 Adam Heller Biosensor and method for analyzing subject
JPH08196626A (en) 1991-04-25 1996-08-06 Toyobo Co Ltd Blood compatible artificial pulmonary membrane
US5397848A (en) * 1991-04-25 1995-03-14 Allergan, Inc. Enhancing the hydrophilicity of silicone polymers
US5271736A (en) 1991-05-13 1993-12-21 Applied Medical Research Collagen disruptive morphology for implants
JP3118015B2 (en) * 1991-05-17 2000-12-18 アークレイ株式会社 Biosensor and separation and quantification method using the same
FI88223C (en) * 1991-05-22 1993-04-13 Polar Electro Oy Telemetric transmitter unit
JP3084642B2 (en) 1991-05-30 2000-09-04 株式会社ジェルテック Pad for dressing and method of manufacturing the same
JP2816262B2 (en) 1991-07-09 1998-10-27 工業技術院長 Carbon microsensor electrode and method of manufacturing the same
US5766151A (en) 1991-07-16 1998-06-16 Heartport, Inc. Endovascular system for arresting the heart
ATE137912T1 (en) 1991-09-13 1996-06-15 Rodney Arthur Stafford ELECTRONIC ANIMAL IDENTIFICATION SYSTEM
US5312361A (en) 1991-09-13 1994-05-17 Zadini Filiberto P Automatic cannulation device
DE4130742A1 (en) 1991-09-16 1993-03-18 Inst Diabetestechnologie Gemei METHOD AND ARRANGEMENT FOR DETERMINING THE CONCENTRATION OF INGREDIENTS IN BODY LIQUIDS
GB9120144D0 (en) 1991-09-20 1991-11-06 Imperial College A dialysis electrode device
US5155149A (en) 1991-10-10 1992-10-13 Boc Health Care, Inc. Silicone polyurethane copolymers containing oxygen sensitive phosphorescent dye compounds
US5605162A (en) 1991-10-15 1997-02-25 Advanced Cardiovascular Systems, Inc. Method for using a variable stiffness guidewire
US5249576A (en) 1991-10-24 1993-10-05 Boc Health Care, Inc. Universal pulse oximeter probe
EP0539625A1 (en) 1991-10-28 1993-05-05 Dräger Medical Electronics B.V. Electrochemical sensor for measuring the glucose content of glucose containing fluids
US5866217A (en) 1991-11-04 1999-02-02 Possis Medical, Inc. Silicone composite vascular graft
US5310469A (en) 1991-12-31 1994-05-10 Abbott Laboratories Biosensor with a membrane containing biologically active material
US5296144A (en) * 1992-01-02 1994-03-22 World Trade Corporation Composite membrane of a hydrophilic asymmetric membrane coated with an organosiloxane block copolymer
US5217594A (en) 1992-01-15 1993-06-08 Enzyme Technology Research Group, Inc. Convenient determination of trace lead in whole blood and other fluids
EP0553372B1 (en) 1992-01-29 1996-11-13 Hewlett-Packard GmbH Method and system for monitoring vital signs
US5582497A (en) 1992-01-29 1996-12-10 Wing Labo Co., Ltd. Automatic warehouse system
WO1993014693A1 (en) 1992-02-01 1993-08-05 The Victoria University Of Manchester Electrode
NL9200207A (en) 1992-02-05 1993-09-01 Nedap Nv IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION.
JPH05279447A (en) 1992-03-31 1993-10-26 Mitsubishi Rayon Co Ltd Silicon-based block copolymer and membrane made thereof
DE69319771T2 (en) 1992-03-31 1999-04-22 Dainippon Printing Co Ltd Immobilized enzyme electrode, composition for its production and electrically conductive enzymes
ES2167332T3 (en) 1992-04-01 2002-05-16 Baxter Int PROCEDURE AND SYSTEMS FOR THE IMPLANT OF LIVE CELLS IN GUESTS ORGANISMS.
US5324322A (en) 1992-04-20 1994-06-28 Case Western Reserve University Thin film implantable electrode and method of manufacture
US5589563A (en) 1992-04-24 1996-12-31 The Polymer Technology Group Surface-modifying endgroups for biomedical polymers
JP3857306B2 (en) 1992-04-24 2006-12-13 ザ ポリマー テクノロジー グループ,インコーポレイティド Copolymers and their non-porous, semi-permeable membranes and their use to permeate molecules of a given molecular weight range
GB9211402D0 (en) 1992-05-29 1992-07-15 Univ Manchester Sensor devices
US5330521A (en) 1992-06-29 1994-07-19 Cohen Donald M Low resistance implantable electrical leads
US5208313A (en) 1992-07-16 1993-05-04 Surface Coatings, Inc. Waterproof breathable polyurethane membranes and porous substrates protected therewith
JPH0634596A (en) 1992-07-20 1994-02-08 Fujitsu Ltd Oxygen electrode, biosensor and manufacture thereof
US5330634A (en) 1992-08-28 1994-07-19 Via Medical Corporation Calibration solutions useful for analyses of biological fluids and methods employing same
US5298144A (en) 1992-09-15 1994-03-29 The Yellow Springs Instrument Company, Inc. Chemically wired fructose dehydrogenase electrodes
EP1130388A1 (en) 1992-10-01 2001-09-05 Australian Membrane And Biotechnology Research Institute Improved sensor membranes
US5750029A (en) 1992-10-16 1998-05-12 Suprex Corporation Method and apparatus for determination of analyte concentration
US5307263A (en) 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
ZA938555B (en) 1992-11-23 1994-08-02 Lilly Co Eli Technique to improve the performance of electrochemical sensors
US5285513A (en) 1992-11-30 1994-02-08 At&T Bell Laboratories Optical fiber cable provided with stabilized waterblocking material
US5299571A (en) 1993-01-22 1994-04-05 Eli Lilly And Company Apparatus and method for implantation of sensors
JPH06229973A (en) * 1993-01-29 1994-08-19 Kyoto Daiichi Kagaku:Kk Current detection type dry ion selective electrode
US5389430A (en) 1993-02-05 1995-02-14 Th. Goldschmidt Ag Textiles coated with waterproof, moisture vapor permeable polymers
WO1994022367A1 (en) 1993-03-30 1994-10-13 Pfizer Inc. Radiotelemetry impedance plethysmography device
US5411866A (en) 1993-03-30 1995-05-02 National Research Council Of Canada Method and system for determining bioactive substances
US5387329A (en) 1993-04-09 1995-02-07 Ciba Corning Diagnostics Corp. Extended use planar sensors
US5425717A (en) 1993-05-07 1995-06-20 The Kendall Company Epidural catheter system utilizing splittable needle
US5352351A (en) 1993-06-08 1994-10-04 Boehringer Mannheim Corporation Biosensing meter with fail/safe procedures to prevent erroneous indications
CA2127817C (en) 1993-07-13 2007-07-03 Hitoshi Tsugaya Tobacco filters and method of producing the same
DE4427363A1 (en) 1993-08-03 1995-03-09 A & D Co Ltd A disposable chemical sensor
DE4329898A1 (en) 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
WO1995007109A1 (en) 1993-09-10 1995-03-16 Ottawa Heart Institute Research Corporation Electrohydraulic ventricular assist device
FR2710413B1 (en) 1993-09-21 1995-11-03 Asulab Sa Measuring device for removable sensors.
US5582184A (en) 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
KR970010981B1 (en) 1993-11-04 1997-07-05 엘지전자 주식회사 Alcohol concentration measuring bio-sensor, manufacturing method and related apparatus
US5545220A (en) 1993-11-04 1996-08-13 Lipomatrix Incorporated Implantable prosthesis with open cell textured surface and method for forming same
US5508509A (en) 1993-11-30 1996-04-16 Minnesota Mining And Manufacturing Company Sensing elements and methods for uniformly making individual sensing elements
US5437824A (en) 1993-12-23 1995-08-01 Moghan Medical Corp. Method of forming a molded silicone foam implant having open-celled interstices
DE4401400A1 (en) 1994-01-19 1995-07-20 Ernst Prof Dr Pfeiffer Method and arrangement for continuously monitoring the concentration of a metabolite
AUPM506894A0 (en) 1994-04-14 1994-05-05 Memtec Limited Novel electrochemical cells
ATE202942T1 (en) * 1994-04-15 2001-07-15 Cobe Cardiovascular Inc BLOOD COMPATIBLE COATED ITEM
US5466356A (en) 1994-04-29 1995-11-14 Mine Safety Appliances Company Potentiostat circuit for electrochemical cells
US5584876A (en) 1994-04-29 1996-12-17 W. L. Gore & Associates, Inc. Cell excluding sheath for vascular grafts
DE4415896A1 (en) 1994-05-05 1995-11-09 Boehringer Mannheim Gmbh Analysis system for monitoring the concentration of an analyte in the blood of a patient
US5484404A (en) * 1994-05-06 1996-01-16 Alfred E. Mann Foundation For Scientific Research Replaceable catheter system for physiological sensors, tissue stimulating electrodes and/or implantable fluid delivery systems
US5482473A (en) * 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
DE59509994D1 (en) 1994-06-03 2002-02-21 Metrohm Ag Herisau Device for voltammetry, indicator electrode arrangement for such a device, in particular as part of a tape cassette, and row analysis method for voltammetry
US5766839A (en) 1994-06-17 1998-06-16 Ysi Incorporated Processes for preparing barrier layer films for use in enzyme electrodes and films made thereby
DE4422068A1 (en) 1994-06-23 1996-01-04 Siemens Ag Electro-catalytic glucose sensor in catheter form
US5429735A (en) 1994-06-27 1995-07-04 Miles Inc. Method of making and amperometric electrodes
US5474552A (en) 1994-06-27 1995-12-12 Cb-Carmel Biotechnology Ltd. Implantable drug delivery pump
US5494562A (en) 1994-06-27 1996-02-27 Ciba Corning Diagnostics Corp. Electrochemical sensors
CN1157560A (en) 1994-07-08 1997-08-20 巴克斯特国际有限公司 Implanted device containing tumor cells for treatment of cancer
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5513636A (en) 1994-08-12 1996-05-07 Cb-Carmel Biotechnology Ltd. Implantable sensor chip
US5462051A (en) 1994-08-31 1995-10-31 Colin Corporation Medical communication system
US5624537A (en) * 1994-09-20 1997-04-29 The University Of British Columbia - University-Industry Liaison Office Biosensor and interface membrane
US5486776A (en) 1994-09-29 1996-01-23 Xilinx, Inc. Antifuse-based programmable logic circuit
US5552112A (en) 1995-01-26 1996-09-03 Quiclave, Llc Method and system for sterilizing medical instruments
CA2159052C (en) 1994-10-28 2007-03-06 Rainer Alex Injection device
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
DK0792454T3 (en) * 1994-11-14 2002-06-03 Bayer Ag Randomly segmented thermoplastic polyurethanes as matrix for electrochemical analysis of Ca ++ ions
US5670097A (en) 1994-12-08 1997-09-23 Minnesota Mining And Manufacturing Company Method of making blood gas sensors overcoats using permeable polymeric compositions
US5700559A (en) 1994-12-16 1997-12-23 Advanced Surface Technology Durable hydrophilic surface coatings
EP0722691A1 (en) 1994-12-24 1996-07-24 Roche Diagnostics GmbH System for determining properties of tissue
US5590651A (en) * 1995-01-17 1997-01-07 Temple University - Of The Commonwealth System Of Higher Education Breathable liquid elimination analysis
US5837728A (en) 1995-01-27 1998-11-17 Molecular Design International 9-cis retinoic acid esters and amides and uses thereof
US5697366A (en) 1995-01-27 1997-12-16 Optical Sensors Incorporated In situ calibration system for sensors located in a physiologic line
US5676820A (en) 1995-02-03 1997-10-14 New Mexico State University Technology Transfer Corp. Remote electrochemical sensor
US5586553A (en) 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
US5568806A (en) 1995-02-16 1996-10-29 Minimed Inc. Transcutaneous sensor insertion set
KR100449615B1 (en) 1995-03-10 2004-12-08 메소 스케일 테크놀러지즈, 엘엘시 Multi-array, multi-specific electrochemiluminescence test
US5582697A (en) 1995-03-17 1996-12-10 Matsushita Electric Industrial Co., Ltd. Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same
US5571401A (en) 1995-03-27 1996-11-05 California Institute Of Technology Sensor arrays for detecting analytes in fluids
US5607565A (en) * 1995-03-27 1997-03-04 Coulter Corporation Apparatus for measuring analytes in a fluid sample
US5786439A (en) 1996-10-24 1998-07-28 Minimed Inc. Hydrophilic, swellable coatings for biosensors
DE29624309U1 (en) * 1995-04-04 2002-01-03 Novartis Ag Duration supporting lenses
TW393498B (en) 1995-04-04 2000-06-11 Novartis Ag The preparation and use of Polysiloxane-comprising perfluoroalkyl ethers
WO1996032076A1 (en) 1995-04-11 1996-10-17 Baxter Internatonal Inc. Tissue implant systems
FR2733104B1 (en) 1995-04-12 1997-06-06 Droz Francois SMALL-DIMENSIONAL ANSWERING MACHINE AND METHOD FOR MANUFACTURING SUCH ANSWERING MACHINES
US5620579A (en) 1995-05-05 1997-04-15 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
US6060640A (en) 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
CA2190628C (en) 1995-06-07 2000-05-30 Mark D. Butler An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
US5626561A (en) 1995-06-07 1997-05-06 Gore Hybrid Technologies, Inc. Implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
US5743262A (en) 1995-06-07 1998-04-28 Masimo Corporation Blood glucose monitoring system
US5584813A (en) 1995-06-07 1996-12-17 Minimed Inc. Subcutaneous injection set
US5656707A (en) 1995-06-16 1997-08-12 Regents Of The University Of Minnesota Highly cross-linked polymeric supports
US5840148A (en) 1995-06-30 1998-11-24 Bio Medic Data Systems, Inc. Method of assembly of implantable transponder
US5611900A (en) * 1995-07-20 1997-03-18 Michigan State University Microbiosensor used in-situ
US5700902A (en) 1995-07-27 1997-12-23 Circe Biomedical, Inc. Block copolymers
US6001471A (en) 1995-08-11 1999-12-14 3M Innovative Properties Company Removable adhesive tape with controlled sequential release
AUPN487495A0 (en) 1995-08-18 1995-09-14 Cardiac Crc Nominees Pty Limited A multipolar transmural probe
US5989409A (en) 1995-09-11 1999-11-23 Cygnus, Inc. Method for glucose sensing
US5735273A (en) * 1995-09-12 1998-04-07 Cygnus, Inc. Chemical signal-impermeable mask
JP2000501069A (en) 1995-09-21 2000-02-02 ノバルティス・アクチエンゲゼルシャフト Polymer-bound fluorophores as photoion sensors
CA2232588A1 (en) 1995-09-26 1997-04-03 Ameron International Corporation Polysiloxane polyurethane compositions
US5972199A (en) 1995-10-11 1999-10-26 E. Heller & Company Electrochemical analyte sensors using thermostable peroxidase
US6689265B2 (en) 1995-10-11 2004-02-10 Therasense, Inc. Electrochemical analyte sensors using thermostable soybean peroxidase
US5665222A (en) 1995-10-11 1997-09-09 E. Heller & Company Soybean peroxidase electrochemical sensor
US5855613A (en) 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
BR9611043A (en) 1995-10-16 1999-07-06 Procter & Gamble Compositions for conditioner shampoo with improved stability
WO1997014405A1 (en) 1995-10-16 1997-04-24 The Procter & Gamble Company Conditioning shampoos containing polyalkylene glycol
JP3592416B2 (en) 1995-10-31 2004-11-24 晃敏 吉田 Measuring device for intraocular substances
WO1997017607A1 (en) 1995-11-08 1997-05-15 The Victoria University Of Manchester Membrane for chemical and biosensors
AU1058297A (en) * 1995-11-22 1997-06-11 Minimed, Inc. Detection of biological molecules using chemical amplification and optical sensors
US6002954A (en) 1995-11-22 1999-12-14 The Regents Of The University Of California Detection of biological molecules using boronate-based chemical amplification and optical sensors
US6063637A (en) 1995-12-13 2000-05-16 California Institute Of Technology Sensors for sugars and other metal binding analytes
DE69623647T2 (en) 1995-12-22 2003-05-28 Novartis Ag POLYURETHANE MADE OF POLYSILOXANE-POLYOL MACROMER
US5588560A (en) 1996-01-11 1996-12-31 Dow Corning Corporation Ergonomeric dispenser for viscous materials
US5795453A (en) 1996-01-23 1998-08-18 Gilmartin; Markas A. T. Electrodes and metallo isoindole ringed compounds
US5977613A (en) * 1996-03-07 1999-11-02 Matsushita Electronics Corporation Electronic component, method for making the same, and lead frame and mold assembly for use therein
US5833603A (en) 1996-03-13 1998-11-10 Lipomatrix, Inc. Implantable biosensing transponder
US5932299A (en) 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US6407195B2 (en) 1996-04-25 2002-06-18 3M Innovative Properties Company Tackified polydiorganosiloxane oligourea segmented copolymers and a process for making same
US6022463A (en) * 1996-05-16 2000-02-08 Sendx Medical, Inc. Sensors with subminiature through holes
US5776324A (en) 1996-05-17 1998-07-07 Encelle, Inc. Electrochemical biosensors
US5914182A (en) * 1996-06-03 1999-06-22 Gore Hybrid Technologies, Inc. Materials and methods for the immobilization of bioactive species onto polymeric substrates
EP0923335B1 (en) * 1996-07-08 2006-08-23 Animas Corporation Implantable sensor and system for in vivo measurement and control of fluid constituent levels
JP2943700B2 (en) 1996-07-10 1999-08-30 日本電気株式会社 Biosensor
US5707502A (en) 1996-07-12 1998-01-13 Chiron Diagnostics Corporation Sensors for measuring analyte concentrations and methods of making same
US6325978B1 (en) 1998-08-04 2001-12-04 Ntc Technology Inc. Oxygen monitoring and apparatus
US5703359A (en) 1996-07-29 1997-12-30 Leybold Inficon, Inc. Composite membrane and support assembly
US6054142A (en) 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US5804048A (en) 1996-08-15 1998-09-08 Via Medical Corporation Electrode assembly for assaying glucose
US6018013A (en) * 1996-09-03 2000-01-25 Nkk Corporation Coating composition and method for producing precoated steel sheets
US5885566A (en) * 1996-09-25 1999-03-23 University Of Florida Surface modified surgical instruments, medical devices, implants, contact lenses and the like
US5963132A (en) 1996-10-11 1999-10-05 Avid Indentification Systems, Inc. Encapsulated implantable transponder
DE19642453C2 (en) 1996-10-15 1998-07-23 Bosch Gmbh Robert Arrangement for gas sensor electrodes
US6001068A (en) 1996-10-22 1999-12-14 Terumo Kabushiki Kaisha Guide wire having tubular connector with helical slits
ES2401046T3 (en) 1996-10-30 2013-04-16 F.Hoffmann-La Roche Ag Synchronized analyte test system
JP4451931B2 (en) 1996-11-12 2010-04-14 ホアットマン,インコーポレーテッド Hydrophilic polymer phase change membrane
DK0944731T3 (en) 1996-11-14 2006-05-22 Radiometer Medical Aps enzyme Sensor
AU5461298A (en) 1996-12-04 1998-06-29 Enact Health Management Systems System for downloading and reporting medical information
US6071249A (en) 1996-12-06 2000-06-06 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests
US5811487A (en) 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
US5708354A (en) * 1996-12-18 1998-01-13 Mcdermott Technology, Inc. Portable electromagnetic acoustic transducer pulser controller
US5964993A (en) 1996-12-19 1999-10-12 Implanted Biosystems Inc. Glucose sensor
US5914026A (en) 1997-01-06 1999-06-22 Implanted Biosystems Inc. Implantable sensor employing an auxiliary electrode
US5851197A (en) 1997-02-05 1998-12-22 Minimed Inc. Injector for a subcutaneous infusion set
US6607509B2 (en) 1997-12-31 2003-08-19 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6093172A (en) 1997-02-05 2000-07-25 Minimed Inc. Injector for a subcutaneous insertion set
US6293925B1 (en) 1997-12-31 2001-09-25 Minimed Inc. Insertion device for an insertion set and method of using the same
US6891317B2 (en) * 2001-05-22 2005-05-10 Sri International Rolled electroactive polymers
US5977241A (en) 1997-02-26 1999-11-02 Integument Technologies, Inc. Polymer and inorganic-organic hybrid composites and methods for making same
US7657297B2 (en) 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US6862465B2 (en) 1997-03-04 2005-03-01 Dexcom, Inc. Device and method for determining analyte levels
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US6558321B1 (en) 1997-03-04 2003-05-06 Dexcom, Inc. Systems and methods for remote monitoring and modulation of medical devices
US20050033132A1 (en) 1997-03-04 2005-02-10 Shults Mark C. Analyte measuring device
US6741877B1 (en) * 1997-03-04 2004-05-25 Dexcom, Inc. Device and method for determining analyte levels
US7192450B2 (en) * 2003-05-21 2007-03-20 Dexcom, Inc. Porous membranes for use with implantable devices
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
FR2760962B1 (en) 1997-03-20 1999-05-14 Sillonville Francis Klefstad REMOTE MEDICAL ASSISTANCE AND SURVEILLANCE SYSTEM
US6270455B1 (en) 1997-03-28 2001-08-07 Health Hero Network, Inc. Networked system for interactive communications and remote monitoring of drug delivery
US5961451A (en) 1997-04-07 1999-10-05 Motorola, Inc. Noninvasive apparatus having a retaining member to retain a removable biosensor
US6059946A (en) 1997-04-14 2000-05-09 Matsushita Electric Industrial Co., Ltd. Biosensor
US5944661A (en) 1997-04-16 1999-08-31 Giner, Inc. Potential and diffusion controlled solid electrolyte sensor for continuous measurement of very low levels of transdermal alcohol
AT404992B (en) * 1997-04-17 1999-04-26 Avl List Gmbh SENSOR FOR DETERMINING AN ENZYME SUBSTRATE
US6115634A (en) 1997-04-30 2000-09-05 Medtronic, Inc. Implantable medical device and method of manufacture
US5779665A (en) 1997-05-08 1998-07-14 Minimed Inc. Transdermal introducer assembly
US6018033A (en) * 1997-05-13 2000-01-25 Purdue Research Foundation Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US7267665B2 (en) 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US5954643A (en) 1997-06-09 1999-09-21 Minimid Inc. Insertion set for a transcutaneous sensor
JP2002505008A (en) 1997-06-16 2002-02-12 エラン コーポレーション ピーエルシー Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods
US6093167A (en) 1997-06-16 2000-07-25 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6013711A (en) 1997-06-18 2000-01-11 Ck Witco Corporation Hydrophilic polysiloxane compositions
US6309526B1 (en) 1997-07-10 2001-10-30 Matsushita Electric Industrial Co., Ltd. Biosensor
US5861019A (en) * 1997-07-25 1999-01-19 Medtronic Inc. Implantable medical device microstrip telemetry antenna
US5823802A (en) 1997-07-30 1998-10-20 General Motors Corporation Electrical connector with combination seal and contact member
US5871514A (en) 1997-08-01 1999-02-16 Medtronic, Inc. Attachment apparatus for an implantable medical device employing ultrasonic energy
ES2227880T3 (en) 1997-08-09 2005-04-01 Roche Diagnostics Gmbh ANALYSIS DEVICE FOR PERFORMING LIVE ANALYSIS IN A PATIENT'S BODY.
US6731976B2 (en) 1997-09-03 2004-05-04 Medtronic, Inc. Device and method to measure and communicate body parameters
US5917346A (en) 1997-09-12 1999-06-29 Alfred E. Mann Foundation Low power current to frequency converter circuit for use in implantable sensors
US5999848A (en) 1997-09-12 1999-12-07 Alfred E. Mann Foundation Daisy chainable sensors and stimulators for implantation in living tissue
US6117290A (en) 1997-09-26 2000-09-12 Pepex Biomedical, Llc System and method for measuring a bioanalyte such as lactate
WO1999017095A1 (en) 1997-09-30 1999-04-08 M-Biotech, Inc. Biosensor
US7115884B1 (en) 1997-10-06 2006-10-03 Trustees Of Tufts College Self-encoding fiber optic sensor
US6409674B1 (en) 1998-09-24 2002-06-25 Data Sciences International, Inc. Implantable sensor with wireless communication
US6585763B1 (en) 1997-10-14 2003-07-01 Vascusense, Inc. Implantable therapeutic device and method
US6088608A (en) 1997-10-20 2000-07-11 Alfred E. Mann Foundation Electrochemical sensor and integrity tests therefor
US6104280A (en) 1997-10-20 2000-08-15 Micron Technology, Inc. Method of manufacturing and testing an electronic device, and an electronic device
US6081736A (en) * 1997-10-20 2000-06-27 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems adapted for long term use
US6579690B1 (en) 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
US6893552B1 (en) 1997-12-29 2005-05-17 Arrowhead Center, Inc. Microsensors for glucose and insulin monitoring
US6030827A (en) * 1998-01-23 2000-02-29 I-Stat Corporation Microfabricated aperture-based sensor
US7052131B2 (en) * 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6103033A (en) 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6013113A (en) * 1998-03-06 2000-01-11 Wilson Greatbatch Ltd. Slotted insulator for unsealed electrode edges in electrochemical cells
US5928130A (en) 1998-03-16 1999-07-27 Schmidt; Bruno Apparatus and method for implanting radioactive seeds in tissue
US5904708A (en) 1998-03-19 1999-05-18 Medtronic, Inc. System and method for deriving relative physiologic signals
GB9805896D0 (en) 1998-03-20 1998-05-13 Eglise David Remote analysis system
JP3104672B2 (en) 1998-03-31 2000-10-30 日本電気株式会社 Current detection type sensor element and method of manufacturing the same
US6091975A (en) 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
US6074775A (en) 1998-04-02 2000-06-13 The Procter & Gamble Company Battery having a built-in controller
US6537318B1 (en) * 1998-04-06 2003-03-25 Konjac Technologies, Llc Use of glucomannan hydrocolloid as filler material in prostheses
US6534711B1 (en) 1998-04-14 2003-03-18 The Goodyear Tire & Rubber Company Encapsulation package and method of packaging an electronic circuit module
US6241863B1 (en) 1998-04-27 2001-06-05 Harold G. Monbouquette Amperometric biosensors based on redox enzymes
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
AU3872799A (en) 1998-05-04 1999-11-23 Gamut Technology, Inc. Flexible armored communication cable and method of manufacture
US5969076A (en) 1998-05-15 1999-10-19 Bausch & Lomb Incorporated Thermoplastic silicone-containing hydrogels
US6129757A (en) 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
US7540875B2 (en) * 1998-06-01 2009-06-02 Avatar Design & Development, Inc. Surgical cutting tool with automatically retractable blade assembly
US6702972B1 (en) * 1998-06-09 2004-03-09 Diametrics Medical Limited Method of making a kink-resistant catheter
US7344499B1 (en) * 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
JP3293556B2 (en) 1998-06-12 2002-06-17 住友電装株式会社 Protector
US6187062B1 (en) * 1998-06-16 2001-02-13 Alcatel Current collection through thermally sprayed tabs at the ends of a spirally wound electrochemical cell
US6294281B1 (en) 1998-06-17 2001-09-25 Therasense, Inc. Biological fuel cell and method
US6290839B1 (en) 1998-06-23 2001-09-18 Clinical Micro Sensors, Inc. Systems for electrophoretic transport and detection of analytes
EP0967788A2 (en) 1998-06-26 1999-12-29 Hewlett-Packard Company Dynamic generation of multi-resolution and tile-based images from flat compressed images
US6495023B1 (en) 1998-07-09 2002-12-17 Michigan State University Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration
US6558320B1 (en) 2000-01-20 2003-05-06 Medtronic Minimed, Inc. Handheld personal data assistant (PDA) with a medical device and method of using the same
US6248067B1 (en) 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
JP3267936B2 (en) * 1998-08-26 2002-03-25 松下電器産業株式会社 Biosensor
TW495608B (en) 1998-08-26 2002-07-21 Sensors For Med & Science Inc Optical-based sensing devices
US6039913A (en) * 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
US6740518B1 (en) 1998-09-17 2004-05-25 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes
ATE514372T1 (en) 1998-10-08 2011-07-15 Medtronic Minimed Inc LICENSE PLATE MONITORING SYSTEM WITH REMOTE MEASUREMENT
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
ATE241705T1 (en) 1998-10-23 2003-06-15 Pierre Beuret HEAT TREATMENT SYSTEM FOR A BATCH OF METALLIC WORKPIECES
US6016448A (en) * 1998-10-27 2000-01-18 Medtronic, Inc. Multilevel ERI for implantable medical devices
US6156013A (en) * 1998-11-04 2000-12-05 Mahurkar; Sakharam D. Safety syringe
US6329488B1 (en) 1998-11-10 2001-12-11 C. R. Bard, Inc. Silane copolymer coatings
US6478771B1 (en) * 1998-11-13 2002-11-12 Elan Pharma International Limited Drug delivery systems and methods
DE69924749T2 (en) 1998-11-20 2006-04-27 The University Of Connecticut, Farmington Generically integrated implantable potentiostat remote sensing device for electrochemical probes
US6066083A (en) 1998-11-27 2000-05-23 Syntheon Llc Implantable brachytherapy device having at least partial deactivation capability
CA2352571C (en) 1998-12-02 2007-02-27 Gary S. Sayler In vivo biosensor apparatus and method of use
WO2000038570A1 (en) 1998-12-31 2000-07-06 Ball Semiconductor, Inc. Miniature implanted orthopedic sensors
US6169155B1 (en) * 1999-01-14 2001-01-02 Dow Corning Corporation Silicone gel composition and silicone gel produced therefrom
US6309384B1 (en) 1999-02-01 2001-10-30 Adiana, Inc. Method and apparatus for tubal occlusion
ATE552771T1 (en) 1999-02-25 2012-04-15 Medtronic Minimed Inc TEST PLUG AND CABLE FOR GLUCOSE MONITORING DEVICE
US6424847B1 (en) 1999-02-25 2002-07-23 Medtronic Minimed, Inc. Glucose monitor calibration methods
KR100342165B1 (en) * 1999-03-25 2002-06-27 배병우 Solid-State Type Micro Reference Electrode with Self-Diagnostic Function
WO2000059373A1 (en) * 1999-04-07 2000-10-12 Spectrx, Inc. Assay device for measuring characteristics of a fluid on a continual basis
EP1175176B1 (en) 1999-04-07 2010-09-22 Endonetics, Inc. Implantable monitoring probe
US6285897B1 (en) 1999-04-07 2001-09-04 Endonetics, Inc. Remote physiological monitoring system
US6189536B1 (en) * 1999-04-15 2001-02-20 Medtronic Inc. Method for protecting implantable devices
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
JP2002542498A (en) 1999-04-22 2002-12-10 シグナス, インコーポレイテッド Methods and devices for removing interfering species
US6475750B1 (en) 1999-05-11 2002-11-05 M-Biotech, Inc. Glucose biosensor
US6300002B1 (en) 1999-05-13 2001-10-09 Moltech Power Systems, Inc. Notched electrode and method of making same
US6546268B1 (en) 1999-06-02 2003-04-08 Ball Semiconductor, Inc. Glucose sensor
EP1106681A4 (en) 1999-06-10 2005-03-23 Matsushita Electric Ind Co Ltd Electrochemical device for moving particles covered with protein
AU5747100A (en) 1999-06-18 2001-01-09 Therasense, Inc. Mass transport limited in vivo analyte sensor
GB2351153B (en) 1999-06-18 2003-03-26 Abbott Lab Electrochemical sensor for analysis of liquid samples
US7247138B2 (en) 1999-07-01 2007-07-24 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US6368274B1 (en) 1999-07-01 2002-04-09 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
US6413393B1 (en) 1999-07-07 2002-07-02 Minimed, Inc. Sensor including UV-absorbing polymer and method of manufacture
DE19935063A1 (en) * 1999-07-28 2001-02-01 Basf Ag Graft polymers as gas hydrate inhibitors
US6471689B1 (en) 1999-08-16 2002-10-29 Thomas Jefferson University Implantable drug delivery catheter system with capillary interface
US6346583B1 (en) 1999-08-25 2002-02-12 General Electric Company Polar solvent compatible polyethersiloxane elastomers
US6358557B1 (en) * 1999-09-10 2002-03-19 Sts Biopolymers, Inc. Graft polymerization of substrate surfaces
US6312469B1 (en) 1999-09-13 2001-11-06 Medtronic Inc. Lamina prosthesis for delivery of medical treatment
US6343225B1 (en) 1999-09-14 2002-01-29 Implanted Biosystems, Inc. Implantable glucose sensor
EP1214596A1 (en) 1999-09-15 2002-06-19 The Regents Of The University Of California Glucose sensing molecules having selected fluorescent properties
US6541107B1 (en) 1999-10-25 2003-04-01 Dow Corning Corporation Nanoporous silicone resins having low dielectric constants
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US6527729B1 (en) * 1999-11-10 2003-03-04 Pacesetter, Inc. Method for monitoring patient using acoustic sensor
JP3426549B2 (en) 1999-11-12 2003-07-14 本田技研工業株式会社 Exhaust pipe connection structure
US8268143B2 (en) 1999-11-15 2012-09-18 Abbott Diabetes Care Inc. Oxygen-effect free analyte sensor
US6670115B1 (en) 1999-11-24 2003-12-30 Biotronic Technologies, Inc. Devices and methods for detecting analytes using electrosensor having capture reagent
DE19956822B4 (en) 1999-11-25 2004-01-29 Siemens Ag Method for determining the NOx concentration
GB9928071D0 (en) * 1999-11-29 2000-01-26 Polybiomed Ltd Blood compatible medical articles
US6612984B1 (en) 1999-12-03 2003-09-02 Kerr, Ii Robert A. System and method for collecting and transmitting medical data
US6520997B1 (en) 1999-12-08 2003-02-18 Baxter International Inc. Porous three dimensional structure
US7369635B2 (en) 2000-01-21 2008-05-06 Medtronic Minimed, Inc. Rapid discrimination preambles and methods for using the same
US6974437B2 (en) 2000-01-21 2005-12-13 Medtronic Minimed, Inc. Microprocessor controlled ambulatory medical apparatus with hand held communication device
US20020016535A1 (en) * 2000-01-28 2002-02-07 Martin W. Blake Subcutaneous glucose measurement device
US6484045B1 (en) 2000-02-10 2002-11-19 Medtronic Minimed, Inc. Analyte sensor and method of making the same
US7003336B2 (en) 2000-02-10 2006-02-21 Medtronic Minimed, Inc. Analyte sensor method of making the same
WO2001058348A2 (en) 2000-02-10 2001-08-16 Minimed Inc. Improved analyte sensor and method of making the same
US6895263B2 (en) 2000-02-23 2005-05-17 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US6303670B1 (en) 2000-02-25 2001-10-16 Nippon Paper Industries Co., Ltd. Cellulose based coating composition curable with ultraviolet ray
CA2399842C (en) 2000-03-02 2006-11-14 Microchips, Inc. Microfabricated devices for the storage and selective exposure of chemicals and devices
US6551496B1 (en) 2000-03-03 2003-04-22 Ysi Incorporated Microstructured bilateral sensor
US6733655B1 (en) 2000-03-08 2004-05-11 Oliver W. H. Davies Measurement of substances in liquids
US6498941B1 (en) 2000-03-09 2002-12-24 Advanced Cardiovascular Systems, Inc. Catheter based probe and method of using same for detecting chemical analytes
US6365670B1 (en) 2000-03-10 2002-04-02 Wacker Silicones Corporation Organopolysiloxane gels for use in cosmetics
WO2001069222A2 (en) 2000-03-17 2001-09-20 F. Hoffmann-La Roche Ag Implantable analyte sensor
US6405066B1 (en) 2000-03-17 2002-06-11 The Regents Of The University Of California Implantable analyte sensor
US6612111B1 (en) 2000-03-27 2003-09-02 Lifescan, Inc. Method and device for sampling and analyzing interstitial fluid and whole blood samples
AU2001263022A1 (en) 2000-05-12 2001-11-26 Therasense, Inc. Electrodes with multilayer membranes and methods of using and making the electrodes
US6442413B1 (en) 2000-05-15 2002-08-27 James H. Silver Implantable sensor
US7181261B2 (en) 2000-05-15 2007-02-20 Silver James H Implantable, retrievable, thrombus minimizing sensors
US7769420B2 (en) 2000-05-15 2010-08-03 Silver James H Sensors for detecting substances indicative of stroke, ischemia, or myocardial infarction
US6885883B2 (en) 2000-05-16 2005-04-26 Cygnus, Inc. Methods for improving performance and reliability of biosensors
US6459917B1 (en) 2000-05-22 2002-10-01 Ashok Gowda Apparatus for access to interstitial fluid, blood, or blood plasma components
JP3701608B2 (en) 2000-05-23 2005-10-05 ラジオメーター・メディカル・アー・ペー・エス Sensor membrane, method for its preparation, sensor and layered membrane structure for such a sensor
US6991652B2 (en) * 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US6773565B2 (en) 2000-06-22 2004-08-10 Kabushiki Kaisha Riken NOx sensor
KR100409017B1 (en) 2000-06-23 2003-12-06 주식회사 엘지화학 Multi-component composite membrane and method for preparing the same
US6400974B1 (en) 2000-06-29 2002-06-04 Sensors For Medicine And Science, Inc. Implanted sensor processing system and method for processing implanted sensor output
US6569521B1 (en) 2000-07-06 2003-05-27 3M Innovative Properties Company Stretch releasing pressure sensitive adhesive tape and articles
US6477392B1 (en) 2000-07-14 2002-11-05 Futrex Inc. Calibration of near infrared quantitative measurement device using optical measurement cross-products
US6683535B1 (en) * 2000-08-09 2004-01-27 Alderon Industries, Llc Water detection system and method
US7470488B2 (en) 2000-08-12 2008-12-30 Lg Chemical Co., Ltd. Multi-component composite film method for preparing the same
WO2002017210A2 (en) 2000-08-18 2002-02-28 Cygnus, Inc. Formulation and manipulation of databases of analyte and associated values
US6553241B2 (en) 2000-08-31 2003-04-22 Mallinckrodt Inc. Oximeter sensor with digital memory encoding sensor expiration data
US6793789B2 (en) 2000-09-30 2004-09-21 Geun Sig Cha Reference electrode with a polymeric reference electrode membrane
FR2815199B1 (en) 2000-10-10 2003-01-17 Canon Kk CIRCULAR TURBOCODING METHODS OF LARGE MINIMUM DISTANCE, AND SYSTEMS FOR IMPLEMENTING THE SAME
EP1695727B1 (en) * 2000-11-09 2008-07-23 Insulet Corporation Transcutaneous delivery means
US6695860B1 (en) * 2000-11-13 2004-02-24 Isense Corp. Transcutaneous sensor insertion device
DE10060852A1 (en) 2000-12-06 2002-06-20 Hexal Ag Active ingredient-impermeable cover layer or removable protective layer of a transdermal therapeutic system containing absorbents and channel formers
US6742635B2 (en) 2000-12-20 2004-06-01 Jr286 Inc. Sports bag including an attached mat
JP2002189015A (en) 2000-12-20 2002-07-05 Sankyo Co Ltd Reaction-current measuring method by enzyme electrode
US6642015B2 (en) 2000-12-29 2003-11-04 Minimed Inc. Hydrophilic polymeric material for coating biosensors
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
WO2002053193A2 (en) 2001-01-02 2002-07-11 The Charles Stark Draper Laboratory, Inc. Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
US6793802B2 (en) 2001-01-04 2004-09-21 Tyson Bioresearch, Inc. Biosensors having improved sample application and measuring properties and uses thereof
US6666821B2 (en) * 2001-01-08 2003-12-23 Medtronic, Inc. Sensor system
US7078582B2 (en) 2001-01-17 2006-07-18 3M Innovative Properties Company Stretch removable adhesive articles and methods
US6547839B2 (en) 2001-01-23 2003-04-15 Skc Co., Ltd. Method of making an electrochemical cell by the application of polysiloxane onto at least one of the cell components
US6510329B2 (en) 2001-01-24 2003-01-21 Datex-Ohmeda, Inc. Detection of sensor off conditions in a pulse oximeter
US7014610B2 (en) 2001-02-09 2006-03-21 Medtronic, Inc. Echogenic devices and methods of making and using such devices
US6721587B2 (en) 2001-02-15 2004-04-13 Regents Of The University Of California Membrane and electrode structure for implantable sensor
KR100406690B1 (en) * 2001-03-05 2003-11-21 주식회사 엘지화학 Electrochemical device using multicomponent composite membrane film
US6952603B2 (en) 2001-03-16 2005-10-04 Roche Diagnostics Operations, Inc. Subcutaneous analyte sensor
US6576102B1 (en) 2001-03-23 2003-06-10 Virotek, L.L.C. Electrochemical sensor and method thereof
FR2822383B1 (en) 2001-03-23 2004-12-17 Perouse Lab PROSTHESIS FOR PLASTIC RECONSTRUCTION WITH IMPROVED HYDROPHILICITY PROPERTIES, AND METHOD FOR OBTAINING SAME
US6454710B1 (en) 2001-04-11 2002-09-24 Motorola, Inc. Devices and methods for monitoring an analyte
US6528584B2 (en) 2001-04-12 2003-03-04 The University Of Akron Multi-component polymeric networks containing poly(ethylene glycol)
DE10119036C1 (en) * 2001-04-18 2002-12-12 Disetronic Licensing Ag Immersion sensor for measuring the concentration of an analyte using an oxidase
US6613379B2 (en) 2001-05-08 2003-09-02 Isense Corp. Implantable analyte sensor
US6932894B2 (en) 2001-05-15 2005-08-23 Therasense, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US20020177763A1 (en) 2001-05-22 2002-11-28 Burns David W. Integrated lancets and methods
US6960466B2 (en) 2001-05-31 2005-11-01 Instrumentation Laboratory Company Composite membrane containing a cross-linked enzyme matrix for a biosensor
US6501976B1 (en) 2001-06-12 2002-12-31 Lifescan, Inc. Percutaneous biological fluid sampling and analyte measurement devices and methods
US6837988B2 (en) 2001-06-12 2005-01-04 Lifescan, Inc. Biological fluid sampling and analyte measurement devices and methods
US6650835B2 (en) * 2001-06-14 2003-11-18 Konica Corporation Photographing device, recording medium, program, camera and camera production method
US6802827B2 (en) 2001-06-26 2004-10-12 Stig O. Andersson Hypodermic implant device
AU2002361545B2 (en) 2001-06-28 2007-03-15 Microchips, Inc. Methods for hermetically sealing microchip reservoir devices
GB0115793D0 (en) 2001-06-28 2001-08-22 Univ Cranfield A novel mediator for electrochemical detection
US6569309B2 (en) 2001-07-05 2003-05-27 Asahi Kasei Kabushiki Kaisha Fuel cell type reactor and method for producing a chemical compound by using the same
US7150737B2 (en) 2001-07-13 2006-12-19 Sci/Med Life Systems, Inc. Methods and apparatuses for navigating the subarachnoid space
US20030032874A1 (en) * 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US6702857B2 (en) * 2001-07-27 2004-03-09 Dexcom, Inc. Membrane for use with implantable devices
US7481759B2 (en) 2001-08-03 2009-01-27 Cardiac Pacemakers, Inc. Systems and methods for treatment of coronary artery disease
US6913626B2 (en) * 2001-08-14 2005-07-05 Mcghan Jim J. Medical implant having bioabsorbable textured surface
US7456025B2 (en) 2001-08-28 2008-11-25 Porex Corporation Sintered polymer membrane for analyte detection device
US7025760B2 (en) 2001-09-07 2006-04-11 Medtronic Minimed, Inc. Method and system for non-vascular sensor implantation
CN1282870C (en) 2001-09-11 2006-11-01 爱科来株式会社 Measuring instrument, installation body, and density measurer
US6830562B2 (en) 2001-09-27 2004-12-14 Unomedical A/S Injector device for placing a subcutaneous infusion set
US6802957B2 (en) 2001-09-28 2004-10-12 Marine Biological Laboratory Self-referencing enzyme-based microsensor and method of use
US6809507B2 (en) 2001-10-23 2004-10-26 Medtronic Minimed, Inc. Implantable sensor electrodes and electronic circuitry
US6705833B2 (en) 2001-11-15 2004-03-16 Hewlett-Packard Development Company, L.P. Airflow flapper valve
JP2005510608A (en) 2001-11-21 2005-04-21 ポレックス,コーポレーション Individual hydrophilic-hydrophobic porous material and method for producing the same
US20040030294A1 (en) * 2001-11-28 2004-02-12 Mahurkar Sakharam D. Retractable needle single use safety syringe
US20050101841A9 (en) 2001-12-04 2005-05-12 Kimberly-Clark Worldwide, Inc. Healthcare networks with biosensors
WO2003051191A1 (en) * 2001-12-17 2003-06-26 Danfoss A/S Method and device for monitoring analyte concentration by optical detection
US6952604B2 (en) 2001-12-21 2005-10-04 Becton, Dickinson And Company Minimally-invasive system and method for monitoring analyte levels
US6872927B2 (en) 2001-12-26 2005-03-29 Lambda Technologies, Inc. Systems and methods for processing pathogen-contaminated mail pieces
US20050027182A1 (en) 2001-12-27 2005-02-03 Uzair Siddiqui System for monitoring physiological characteristics
US7399277B2 (en) 2001-12-27 2008-07-15 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US7018336B2 (en) 2001-12-27 2006-03-28 Medtronic Minimed, Inc. Implantable sensor flush sleeve
US7956525B2 (en) 2003-05-16 2011-06-07 Nanomix, Inc. Flexible nanostructure electronic devices
WO2003061475A1 (en) 2002-01-23 2003-07-31 Danfoss A/S Method and device for monitoring analyte concentration by use of differential osmotic pressure measurement
CA2474359A1 (en) 2002-01-29 2003-08-07 Sicel Technologies, Inc. Implantable sensor housing and fabrication methods
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7828728B2 (en) 2003-07-25 2010-11-09 Dexcom, Inc. Analyte sensor
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US20030157409A1 (en) 2002-02-21 2003-08-21 Sui-Yang Huang Polymer lithium battery with ionic electrolyte
DE10211051A1 (en) 2002-03-13 2003-10-02 Fresenius Medical Care De Gmbh Capillary membrane and device for producing the same
US6936006B2 (en) 2002-03-22 2005-08-30 Novo Nordisk, A/S Atraumatic insertion of a subcutaneous device
US7470250B2 (en) 2002-03-22 2008-12-30 Novo Nordisk A/S Apparatus for automatic insertion of a solid medicine
CA2480550C (en) 2002-03-22 2011-07-12 Cygnus, Inc. Improving performance of an analyte monitoring device
GB2388898B (en) 2002-04-02 2005-10-05 Inverness Medical Ltd Integrated sample testing meter
US20030225437A1 (en) 2002-04-04 2003-12-04 Ferguson Patrick J. Device for retaining material
CA2481501A1 (en) 2002-04-05 2003-10-23 Eyelab Group, Llc Monitoring blood substances using self-sampled tears
AU2003221808A1 (en) 2002-04-05 2003-10-27 Powerzyme, Inc. Analyte sensor
US20070227907A1 (en) 2006-04-04 2007-10-04 Rajiv Shah Methods and materials for controlling the electrochemistry of analyte sensors
US7153265B2 (en) 2002-04-22 2006-12-26 Medtronic Minimed, Inc. Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance
US7813780B2 (en) 2005-12-13 2010-10-12 Medtronic Minimed, Inc. Biosensors and methods for making and using them
FI118172B (en) 2002-04-22 2007-08-15 Inion Ltd Surgical implant
US6743635B2 (en) 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
EP1499705A2 (en) 2002-05-01 2005-01-26 Massachusetts Institute of Technology Microfermentors for rapid screening and analysis of biochemical processes
US7166235B2 (en) 2002-05-09 2007-01-23 The Procter & Gamble Company Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith
DE10393060D2 (en) 2002-05-09 2005-05-04 Hemoteq Gmbh Reduction of the noise emission of thin-walled components in magnetic resonance instruments
US6801041B2 (en) 2002-05-14 2004-10-05 Abbott Laboratories Sensor having electrode for determining the rate of flow of a fluid
US20060258761A1 (en) 2002-05-22 2006-11-16 Robert Boock Silicone based membranes for use in implantable glucose sensors
US7226978B2 (en) 2002-05-22 2007-06-05 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
AU2003240018A1 (en) 2002-05-31 2003-12-19 Dow Corning Toray Silicone Co., Ltd. Cartridge for moisture-curable sealant
US20030225324A1 (en) 2002-06-03 2003-12-04 Anderson Edward J. Noninvasive detection of a physiologic Parameter within a body tissue of a patient
US8996090B2 (en) * 2002-06-03 2015-03-31 Exostat Medical, Inc. Noninvasive detection of a physiologic parameter within a body tissue of a patient
AU2003279777A1 (en) 2002-06-28 2004-01-19 November Aktiengesellschaft Gesellschaft Fur Molekulare Medizin Electrochemical detection method and device
AU2003245862A1 (en) * 2002-07-12 2004-02-02 Novo Nordisk A/S Minimising calibration problems of in vivo glucose sensors
US20040010207A1 (en) * 2002-07-15 2004-01-15 Flaherty J. Christopher Self-contained, automatic transcutaneous physiologic sensing system
US20040068230A1 (en) 2002-07-24 2004-04-08 Medtronic Minimed, Inc. System for providing blood glucose measurements to an infusion device
US20040106741A1 (en) 2002-09-17 2004-06-03 Kriesel Joshua W. Nanofilm compositions with polymeric components
US20040180391A1 (en) 2002-10-11 2004-09-16 Miklos Gratzl Sliver type autonomous biosensors
KR101226540B1 (en) 2002-10-11 2013-01-25 벡톤 디킨슨 앤드 컴퍼니 System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device
US20040074785A1 (en) 2002-10-18 2004-04-22 Holker James D. Analyte sensors and methods for making them
US20050272989A1 (en) 2004-06-04 2005-12-08 Medtronic Minimed, Inc. Analyte sensors and methods for making and using them
US6737158B1 (en) 2002-10-30 2004-05-18 Gore Enterprise Holdings, Inc. Porous polymeric membrane toughened composites
KR100482285B1 (en) 2002-10-30 2005-04-14 한국전자통신연구원 Fluid-type multiple electrochemical system and the preparation thereof
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
EP1567559A4 (en) 2002-11-12 2008-04-16 Polymer Technology Group Inc Control of polymer surface molecular architecture via amphipathic endgroups
US20050032246A1 (en) * 2002-11-14 2005-02-10 Mcmaster University Method of immobilizing membrane-associated molecules
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
US20050266582A1 (en) 2002-12-16 2005-12-01 Modlin Douglas N Microfluidic system with integrated permeable membrane
US20040120848A1 (en) 2002-12-20 2004-06-24 Maria Teodorczyk Method for manufacturing a sterilized and calibrated biosensor-based medical device
US20040127818A1 (en) 2002-12-27 2004-07-01 Roe Steven N. Precision depth control lancing tip
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US20040133131A1 (en) 2003-01-03 2004-07-08 Kuhn David L. In vivo ruminant health sensor
US7120483B2 (en) 2003-01-13 2006-10-10 Isense Corporation Methods for analyte sensing and measurement
US7288609B1 (en) * 2003-03-04 2007-10-30 Advanced Cardiovascular Systems, Inc. Coatings for drug delivery devices based on poly (orthoesters)
US6965791B1 (en) 2003-03-26 2005-11-15 Sorenson Medical, Inc. Implantable biosensor system, apparatus and method
US7070580B2 (en) 2003-04-01 2006-07-04 Unomedical A/S Infusion device and an adhesive sheet material and a release liner
US7134999B2 (en) 2003-04-04 2006-11-14 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
US6797877B1 (en) 2003-04-28 2004-09-28 Jonn Maneely Company Electrical metallic tube, coupling, and connector apparatus and method
US7279174B2 (en) * 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
CA2525631C (en) 2003-05-13 2012-12-18 Medtronic, Inc. Moisture curable materials for delivery of agents, methods, and medical devices
AU2004238026A1 (en) 2003-05-16 2004-11-25 Cinvention Ag Medical implants comprising biocompatible coatings
US7875293B2 (en) 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US7687586B2 (en) * 2003-05-21 2010-03-30 Isense Corporation Biosensor membrane material
US6789634B1 (en) 2003-05-28 2004-09-14 Smith International, Inc Self-lubricating elastomeric seal with polarized graphite
WO2004108810A1 (en) 2003-06-06 2004-12-16 Humanautocell Gmbh Matrix, cell implantation and method for their production and use
US20040254433A1 (en) 2003-06-12 2004-12-16 Bandis Steven D. Sensor introducer system, apparatus and method
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
DK200301027A (en) 2003-07-04 2005-01-05 Nkt Res & Innovation As A method of producing interpenetrating polymer networks (IPNs) and applications of IPNs
US8425926B2 (en) * 2003-07-16 2013-04-23 Yongxing Qiu Antimicrobial medical devices
WO2005010518A1 (en) 2003-07-23 2005-02-03 Dexcom, Inc. Rolled electrode array and its method for manufacture
EP1648298A4 (en) 2003-07-25 2010-01-13 Dexcom Inc Oxygen enhancing membrane systems for implantable devices
US7460898B2 (en) 2003-12-05 2008-12-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7366556B2 (en) 2003-12-05 2008-04-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
WO2005019795A2 (en) 2003-07-25 2005-03-03 Dexcom, Inc. Electrochemical sensors including electrode systems with increased oxygen generation
US20050176136A1 (en) 2003-11-19 2005-08-11 Dexcom, Inc. Afinity domain for analyte sensor
US7424318B2 (en) 2003-12-05 2008-09-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7467003B2 (en) 2003-12-05 2008-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP1649260A4 (en) 2003-07-25 2010-07-07 Dexcom Inc Electrode systems for electrochemical sensors
WO2007120442A2 (en) 2003-07-25 2007-10-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20050056552A1 (en) 2003-07-25 2005-03-17 Simpson Peter C. Increasing bias for oxygen production in an electrode system
DE10335131A1 (en) 2003-07-31 2005-02-24 Blue Membranes Gmbh Porous carbon moldings, e.g. for catalyst support; insulant, tube membrane, ex or in vivo cell culture substrate or scaffold or implant, are made by molding carbonizable polymer and removing filler or partial oxidation to form pores
US6931327B2 (en) 2003-08-01 2005-08-16 Dexcom, Inc. System and methods for processing analyte sensor data
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US7172075B1 (en) * 2003-08-08 2007-02-06 Accord Partner Limited Defect free composite membranes, method for producing said membranes and use of the same
US7287043B2 (en) * 2003-08-21 2007-10-23 International Business Machines Corporation System and method for asynchronous data replication without persistence for distributed computing
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7723099B2 (en) 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US7433727B2 (en) 2003-09-24 2008-10-07 Legacy Good Samaritan Hospital And Medical Center Implantable biosensor
DE602004026763D1 (en) * 2003-09-30 2010-06-02 Roche Diagnostics Gmbh SENSOR WITH IMPROVED BIOKOMPATIBILITY
US20050090607A1 (en) 2003-10-28 2005-04-28 Dexcom, Inc. Silicone composition for biocompatible membrane
CA2544424A1 (en) 2003-10-31 2005-05-19 Lifescan Scotland Limited Electrochemical test strip for reducing the effect of direct interference current
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US20090012376A1 (en) 2003-11-03 2009-01-08 Children's Medical Center Corporation Continuous Analyte Monitor and Method of Using Same
US7329413B1 (en) 2003-11-06 2008-02-12 Advanced Cardiovascular Systems, Inc. Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof
US20050158356A1 (en) 2003-11-20 2005-07-21 Angiotech International Ag Implantable sensors and implantable pumps and anti-scarring agents
US7524455B2 (en) 2003-11-24 2009-04-28 General Electric Company Methods for deposition of sensor regions onto optical storage media substrates and resulting devices
US7807722B2 (en) 2003-11-26 2010-10-05 Advanced Cardiovascular Systems, Inc. Biobeneficial coating compositions and methods of making and using thereof
ATE480761T1 (en) 2003-12-05 2010-09-15 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTICAL SENSOR
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
ATE474219T1 (en) 2003-12-08 2010-07-15 Dexcom Inc SYSTEMS AND METHODS FOR IMPROVING ELECTROCHEMICAL ANALYT SENSORS
US8147426B2 (en) 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
CN101039975A (en) 2004-01-08 2007-09-19 荷兰聚合物研究所基金会 Polyurethanes, polyurethaneureas and polyureas and use thereof
US7637868B2 (en) 2004-01-12 2009-12-29 Dexcom, Inc. Composite material for implantable device
US20050182451A1 (en) 2004-01-12 2005-08-18 Adam Griffin Implantable device with improved radio frequency capabilities
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
AU2005220150A1 (en) 2004-02-13 2005-09-15 The University Of North Carolina At Chapel Hill Functional materials and novel methods for the fabrication of microfluidic devices
US20050197554A1 (en) 2004-02-26 2005-09-08 Michael Polcha Composite thin-film glucose sensor
AU2005216592B8 (en) * 2004-02-28 2009-06-04 Hemoteq Ag Biocompatible coating, method, and use of medical surfaces
DE602004011688D1 (en) 2004-03-05 2008-03-20 Egomedical Swiss Ag ANALYSIS TEST SYSTEM FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A PHYSIOLOGICAL LIQUID
US8277713B2 (en) 2004-05-03 2012-10-02 Dexcom, Inc. Implantable analyte sensor
US20050245799A1 (en) 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
US7241266B2 (en) 2004-05-20 2007-07-10 Digital Angel Corporation Transducer for embedded bio-sensor using body energy as a power source
US7118667B2 (en) 2004-06-02 2006-10-10 Jin Po Lee Biosensors having improved sample application and uses thereof
DE602005022704D1 (en) 2004-06-09 2010-09-16 Dickinson And Co SENSOR FOR SEVERAL ANALYTICS
US20060015020A1 (en) 2004-07-06 2006-01-19 Dexcom, Inc. Systems and methods for manufacture of an analyte-measuring device including a membrane system
US7246551B2 (en) 2004-07-09 2007-07-24 Protedyne Corporation Liquid handling device with surface features at a seal
US20060020192A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
WO2006127694A2 (en) 2004-07-13 2006-11-30 Dexcom, Inc. Analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20080242961A1 (en) 2004-07-13 2008-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US20060016700A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US8962165B2 (en) 2006-05-02 2015-02-24 The Penn State Research Foundation Materials and configurations for scalable microbial fuel cells
JP2008510154A (en) 2004-08-16 2008-04-03 ノボ ノルディスク アクティーゼルスカブ Multiphase biocompatible semipermeable membrane for biosensors
WO2006127023A2 (en) 2004-08-24 2006-11-30 University Of South Florida Epoxy enhanced polymer membrane to increase durability of biosensors
US7244443B2 (en) 2004-08-31 2007-07-17 Advanced Cardiovascular Systems, Inc. Polymers of fluorinated monomers and hydrophilic monomers
US7229471B2 (en) 2004-09-10 2007-06-12 Advanced Cardiovascular Systems, Inc. Compositions containing fast-leaching plasticizers for improved performance of medical devices
US20060065527A1 (en) * 2004-09-24 2006-03-30 Sendx Medical, Inc. Polymeric reference electrode
US9011831B2 (en) * 2004-09-30 2015-04-21 Advanced Cardiovascular Systems, Inc. Methacrylate copolymers for medical devices
CA2586927A1 (en) 2004-11-09 2006-05-18 Angiotech Biocoatings Corp. Antimicrobial needle coating for extended infusion
WO2006063181A1 (en) * 2004-12-06 2006-06-15 Surmodics, Inc. Multifunctional medical articles
CN100367906C (en) * 2004-12-08 2008-02-13 圣美迪诺医疗科技(湖州)有限公司 Endermic implantating biological sensors
US7604818B2 (en) 2004-12-22 2009-10-20 Advanced Cardiovascular Systems, Inc. Polymers of fluorinated monomers and hydrocarbon monomers
EP1838748B1 (en) 2004-12-29 2009-03-11 Bausch & Lomb Incorporated Polysiloxane prepolymers for biomedical devices
ES2329272T3 (en) 2004-12-29 2009-11-24 BAUSCH & LOMB INCORPORATED POLISYLOXAN PREPOLIMEROS FOR BIOMEDICAL DEVICES.
US20060142525A1 (en) 2004-12-29 2006-06-29 Bausch & Lomb Incorporated Hydrogel copolymers for biomedical devices
KR20070104574A (en) 2004-12-30 2007-10-26 신벤션 아게 Combination comprising an agent providing a signal, an implant material and a drug
EP1841814B1 (en) 2005-01-17 2009-11-18 Biomodics A method of coating a polymer surface with a polymer containing coating and an item comprising a polymer coated polymer
JP4810099B2 (en) * 2005-01-20 2011-11-09 株式会社メニコン Transparent gel and contact lens comprising the same
US20060171980A1 (en) 2005-02-01 2006-08-03 Helmus Michael N Implantable or insertable medical devices having optimal surface energy
US7241586B2 (en) 2005-02-17 2007-07-10 Medtronic Minimed, Inc. Polypeptide formulations and methods for making, using and characterizing them
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
WO2006105146A2 (en) 2005-03-29 2006-10-05 Arkal Medical, Inc. Devices, systems, methods and tools for continuous glucose monitoring
US8744546B2 (en) 2005-05-05 2014-06-03 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
US20060249381A1 (en) 2005-05-05 2006-11-09 Petisce James R Cellulosic-based resistance domain for an analyte sensor
WO2006110193A2 (en) 2005-04-08 2006-10-19 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
JP5022621B2 (en) 2005-04-27 2012-09-12 三星エスディアイ株式会社 Cylindrical lithium secondary battery
US20060249446A1 (en) 2005-05-04 2006-11-09 Gary Yeager Solvent-resistant composite membrane composition
JP4763777B2 (en) 2005-05-17 2011-08-31 ラジオメーター・メディカル・アー・ペー・エス Enzyme sensor comprising a cover membrane layer coated with a hydrophilic polymer
US20060263839A1 (en) 2005-05-17 2006-11-23 Isense Corporation Combined drug delivery and analyte sensor apparatus
US20060275859A1 (en) 2005-05-17 2006-12-07 Kjaer Thomas Enzyme sensor including a water-containing spacer layer
US7725148B2 (en) 2005-09-23 2010-05-25 Medtronic Minimed, Inc. Sensor with layered electrodes
US20070123963A1 (en) 2005-11-29 2007-05-31 Peter Krulevitch Method for producing flexible, stretchable, and implantable high-density microelectrode arrays
US20070129524A1 (en) 2005-12-06 2007-06-07 Sunkara Hari B Thermoplastic polyurethanes comprising polytrimethylene ether soft segments
US7759408B2 (en) 2005-12-21 2010-07-20 Bausch & Lomb Incorporated Silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups
US20070155851A1 (en) 2005-12-30 2007-07-05 Azaam Alli Silicone containing polymers formed from non-reactive silicone containing prepolymers
US20070161769A1 (en) 2006-01-06 2007-07-12 Schorzman Derek A Polymerizable silicon-containing monomer bearing pendant cationic hydrophilic groups
EP2004796B1 (en) 2006-01-18 2015-04-08 DexCom, Inc. Membranes for an analyte sensor
CA2577760A1 (en) 2006-02-27 2007-08-27 Tyco Healthcare Group Lp Pressurized dip coating system
US8065796B2 (en) 2006-02-27 2011-11-29 Edwards Lifesciences Corporation Method and apparatus for using flex circuit technology to create an electrode
US20070202562A1 (en) 2006-02-27 2007-08-30 Curry Kenneth M Flux limiting membrane for intravenous amperometric biosensor
EP1989537B1 (en) 2006-02-27 2017-02-22 Edwards Lifesciences Corporation Method and apparatus for using flex circuit technology to create a reference electrode channel
US20070233013A1 (en) 2006-03-31 2007-10-04 Schoenberg Stephen J Covers for tissue engaging members
US7960447B2 (en) 2006-04-13 2011-06-14 Bausch & Lomb Incorporated Cationic end-capped siloxane prepolymer for reduced cross-link density
US7468397B2 (en) * 2006-06-30 2008-12-23 Bausch & Lomb Incorporated Polymerizable siloxane-quaternary amine copolymers
EP2054476B9 (en) 2006-07-25 2012-03-14 Glumetrics, Inc. Flourescent dyes for use in glucose sensing
US8114023B2 (en) * 2006-07-28 2012-02-14 Legacy Emanuel Hospital & Health Center Analyte sensing and response system
US7871456B2 (en) * 2006-08-10 2011-01-18 The Regents Of The University Of California Membranes with controlled permeability to polar and apolar molecules in solution and methods of making same
CA2701006C (en) 2006-09-27 2016-07-12 University Of Connecticut Implantable biosensor and methods of use thereof
US20080076897A1 (en) * 2006-09-27 2008-03-27 Kunzler Jay F Pendant end-capped low modulus cationic siloxanyls
JP2008086855A (en) 2006-09-29 2008-04-17 Fujifilm Corp Biochemical instrument
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20080143014A1 (en) 2006-12-18 2008-06-19 Man-Wing Tang Asymmetric Gas Separation Membranes with Superior Capabilities for Gas Separation
DK2989975T3 (en) 2007-02-06 2018-09-24 Medtronic Minimed Inc OPTICAL SYSTEMS AND PROCEDURES FOR RATIOMETRIC MEASUREMENT OF BLOOD GLUCOSE CONCENTRATION
US8738107B2 (en) 2007-05-10 2014-05-27 Medtronic Minimed, Inc. Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement
WO2008098011A1 (en) 2007-02-06 2008-08-14 Glumetrics, Inc. Method for polymerizing a monomer solution within a cavity to generate a smooth polymer surface
US7751863B2 (en) 2007-02-06 2010-07-06 Glumetrics, Inc. Optical determination of ph and glucose
US8088097B2 (en) 2007-11-21 2012-01-03 Glumetrics, Inc. Use of an equilibrium intravascular sensor to achieve tight glycemic control
JP5706686B2 (en) 2007-05-01 2015-04-22 メドトロニック ミニメド インコーポレイテッド Pyridinium boronic acid quencher, method for producing the same, and glucose sensor
WO2008141243A2 (en) * 2007-05-10 2008-11-20 Glumetrics, Inc. Device and methods for calibrating analyte sensors
US7691917B2 (en) 2007-06-14 2010-04-06 Bausch & Lomb Incorporated Silcone-containing prepolymers
US20090004243A1 (en) * 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
JP5675350B2 (en) * 2007-07-11 2015-02-25 メドトロニック ミニメド インコーポレイテッド Polyviologen compound, method for synthesizing the compound, glucose sensor, and composition for measuring glucose
EP2181160B1 (en) * 2007-08-06 2016-05-11 Medtronic Minimed, Inc. Hpts-mono cys-ma polymerizable fluorescent dyes for use in analyte sensors
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US20090242399A1 (en) 2008-03-25 2009-10-01 Dexcom, Inc. Analyte sensor
US20090247855A1 (en) 2008-03-28 2009-10-01 Dexcom, Inc. Polymer membranes for continuous analyte sensors
WO2009129186A2 (en) 2008-04-17 2009-10-22 Glumetrics, Inc. Sensor for percutaneous intravascular deployment without an indwelling cannula
CN101342465B (en) 2008-09-01 2011-11-09 天津工业大学 Hollow fiber porous film and process for producing same

Patent Citations (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686044A (en) * 1979-08-13 1987-08-11 Akzo Nv Polycarbonate-polyether-copolymer membrane
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4436094A (en) * 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
US4453537A (en) * 1981-08-04 1984-06-12 Spitzer Daniel E Apparatus for powering a body implant device
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4484987A (en) * 1983-05-19 1984-11-27 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US5171689A (en) * 1984-11-08 1992-12-15 Matsushita Electric Industrial Co., Ltd. Solid state bio-sensor
US4787398A (en) * 1985-04-08 1988-11-29 Garid, Inc. Glucose medical monitoring system
US5578463A (en) * 1985-08-29 1996-11-26 Genencor International, Inc. Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4803243A (en) * 1986-03-26 1989-02-07 Shin-Etsu Chemical Co., Ltd. Block-graft copolymer
US4757022A (en) * 1986-04-15 1988-07-12 Markwell Medical Institute, Inc. Biological fluid measuring device
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US4703756A (en) * 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4902294A (en) * 1986-12-03 1990-02-20 Olivier Gosserez Implantable mammary prosthesis adapted to combat the formation of a retractile shell
US4759828A (en) * 1987-04-09 1988-07-26 Nova Biomedical Corporation Glucose electrode and method of determining glucose
US4871440A (en) * 1987-07-06 1989-10-03 Daiken Industries, Ltd. Biosensor
US4823808A (en) * 1987-07-06 1989-04-25 Clegg Charles T Method for control of obesity, overweight and eating disorders
US5431160A (en) * 1989-07-19 1995-07-11 University Of New Mexico Miniature implantable refillable glucose sensor and material therefor
US5190041A (en) * 1989-08-11 1993-03-02 Palti Yoram Prof System for monitoring and controlling blood glucose
US5985129A (en) * 1989-12-14 1999-11-16 The Regents Of The University Of California Method for increasing the service life of an implantable sensor
US5321414A (en) * 1990-03-01 1994-06-14 Her Majesty In Right Of Canada As Represented By The Minister Of Communications Dual polarization dipole array antenna
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5380536A (en) * 1990-10-15 1995-01-10 The Board Of Regents, The University Of Texas System Biocompatible microcapsules
US5733336A (en) * 1990-10-31 1998-03-31 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5741330A (en) * 1990-10-31 1998-04-21 Baxter International, Inc. Close vascularization implant material
US5882354A (en) * 1990-10-31 1999-03-16 Baxter International Inc. Close vascularization implant material
US5800529A (en) * 1990-10-31 1998-09-01 Baxter International, Inc. Close vascularization implant material
US5782912A (en) * 1990-10-31 1998-07-21 Baxter International, Inc. Close vascularization implant material
US5593440A (en) * 1990-10-31 1997-01-14 Baxter International Inc. Tissue implant systems and methods for sustaining viable high cell densities within a host
US5545223A (en) * 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5653756A (en) * 1990-10-31 1997-08-05 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US5713888A (en) * 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
US5344454A (en) * 1991-07-24 1994-09-06 Baxter International Inc. Closed porous chambers for implanting tissue in a host
US5453278A (en) * 1991-07-24 1995-09-26 Baxter International Inc. Laminated barriers for tissue implants
US5314471A (en) * 1991-07-24 1994-05-24 Baxter International Inc. Tissue inplant systems and methods for sustaining viable high cell densities within a host
US5322063A (en) * 1991-10-04 1994-06-21 Eli Lilly And Company Hydrophilic polyurethane membranes for electrochemical glucose sensors
US5476094A (en) * 1992-02-11 1995-12-19 Eli Lilly And Company Acrylic copolymer membranes for biosensors
US5384028A (en) * 1992-08-28 1995-01-24 Nec Corporation Biosensor with a data memory
US5575930A (en) * 1992-10-07 1996-11-19 Tietje-Girault; Jordis Method of making gas permeable membranes for amperometric gas electrodes
US5469846A (en) * 1992-10-19 1995-11-28 Duquesne University Of The Holy Ghost Implantable non-enzymatic electrochemical glucose sensor
US6256522B1 (en) * 1992-11-23 2001-07-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Sensors for continuous monitoring of biochemicals and related method
US5417395A (en) * 1993-06-30 1995-05-23 Medex, Inc. Modular interconnecting component support plate
US5569462A (en) * 1993-09-24 1996-10-29 Baxter International Inc. Methods for enhancing vascularization of implant devices
US5791344A (en) * 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5660163A (en) * 1993-11-19 1997-08-26 Alfred E. Mann Foundation For Scientific Research Glucose sensor assembly
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US6329161B1 (en) * 1993-12-02 2001-12-11 Therasense, Inc. Subcutaneous glucose electrode
US5421923A (en) * 1993-12-03 1995-06-06 Baxter International, Inc. Ultrasonic welding horn with sonics dampening insert
US5462064A (en) * 1993-12-22 1995-10-31 International Medical Associates, Inc. Integrated system for biological fluid constituent analysis
US5549675A (en) * 1994-01-11 1996-08-27 Baxter International, Inc. Method for implanting tissue in a host
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5391250A (en) * 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5538511A (en) * 1994-04-01 1996-07-23 Minimed Inc. Indwelling catheter with stable enzyme coating
US5569186A (en) * 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5683562A (en) * 1994-09-14 1997-11-04 Avl Medical Instruments Ag Planar sensor for determining a chemical parameter of a sample
US5807406A (en) * 1994-10-07 1998-09-15 Baxter International Inc. Porous microfabricated polymer membrane structures
US5882494A (en) * 1995-03-27 1999-03-16 Minimed, Inc. Polyurethane/polyurea compositions containing silicone for biosensor membranes
US5777060A (en) * 1995-03-27 1998-07-07 Minimed, Inc. Silicon-containing biocompatible membranes
US6122536A (en) * 1995-07-06 2000-09-19 Animas Corporation Implantable sensor and system for measurement and control of blood constituent levels
US5628890A (en) * 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
US6212416B1 (en) * 1995-11-22 2001-04-03 Good Samaritan Hospital And Medical Center Device for monitoring changes in analyte concentration
US6309351B1 (en) * 1995-12-28 2001-10-30 Cygnus, Inc. Methods for monitoring a physiological analyte
US6299578B1 (en) * 1995-12-28 2001-10-09 Cygnus, Inc. Methods for monitoring a physiological analyte
US5964261A (en) * 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US6208894B1 (en) * 1997-02-26 2001-03-27 Alfred E. Mann Foundation For Scientific Research And Advanced Bionics System of implantable devices for monitoring and/or affecting body parameters
US6001067A (en) * 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6200772B1 (en) * 1997-08-23 2001-03-13 Sensalyse Holdings Limited Modified polyurethane membrane sensors and analytical methods
US6259937B1 (en) * 1997-09-12 2001-07-10 Alfred E. Mann Foundation Implantable substrate sensor
US6119028A (en) * 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
US6223080B1 (en) * 1998-04-29 2001-04-24 Medtronic, Inc. Power consumption reduction in medical devices employing multiple digital signal processors and different supply voltages
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6272364B1 (en) * 1998-05-13 2001-08-07 Cygnus, Inc. Method and device for predicting physiological values
US6144869A (en) * 1998-05-13 2000-11-07 Cygnus, Inc. Monitoring of physiological analytes
US6233471B1 (en) * 1998-05-13 2001-05-15 Cygnus, Inc. Signal processing for measurement of physiological analysis
US6272382B1 (en) * 1998-07-31 2001-08-07 Advanced Bionics Corporation Fully implantable cochlear implant system
US6254586B1 (en) * 1998-09-25 2001-07-03 Minimed Inc. Method and kit for supplying a fluid to a subcutaneous placement site
US6180416B1 (en) * 1998-09-30 2001-01-30 Cygnus, Inc. Method and device for predicting physiological values
US6326160B1 (en) * 1998-09-30 2001-12-04 Cygnus, Inc. Microprocessors for use in a device for predicting physiological values
US6201980B1 (en) * 1998-10-05 2001-03-13 The Regents Of The University Of California Implantable medical sensor system
US6360888B1 (en) * 1999-02-25 2002-03-26 Minimed Inc. Glucose sensor package system
US6230059B1 (en) * 1999-03-17 2001-05-08 Medtronic, Inc. Implantable monitor
US6223083B1 (en) * 1999-04-16 2001-04-24 Medtronic, Inc. Receiver employing digital filtering for use with an implantable medical device

Cited By (1429)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100121166A1 (en) * 1991-03-04 2010-05-13 Abbott Diabetes Care Inc. Subcutaneous Glucose Electrode
US8588881B2 (en) 1991-03-04 2013-11-19 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US20100051479A1 (en) * 1991-03-04 2010-03-04 Adam Heller Subcutaneous Glucose Electrode
US20050287620A1 (en) * 1991-03-04 2005-12-29 Therasense, Inc. Method of determining analyte level using subcutaneous electrode
US20100030048A1 (en) * 1991-03-04 2010-02-04 Abbott Diabetes Care Inc. Subcutaneous Glucose Electrode
US20100030046A1 (en) * 1991-03-04 2010-02-04 Abbott Diabetes Care Inc. Subcutaneous Glucose Electrode
US8741590B2 (en) 1991-03-04 2014-06-03 Abbott Diabetes Care Inc. Subcutaneous glucose electrode
US8676288B2 (en) 1997-03-04 2014-03-18 Dexcom, Inc. Device and method for determining analyte levels
US20050177036A1 (en) * 1997-03-04 2005-08-11 Shults Mark C. Device and method for determining analyte levels
US8923947B2 (en) 1997-03-04 2014-12-30 Dexcom, Inc. Device and method for determining analyte levels
US7792562B2 (en) 1997-03-04 2010-09-07 Dexcom, Inc. Device and method for determining analyte levels
US20110144465A1 (en) * 1997-03-04 2011-06-16 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9155496B2 (en) * 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US9339223B2 (en) 1997-03-04 2016-05-17 Dexcom, Inc. Device and method for determining analyte levels
US9439589B2 (en) 1997-03-04 2016-09-13 Dexcom, Inc. Device and method for determining analyte levels
US7901354B2 (en) 1997-03-04 2011-03-08 Dexcom, Inc. Low oxygen in vivo analyte sensor
US8155723B2 (en) 1997-03-04 2012-04-10 Dexcom, Inc. Device and method for determining analyte levels
US7711402B2 (en) 1997-03-04 2010-05-04 Dexcom, Inc. Device and method for determining analyte levels
US7970448B2 (en) 1997-03-04 2011-06-28 Dexcom, Inc. Device and method for determining analyte levels
US20100204555A1 (en) * 1997-03-04 2010-08-12 Dexcom, Inc. Device and method for determining analyte levels
US7860545B2 (en) 1997-03-04 2010-12-28 Dexcom, Inc. Analyte measuring device
US20080296155A1 (en) * 1997-03-04 2008-12-04 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20100204559A1 (en) * 1997-03-04 2010-08-12 Dexcom, Inc. Device and method for determining analyte levels
US8527025B1 (en) 1997-03-04 2013-09-03 Dexcom, Inc. Device and method for determining analyte levels
US9931067B2 (en) 1997-03-04 2018-04-03 Dexcom, Inc. Device and method for determining analyte levels
US7771352B2 (en) 1997-03-04 2010-08-10 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7835777B2 (en) 1997-03-04 2010-11-16 Dexcom, Inc. Device and method for determining analyte levels
US7974672B2 (en) 1997-03-04 2011-07-05 Dexcom, Inc. Device and method for determining analyte levels
US8527026B2 (en) 1997-03-04 2013-09-03 Dexcom, Inc. Device and method for determining analyte levels
US20060118415A1 (en) * 1998-03-04 2006-06-08 Abbott Diabetes Care Inc. Electrochemical Analyte Sensor
US20100204554A1 (en) * 1998-03-04 2010-08-12 Abbott Diabetes Care Inc. Electrochemical Analyte Sensor
US20100305422A1 (en) * 1998-03-04 2010-12-02 Abbott Diabetes Care Inc. Electrochemical Analyte Sensor
US8706180B2 (en) 1998-03-04 2014-04-22 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8463351B2 (en) 1998-03-04 2013-06-11 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US7996054B2 (en) 1998-03-04 2011-08-09 Abbott Diabetes Care Inc. Electrochemical analyte sensor
US8260392B2 (en) 1998-04-30 2012-09-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734346B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8597189B2 (en) 1998-04-30 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8612159B2 (en) 1998-04-30 2013-12-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8617071B2 (en) 1998-04-30 2013-12-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8622906B2 (en) 1998-04-30 2014-01-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8275439B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641619B2 (en) 1998-04-30 2014-02-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8265726B2 (en) 1998-04-30 2012-09-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8287454B2 (en) 1998-04-30 2012-10-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8306598B2 (en) 1998-04-30 2012-11-06 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8649841B2 (en) 1998-04-30 2014-02-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8660627B2 (en) 1998-04-30 2014-02-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8666469B2 (en) 1998-04-30 2014-03-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8670815B2 (en) 1998-04-30 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8255031B2 (en) 1998-04-30 2012-08-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10478108B2 (en) 1998-04-30 2019-11-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8672844B2 (en) 1998-04-30 2014-03-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8473021B2 (en) 1998-04-30 2013-06-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346336B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7885699B2 (en) 1998-04-30 2011-02-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8353829B2 (en) 1998-04-30 2013-01-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8734348B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8273022B2 (en) 1998-04-30 2012-09-25 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8738109B2 (en) 1998-04-30 2014-05-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8744545B2 (en) 1998-04-30 2014-06-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8357091B2 (en) 1998-04-30 2013-01-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8366614B2 (en) 1998-04-30 2013-02-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066697B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066694B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9042953B2 (en) 1998-04-30 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7869853B1 (en) 1998-04-30 2011-01-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8235896B2 (en) 1998-04-30 2012-08-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8231532B2 (en) 1998-04-30 2012-07-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226557B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US7860544B2 (en) 1998-04-30 2010-12-28 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8774887B2 (en) 1998-04-30 2014-07-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226555B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8409131B2 (en) 1998-04-30 2013-04-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8226558B2 (en) 1998-04-30 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8224413B2 (en) 1998-04-30 2012-07-17 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8177716B2 (en) 1998-04-30 2012-05-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8175673B2 (en) 1998-04-30 2012-05-08 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8372005B2 (en) 1998-04-30 2013-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8162829B2 (en) 1998-04-30 2012-04-24 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8391945B2 (en) 1998-04-30 2013-03-05 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8380273B2 (en) 1998-04-30 2013-02-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9610034B2 (en) 2001-01-02 2017-04-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8652043B2 (en) 2001-01-02 2014-02-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8668645B2 (en) 2001-01-02 2014-03-11 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8765059B2 (en) 2001-04-02 2014-07-01 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US8268243B2 (en) 2001-04-02 2012-09-18 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US7976778B2 (en) 2001-04-02 2011-07-12 Abbott Diabetes Care Inc. Blood glucose tracking apparatus
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8236242B2 (en) 2001-04-02 2012-08-07 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US9532741B2 (en) 2001-07-27 2017-01-03 Dexcom, Inc. Membrane for use with implantable devices
US20040186362A1 (en) * 2001-07-27 2004-09-23 Dexcom, Inc. Membrane for use with implantable devices
US8840552B2 (en) 2001-07-27 2014-09-23 Dexcom, Inc. Membrane for use with implantable devices
US20050103625A1 (en) * 2001-07-27 2005-05-19 Rathbun Rhodes Sensor head for use with implantable devices
US9804114B2 (en) 2001-07-27 2017-10-31 Dexcom, Inc. Sensor head for use with implantable devices
US8509871B2 (en) 2001-07-27 2013-08-13 Dexcom, Inc. Sensor head for use with implantable devices
US20100087724A1 (en) * 2001-07-27 2010-04-08 Dexcom, Inc. Membrane for use with implantable devices
US10039480B2 (en) 2001-07-27 2018-08-07 Dexcom, Inc. Membrane for use with implantable devices
US9328371B2 (en) 2001-07-27 2016-05-03 Dexcom, Inc. Sensor head for use with implantable devices
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100179409A1 (en) * 2002-02-12 2010-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20080027287A1 (en) * 2002-04-22 2008-01-31 Rajiv Shah Methods and materials for stabilizing analyte sensors
US9492111B2 (en) * 2002-04-22 2016-11-15 Medtronic Minimed, Inc. Methods and materials for stabilizing analyte sensors
US20090287073A1 (en) * 2002-05-22 2009-11-19 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US11020026B2 (en) 2002-05-22 2021-06-01 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US20060258761A1 (en) * 2002-05-22 2006-11-16 Robert Boock Silicone based membranes for use in implantable glucose sensors
US10052051B2 (en) 2002-05-22 2018-08-21 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US10154807B2 (en) 2002-05-22 2018-12-18 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US8050731B2 (en) 2002-05-22 2011-11-01 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US8543184B2 (en) 2002-05-22 2013-09-24 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US20060086624A1 (en) * 2002-05-22 2006-04-27 Tapsak Mark A Techniques to improve polyurethane membranes for implantable glucose sensors
US20030217966A1 (en) * 2002-05-22 2003-11-27 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US9179869B2 (en) 2002-05-22 2015-11-10 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US9801574B2 (en) 2002-05-22 2017-10-31 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US20070244379A1 (en) * 2002-05-22 2007-10-18 Robert Boock Silicone based membranes for use in implantable glucose sensors
US20170086717A1 (en) * 2002-05-22 2017-03-30 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US8064977B2 (en) * 2002-05-22 2011-11-22 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US20100119693A1 (en) * 2002-05-22 2010-05-13 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US8865249B2 (en) 2002-05-22 2014-10-21 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US8053018B2 (en) 2002-05-22 2011-11-08 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US9549693B2 (en) 2002-05-22 2017-01-24 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US8343093B2 (en) 2002-10-09 2013-01-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US8029245B2 (en) 2002-10-09 2011-10-04 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US20090182276A1 (en) * 2002-10-09 2009-07-16 Abbott Diabetes Care, Inc. Fluid Delivery Device with Autocalibration
US7993108B2 (en) 2002-10-09 2011-08-09 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US7766864B2 (en) * 2002-10-09 2010-08-03 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US20090177160A1 (en) * 2002-10-09 2009-07-09 Abbott Diabetes Care, Inc. Fluid Delivery Device with Autocalibration
US20090179044A1 (en) * 2002-10-09 2009-07-16 Abbott Diabetes Care, Inc. Fluid Delivery Device with Autocalibration
US7753874B2 (en) * 2002-10-09 2010-07-13 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US7753873B2 (en) * 2002-10-09 2010-07-13 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US7727181B2 (en) 2002-10-09 2010-06-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US20050238503A1 (en) * 2002-10-09 2005-10-27 Rush Benjamin M Variable volume, shape memory actuated insulin dispensing pump
US7922458B2 (en) 2002-10-09 2011-04-12 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8029250B2 (en) 2002-10-09 2011-10-04 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US20050235732A1 (en) * 2002-10-09 2005-10-27 Rush Benjamin M Fluid delivery device with autocalibration
US7993109B2 (en) 2002-10-09 2011-08-09 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8047812B2 (en) 2002-10-09 2011-11-01 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US8047811B2 (en) 2002-10-09 2011-11-01 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
US11116430B2 (en) 2002-11-05 2021-09-14 Abbott Diabetes Care Inc. Sensor inserter assembly
US11141084B2 (en) 2002-11-05 2021-10-12 Abbott Diabetes Care Inc. Sensor inserter assembly
US9980670B2 (en) 2002-11-05 2018-05-29 Abbott Diabetes Care Inc. Sensor inserter assembly
US10973443B2 (en) 2002-11-05 2021-04-13 Abbott Diabetes Care Inc. Sensor inserter assembly
US10039881B2 (en) 2002-12-31 2018-08-07 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8622903B2 (en) 2002-12-31 2014-01-07 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8187183B2 (en) 2002-12-31 2012-05-29 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US10750952B2 (en) 2002-12-31 2020-08-25 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US9962091B2 (en) 2002-12-31 2018-05-08 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US8483974B2 (en) 2003-04-04 2013-07-09 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US8560250B2 (en) 2003-04-04 2013-10-15 Abbott Laboratories Method and system for transferring analyte test data
US8682598B2 (en) 2003-04-04 2014-03-25 Abbott Laboratories Method and system for transferring analyte test data
US20100076288A1 (en) * 2003-04-04 2010-03-25 Brian Edmond Connolly Method and System for Transferring Analyte Test Data
US7881763B2 (en) 2003-04-04 2011-02-01 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
US20100309001A1 (en) * 2003-04-04 2010-12-09 Abbott Diabetes Care Inc. Method and System for Transferring Analyte Test Data
US8437966B2 (en) 2003-04-04 2013-05-07 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US20060200022A1 (en) * 2003-04-04 2006-09-07 Brauker James H Optimized sensor geometry for an implantable glucose sensor
US20040199059A1 (en) * 2003-04-04 2004-10-07 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
US20100121168A1 (en) * 2003-04-04 2010-05-13 Abbott Diabetes Care Inc. Method and System for Transferring Analyte Test Data
US20060224108A1 (en) * 2003-04-04 2006-10-05 Brauker James H Optimized sensor geometry for an implantable glucose sensor
US20090083003A1 (en) * 2003-04-28 2009-03-26 Reggiardo Christopher V Method and apparatus for providing peak detection circuitry for data communication systems
US8512246B2 (en) 2003-04-28 2013-08-20 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US7679407B2 (en) 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
US20060204536A1 (en) * 2003-05-21 2006-09-14 Mark Shults Biointerface membranes incorporating bioactive agents
US20050112169A1 (en) * 2003-05-21 2005-05-26 Dexcom, Inc. Porous membranes for use with implantable devices
US8118877B2 (en) 2003-05-21 2012-02-21 Dexcom, Inc. Porous membranes for use with implantable devices
US7875293B2 (en) 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US20140275900A1 (en) * 2003-05-21 2014-09-18 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US20060198864A1 (en) * 2003-05-21 2006-09-07 Mark Shults Biointerface membranes incorporating bioactive agents
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US20040254434A1 (en) * 2003-06-10 2004-12-16 Goodnow Timothy T. Glucose measuring module and insulin pump combination
US8647269B2 (en) 2003-06-10 2014-02-11 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US8512239B2 (en) 2003-06-10 2013-08-20 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US9730584B2 (en) 2003-06-10 2017-08-15 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US20080146900A1 (en) * 2003-06-12 2008-06-19 Abbott Diabetes Care, Inc. Method and apparatus for providing power management in data communication systems
US20050009126A1 (en) * 2003-06-12 2005-01-13 Therasense, Inc. Method and apparatus for providing power management in data communication systems
US20100099174A1 (en) * 2003-06-12 2010-04-22 Abbott Diabetes Care Inc. Method and Apparatus for Providing Power Management in Data Communication Systems
US20100312085A1 (en) * 2003-06-12 2010-12-09 Therasense, Inc. Method and Apparatus for Providing Power Management in Data Communication Systems
US8906307B2 (en) 2003-06-12 2014-12-09 Abbott Diabetes Care Inc. Apparatus for providing power management in data communication systems
US8273295B2 (en) 2003-06-12 2012-09-25 Abbott Diabetes Care Inc. Apparatus for providing power management in data communication systems
US9109926B2 (en) 2003-06-12 2015-08-18 Abbott Diabetes Care Inc. Method and apparatus for providing power management in data communication systems
US20050013684A1 (en) * 2003-07-14 2005-01-20 Wu Kung Chris Single reticle transfer system
US8029443B2 (en) 2003-07-15 2011-10-04 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US20090048501A1 (en) * 2003-07-15 2009-02-19 Therasense, Inc. Glucose measuring device integrated into a holster for a personal area network device
US7722536B2 (en) 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US20080060955A1 (en) * 2003-07-15 2008-03-13 Therasense, Inc. Glucose measuring device integrated into a holster for a personal area network device
US20050051427A1 (en) * 2003-07-23 2005-03-10 Brauker James H. Rolled electrode array and its method for manufacture
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20070197890A1 (en) * 2003-07-25 2007-08-23 Robert Boock Analyte sensor
US8255032B2 (en) 2003-07-25 2012-08-28 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US8255030B2 (en) 2003-07-25 2012-08-28 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US8255033B2 (en) 2003-07-25 2012-08-28 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US9597027B2 (en) 2003-07-25 2017-03-21 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US7074307B2 (en) 2003-07-25 2006-07-11 Dexcom, Inc. Electrode systems for electrochemical sensors
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20060189856A1 (en) * 2003-07-25 2006-08-24 James Petisce Oxygen enhancing membrane systems for implantable devices
US9993186B2 (en) 2003-07-25 2018-06-12 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US20060200019A1 (en) * 2003-07-25 2006-09-07 James Petisce Oxygen enhancing membrane systems for implantable devices
US10376143B2 (en) 2003-07-25 2019-08-13 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7108778B2 (en) 2003-07-25 2006-09-19 Dexcom, Inc. Electrochemical sensors including electrode systems with increased oxygen generation
US10610140B2 (en) 2003-07-25 2020-04-07 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US8909314B2 (en) 2003-07-25 2014-12-09 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
USRE43399E1 (en) 2003-07-25 2012-05-22 Dexcom, Inc. Electrode systems for electrochemical sensors
US20100145172A1 (en) * 2003-07-25 2010-06-10 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US20050115832A1 (en) * 2003-07-25 2005-06-02 Simpson Peter C. Electrode systems for electrochemical sensors
US7379765B2 (en) 2003-07-25 2008-05-27 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US7896809B2 (en) 2003-07-25 2011-03-01 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20070213611A1 (en) * 2003-07-25 2007-09-13 Simpson Peter C Dual electrode system for a continuous analyte sensor
US20070235331A1 (en) * 2003-07-25 2007-10-11 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20050056552A1 (en) * 2003-07-25 2005-03-17 Simpson Peter C. Increasing bias for oxygen production in an electrode system
US20090076356A1 (en) * 2003-07-25 2009-03-19 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20050054909A1 (en) * 2003-07-25 2005-03-10 James Petisce Oxygen enhancing membrane systems for implantable devices
US20050051440A1 (en) * 2003-07-25 2005-03-10 Simpson Peter C. Electrochemical sensors including electrode systems with increased oxygen generation
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20080033254A1 (en) * 2003-07-25 2008-02-07 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US7828728B2 (en) 2003-07-25 2010-11-09 Dexcom, Inc. Analyte sensor
US20090192380A1 (en) * 2003-07-25 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US8700117B2 (en) 2003-08-01 2014-04-15 Dexcom, Inc. System and methods for processing analyte sensor data
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US8052601B2 (en) 2003-08-01 2011-11-08 Dexcom, Inc. System and methods for processing analyte sensor data
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US20080021666A1 (en) * 2003-08-01 2008-01-24 Dexcom, Inc. System and methods for processing analyte sensor data
US20140257067A1 (en) * 2003-08-01 2014-09-11 Dexcom, Inc. System and methods for processing analyte sensor data
US8808182B2 (en) 2003-08-01 2014-08-19 Dexcom, Inc. System and methods for processing analyte sensor data
US8915849B2 (en) 2003-08-01 2014-12-23 Dexcom, Inc. Transcutaneous analyte sensor
US8801612B2 (en) 2003-08-01 2014-08-12 Dexcom, Inc. System and methods for processing analyte sensor data
US8788008B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US8986209B2 (en) 2003-08-01 2015-03-24 Dexcom, Inc. Transcutaneous analyte sensor
US20070203966A1 (en) * 2003-08-01 2007-08-30 Dexcom, Inc. Transcutaneous analyte sensor
US8788007B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. Transcutaneous analyte sensor
US20110231142A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20110231141A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20100168543A1 (en) * 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20110231140A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20100168657A1 (en) * 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20100168544A1 (en) * 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20100168540A1 (en) * 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20110231107A1 (en) * 2003-08-01 2011-09-22 Dexcom, Inc. Transcutaneous analyte sensor
US20100168541A1 (en) * 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US20100168542A1 (en) * 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US8000901B2 (en) 2003-08-01 2011-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US20080183061A1 (en) * 2003-08-01 2008-07-31 Dexcom, Inc. System and methods for processing analyte sensor data
US8206297B2 (en) 2003-08-01 2012-06-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20080189051A1 (en) * 2003-08-01 2008-08-07 Dexcom, Inc. System and methods for processing analyte sensor data
US8788006B2 (en) 2003-08-01 2014-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20080195967A1 (en) * 2003-08-01 2008-08-14 Dexcom, Inc. System and methods for processing analyte sensor data
US7986986B2 (en) 2003-08-01 2011-07-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20080194937A1 (en) * 2003-08-01 2008-08-14 Dexcom, Inc. System and methods for processing analyte sensor data
US7979104B2 (en) 2003-08-01 2011-07-12 Dexcom, Inc. System and methods for processing analyte sensor data
US20100179406A1 (en) * 2003-08-01 2010-07-15 DesCom, Inc. System and methods for processing analyte sensor data
US8771187B2 (en) 2003-08-01 2014-07-08 Dexcom, Inc. System and methods for processing analyte sensor data
US8774888B2 (en) 2003-08-01 2014-07-08 Dexcom, Inc. System and methods for processing analyte sensor data
US20100185072A1 (en) * 2003-08-01 2010-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US8394021B2 (en) 2003-08-01 2013-03-12 Dexcom, Inc. System and methods for processing analyte sensor data
US20100185065A1 (en) * 2003-08-01 2010-07-22 Dexcom, Inc. System and methods for processing analyte sensor data
US20080306368A1 (en) * 2003-08-01 2008-12-11 Dexcom, Inc. System and methods for processing analyte sensor data
US7959569B2 (en) 2003-08-01 2011-06-14 Dexcom, Inc. System and methods for processing analyte sensor data
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US7955261B2 (en) 2003-08-01 2011-06-07 Dexcom, Inc. System and methods for processing analyte sensor data
US9895089B2 (en) * 2003-08-01 2018-02-20 Dexcom, Inc. System and methods for processing analyte sensor data
US7933639B2 (en) 2003-08-01 2011-04-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20090012379A1 (en) * 2003-08-01 2009-01-08 Dexcom, Inc. System and methods for processing analyte sensor data
US7925321B2 (en) 2003-08-01 2011-04-12 Dexcom, Inc. System and methods for processing analyte sensor data
US8622905B2 (en) 2003-08-01 2014-01-07 Dexcom, Inc. System and methods for processing analyte sensor data
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US20050187720A1 (en) * 2003-08-01 2005-08-25 Dexcom, Inc. System and method for processing analyte sensor data
US10786185B2 (en) 2003-08-01 2020-09-29 Dexcom, Inc. System and methods for processing analyte sensor data
US7778680B2 (en) 2003-08-01 2010-08-17 Dexcom, Inc. System and methods for processing analyte sensor data
US7914450B2 (en) 2003-08-01 2011-03-29 Dexcom, Inc. System and methods for processing analyte sensor data
US8588882B2 (en) 2003-08-01 2013-11-19 Dexcom, Inc. System and methods for processing analyte sensor data
US20100214104A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20100217106A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20100217557A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc. System and methods for processing analyte sensor data
US20100217555A1 (en) * 2003-08-01 2010-08-26 Dexcom, Inc System and methods for processing analyte sensor data
US8285354B2 (en) 2003-08-01 2012-10-09 Dexcom, Inc. System and methods for processing analyte sensor data
US8548553B2 (en) 2003-08-01 2013-10-01 Dexcom, Inc. System and methods for processing analyte sensor data
US8290562B2 (en) 2003-08-01 2012-10-16 Dexcom, Inc. System and methods for processing analyte sensor data
US8311749B2 (en) 2003-08-01 2012-11-13 Dexcom, Inc. Transcutaneous analyte sensor
US8321149B2 (en) 2003-08-01 2012-11-27 Dexcom, Inc. Transcutaneous analyte sensor
US8332008B2 (en) 2003-08-01 2012-12-11 Dexcom, Inc. System and methods for processing analyte sensor data
US7797028B2 (en) 2003-08-01 2010-09-14 Dexcom, Inc. System and methods for processing analyte sensor data
US7826981B2 (en) 2003-08-01 2010-11-02 Dexcom, Inc. System and methods for processing analyte sensor data
US20050027462A1 (en) * 2003-08-01 2005-02-03 Goode Paul V. System and methods for processing analyte sensor data
US20050027181A1 (en) * 2003-08-01 2005-02-03 Goode Paul V. System and methods for processing analyte sensor data
US8442610B2 (en) 2003-08-01 2013-05-14 Dexcom, Inc. System and methods for processing analyte sensor data
US20100305869A1 (en) * 2003-08-01 2010-12-02 Dexcom, Inc. Transcutaneous analyte sensor
US8428679B2 (en) 2003-08-01 2013-04-23 Dexcom, Inc. System and methods for processing analyte sensor data
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US20090143659A1 (en) * 2003-08-01 2009-06-04 Dexcom, Inc. Analyte sensor
US20090192745A1 (en) * 2003-08-01 2009-07-30 Dexcom, Inc. Systems and methods for processing sensor data
US20110118579A1 (en) * 2003-08-22 2011-05-19 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8233959B2 (en) 2003-08-22 2012-07-31 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8657747B2 (en) 2003-08-22 2014-02-25 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8672845B2 (en) 2003-08-22 2014-03-18 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8073519B2 (en) 2003-08-22 2011-12-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8073520B2 (en) 2003-08-22 2011-12-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8128562B2 (en) 2003-08-22 2012-03-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8150488B2 (en) 2003-08-22 2012-04-03 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110270062A1 (en) * 2003-08-22 2011-11-03 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8167801B2 (en) 2003-08-22 2012-05-01 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US11589823B2 (en) 2003-08-22 2023-02-28 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036216A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100240975A1 (en) * 2003-08-22 2010-09-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100240976A1 (en) * 2003-08-22 2010-09-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8195265B2 (en) 2003-08-22 2012-06-05 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US11559260B2 (en) 2003-08-22 2023-01-24 Dexcom, Inc. Systems and methods for processing analyte sensor data
US20100036223A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036225A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100235106A1 (en) * 2003-08-22 2010-09-16 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036222A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8229536B2 (en) 2003-08-22 2012-07-24 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8777853B2 (en) 2003-08-22 2014-07-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8790260B2 (en) 2003-08-22 2014-07-29 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8795177B2 (en) 2003-08-22 2014-08-05 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110218414A1 (en) * 2003-08-22 2011-09-08 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8812073B2 (en) 2003-08-22 2014-08-19 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8821400B2 (en) 2003-08-22 2014-09-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8843187B2 (en) 2003-08-22 2014-09-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036224A1 (en) * 2003-08-22 2010-02-11 DecCom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) * 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8005525B2 (en) 2003-08-22 2011-08-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100036215A1 (en) * 2003-08-22 2010-02-11 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7998071B2 (en) 2003-08-22 2011-08-16 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100030053A1 (en) * 2003-08-22 2010-02-04 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9149219B2 (en) 2003-08-22 2015-10-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8491474B2 (en) 2003-08-22 2013-07-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20100179408A1 (en) * 2003-08-22 2010-07-15 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8292810B2 (en) 2003-08-22 2012-10-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9750460B2 (en) 2003-08-22 2017-09-05 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8346338B2 (en) 2003-08-22 2013-01-01 Dexcom, Inc. System and methods for replacing signal artifacts in a glucose sensor data stream
US9724045B1 (en) 2003-08-22 2017-08-08 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9649069B2 (en) 2003-08-22 2017-05-16 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9585607B2 (en) 2003-08-22 2017-03-07 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9510782B2 (en) 2003-08-22 2016-12-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8412301B2 (en) 2003-08-22 2013-04-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7935057B2 (en) 2003-08-22 2011-05-03 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110118580A1 (en) * 2003-08-22 2011-05-19 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20070016381A1 (en) * 2003-08-22 2007-01-18 Apurv Kamath Systems and methods for processing analyte sensor data
US20090124877A1 (en) * 2003-08-22 2009-05-14 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9427183B2 (en) * 2003-08-22 2016-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110137601A1 (en) * 2003-08-22 2011-06-09 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8435179B2 (en) 2003-08-22 2013-05-07 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110124997A1 (en) * 2003-08-22 2011-05-26 Dexcom, Inc. System and methods for replacing signal artifacts in a glucose sensor data stream
US20090124878A1 (en) * 2003-08-22 2009-05-14 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110130971A1 (en) * 2003-08-22 2011-06-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20110130970A1 (en) * 2003-08-22 2011-06-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9420968B2 (en) 2003-08-22 2016-08-23 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20120209097A1 (en) * 2003-09-30 2012-08-16 Andre Mang Sensor with increased biocompatibility
US20050090607A1 (en) * 2003-10-28 2005-04-28 Dexcom, Inc. Silicone composition for biocompatible membrane
US20090204340A1 (en) * 2003-10-31 2009-08-13 Abbott Diabetes Care Inc. Method Of Calibrating An Analyte-Measurement Device, And Associated Methods, Devices And Systems
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8684930B2 (en) 2003-10-31 2014-04-01 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US20100282616A1 (en) * 2003-10-31 2010-11-11 Abbott Diabetes Care Inc. Method of Calibrating an Analyte-Measurement Device, and Associated Methods, Devices and Systems
US20090275817A1 (en) * 2003-10-31 2009-11-05 Abbott Diabetes Care Inc. Method of Calibrating an Analyte-Measurement Device, and Associated Methods, Devices and Systems
US20050239154A1 (en) * 2003-10-31 2005-10-27 Feldman Benjamin J A method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8116840B2 (en) 2003-10-31 2012-02-14 Abbott Diabetes Care Inc. Method of calibrating of an analyte-measurement device, and associated methods, devices and systems
US20080081969A1 (en) * 2003-10-31 2008-04-03 Abbott Diabetes Care, Inc. Method of calibrating of an analyte-measurement device, and associated methods, devices and systems
US8219175B2 (en) 2003-10-31 2012-07-10 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US8219174B2 (en) 2003-10-31 2012-07-10 Abbott Diabetes Care Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
USD902408S1 (en) 2003-11-05 2020-11-17 Abbott Diabetes Care Inc. Analyte sensor control unit
US20080287764A1 (en) * 2003-11-19 2008-11-20 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8282550B2 (en) 2003-11-19 2012-10-09 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7927274B2 (en) 2003-11-19 2011-04-19 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US11564602B2 (en) 2003-11-19 2023-01-31 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US9538946B2 (en) 2003-11-19 2017-01-10 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20100179401A1 (en) * 2003-11-19 2010-07-15 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20050176136A1 (en) * 2003-11-19 2005-08-11 Dexcom, Inc. Afinity domain for analyte sensor
US20100016698A1 (en) * 2003-11-19 2010-01-21 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US20070032717A1 (en) * 2003-12-05 2007-02-08 Mark Brister Dual electrode system for a continuous analyte sensor
US20100198036A1 (en) * 2003-12-05 2010-08-05 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US7917186B2 (en) 2003-12-05 2011-03-29 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8249684B2 (en) 2003-12-05 2012-08-21 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US11000215B1 (en) 2003-12-05 2021-05-11 Dexcom, Inc. Analyte sensor
US7467003B2 (en) * 2003-12-05 2008-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20070093704A1 (en) * 2003-12-05 2007-04-26 Mark Brister Dual electrode system for a continuous analyte sensor
USRE43039E1 (en) * 2003-12-05 2011-12-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8929968B2 (en) 2003-12-05 2015-01-06 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20090099436A1 (en) * 2003-12-05 2009-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8911369B2 (en) 2003-12-05 2014-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7460898B2 (en) * 2003-12-05 2008-12-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7366556B2 (en) * 2003-12-05 2008-04-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20100331648A1 (en) * 2003-12-05 2010-12-30 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US20100063373A1 (en) * 2003-12-05 2010-03-11 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US7424318B2 (en) * 2003-12-05 2008-09-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10188333B2 (en) 2003-12-05 2019-01-29 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US20100185070A1 (en) * 2003-12-05 2010-07-22 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8428678B2 (en) 2003-12-05 2013-04-23 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US10299712B2 (en) 2003-12-05 2019-05-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
USRE44695E1 (en) 2003-12-05 2014-01-07 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8483793B2 (en) 2003-12-05 2013-07-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9579053B2 (en) 2003-12-05 2017-02-28 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8386004B2 (en) 2003-12-05 2013-02-26 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US7715893B2 (en) 2003-12-05 2010-05-11 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US20070027384A1 (en) * 2003-12-05 2007-02-01 Mark Brister Dual electrode system for a continuous analyte sensor
US8160671B2 (en) 2003-12-05 2012-04-17 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
US11627900B2 (en) 2003-12-05 2023-04-18 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US20070027385A1 (en) * 2003-12-05 2007-02-01 Mark Brister Dual electrode system for a continuous analyte sensor
US11020031B1 (en) 2003-12-05 2021-06-01 Dexcom, Inc. Analyte sensor
US20050143635A1 (en) * 2003-12-05 2005-06-30 Kamath Apurv U. Calibration techniques for a continuous analyte sensor
US20050161346A1 (en) * 2003-12-08 2005-07-28 Peter Simpson Systems and methods for improving electrochemical analyte sensors
EP2228642A1 (en) 2003-12-08 2010-09-15 DexCom, Inc. Systems and methods for improving electrochemical analyte sensors
WO2005057173A2 (en) 2003-12-08 2005-06-23 Dexcom, Inc. Systems and methods for improving electrochemical analyte sensors
EP3241490A1 (en) 2003-12-08 2017-11-08 DexCom, Inc. Systems and methods for improving electrochemical analyte sensors
US20100030038A1 (en) * 2003-12-09 2010-02-04 Dexcom. Inc. Signal processing for continuous analyte sensor
US8282549B2 (en) 2003-12-09 2012-10-09 Dexcom, Inc. Signal processing for continuous analyte sensor
US11638541B2 (en) 2003-12-09 2023-05-02 Dexconi, Inc. Signal processing for continuous analyte sensor
US8265725B2 (en) 2003-12-09 2012-09-11 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100022855A1 (en) * 2003-12-09 2010-01-28 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090043525A1 (en) * 2003-12-09 2009-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US8747315B2 (en) 2003-12-09 2014-06-10 Dexcom. Inc. Signal processing for continuous analyte sensor
US20100179400A1 (en) * 2003-12-09 2010-07-15 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100030484A1 (en) * 2003-12-09 2010-02-04 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090043182A1 (en) * 2003-12-09 2009-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US8251906B2 (en) 2003-12-09 2012-08-28 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100016687A1 (en) * 2003-12-09 2010-01-21 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100010332A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090043541A1 (en) * 2003-12-09 2009-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100010324A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090043542A1 (en) * 2003-12-09 2009-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US8657745B2 (en) 2003-12-09 2014-02-25 Dexcom, Inc. Signal processing for continuous analyte sensor
US8801610B2 (en) 2003-12-09 2014-08-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US8233958B2 (en) 2003-12-09 2012-07-31 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100010331A1 (en) * 2003-12-09 2010-01-14 Dexcom, Inc. Signal processing for continuous analyte sensor
US8257259B2 (en) 2003-12-09 2012-09-04 Dexcom, Inc. Signal processing for continuous analyte sensor
US8005524B2 (en) 2003-12-09 2011-08-23 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090299162A1 (en) * 2003-12-09 2009-12-03 Dexcom, Inc. Signal processing for continuous analyte sensor
US10898113B2 (en) 2003-12-09 2021-01-26 Dexcom, Inc. Signal processing for continuous analyte sensor
US8290561B2 (en) 2003-12-09 2012-10-16 Dexcom, Inc. Signal processing for continuous analyte sensor
US9750441B2 (en) 2003-12-09 2017-09-05 Dexcom, Inc. Signal processing for continuous analyte sensor
US8216139B2 (en) 2003-12-09 2012-07-10 Dexcom, Inc. Signal processing for continuous analyte sensor
US20090204341A1 (en) * 2003-12-09 2009-08-13 Dexcom, Inc. Signal processing for continuous analyte sensor
US20050203360A1 (en) * 2003-12-09 2005-09-15 Brauker James H. Signal processing for continuous analyte sensor
US8374667B2 (en) 2003-12-09 2013-02-12 Dexcom, Inc. Signal processing for continuous analyte sensor
US9107623B2 (en) 2003-12-09 2015-08-18 Dexcom, Inc. Signal processing for continuous analyte sensor
US9498155B2 (en) 2003-12-09 2016-11-22 Dexcom, Inc. Signal processing for continuous analyte sensor
US9192328B2 (en) 2003-12-09 2015-11-24 Dexcom, Inc. Signal processing for continuous analyte sensor
US8469886B2 (en) 2003-12-09 2013-06-25 Dexcom, Inc. Signal processing for continuous analyte sensor
US20100045465A1 (en) * 2003-12-09 2010-02-25 Dexcom Inc. Signal processing for continuous analyte sensor
US9420965B2 (en) 2003-12-09 2016-08-23 Dexcom, Inc. Signal processing for continuous analyte sensor
US9351668B2 (en) 2003-12-09 2016-05-31 Dexcom, Inc. Signal processing for continuous analyte sensor
US9364173B2 (en) 2003-12-09 2016-06-14 Dexcom, Inc. Signal processing for continuous analyte sensor
EP1701654A2 (en) * 2003-12-18 2006-09-20 Subq LLC Implantable biosensor and methods of use thereof
EP2659831A1 (en) * 2003-12-18 2013-11-06 Metronom Health, Inc. Stabilized oxygen transport matrix
EP3175780A1 (en) * 2003-12-18 2017-06-07 Metronom Health, Inc. Implantable biosensor and methods of use thereof
EP1701654A4 (en) * 2003-12-18 2010-06-23 Subq Llc Implantable biosensor and methods of use thereof
US20100049024A1 (en) * 2004-01-12 2010-02-25 Dexcom, Inc. Composite material for implantable device
US20050182451A1 (en) * 2004-01-12 2005-08-18 Adam Griffin Implantable device with improved radio frequency capabilities
US20080195232A1 (en) * 2004-02-12 2008-08-14 Dexcom, Inc. Biointerface with macro- and micro-architecture
US7364592B2 (en) 2004-02-12 2008-04-29 Dexcom, Inc. Biointerface membrane with macro-and micro-architecture
US20050251083A1 (en) * 2004-02-12 2005-11-10 Victoria Carr-Brendel Biointerface with macro-and micro-architecture
US8771183B2 (en) 2004-02-17 2014-07-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US11246990B2 (en) 2004-02-26 2022-02-15 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US9155843B2 (en) 2004-02-26 2015-10-13 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8721585B2 (en) 2004-02-26 2014-05-13 Dex Com, Inc. Integrated delivery device for continuous glucose sensor
US8920401B2 (en) 2004-02-26 2014-12-30 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US10966609B2 (en) 2004-02-26 2021-04-06 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8882741B2 (en) 2004-02-26 2014-11-11 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US10835672B2 (en) 2004-02-26 2020-11-17 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US9050413B2 (en) 2004-02-26 2015-06-09 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US7976492B2 (en) 2004-02-26 2011-07-12 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
EP2226086A1 (en) 2004-02-26 2010-09-08 DexCom, Inc. Integrated delivery device for continuous glucose sensor
EP2223710A1 (en) 2004-02-26 2010-09-01 DexCom, Inc. Integrated delivery device for continuous glucose sensor
US8926585B2 (en) 2004-02-26 2015-01-06 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US20050197554A1 (en) * 2004-02-26 2005-09-08 Michael Polcha Composite thin-film glucose sensor
US20050242479A1 (en) * 2004-05-03 2005-11-03 Petisce James R Implantable analyte sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US20050245799A1 (en) * 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
US20050245795A1 (en) * 2004-05-03 2005-11-03 Dexcom, Inc. Implantable analyte sensor
US8277713B2 (en) 2004-05-03 2012-10-02 Dexcom, Inc. Implantable analyte sensor
US10327638B2 (en) 2004-05-03 2019-06-25 Dexcom, Inc. Transcutaneous analyte sensor
US7657297B2 (en) 2004-05-03 2010-02-02 Dexcom, Inc. Implantable analyte sensor
US9833143B2 (en) 2004-05-03 2017-12-05 Dexcom, Inc. Transcutaneous analyte sensor
US20090030294A1 (en) * 2004-05-03 2009-01-29 Dexcom, Inc. Implantable analyte sensor
US10963417B2 (en) 2004-06-04 2021-03-30 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US11507530B2 (en) 2004-06-04 2022-11-22 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US11182332B2 (en) 2004-06-04 2021-11-23 Abbott Diabetes Care Inc. Systems and methods for managing diabetes care data
US20060015020A1 (en) * 2004-07-06 2006-01-19 Dexcom, Inc. Systems and methods for manufacture of an analyte-measuring device including a membrane system
US20060036144A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US8475373B2 (en) 2004-07-13 2013-07-02 Dexcom, Inc. Transcutaneous analyte sensor
US11883164B2 (en) 2004-07-13 2024-01-30 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20060015024A1 (en) * 2004-07-13 2006-01-19 Mark Brister Transcutaneous medical device with variable stiffness
US7654956B2 (en) 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
US8663109B2 (en) 2004-07-13 2014-03-04 Dexcom, Inc. Transcutaneous analyte sensor
EP4299004A2 (en) 2004-07-13 2024-01-03 Dexcom, Inc. Transcutaneous analyte sensor
US20100174163A1 (en) * 2004-07-13 2010-07-08 Dexcom, Inc. Transcutaneous analyte sensor
US10022078B2 (en) 2004-07-13 2018-07-17 Dexcom, Inc. Analyte sensor
US8231531B2 (en) 2004-07-13 2012-07-31 Dexcom, Inc. Analyte sensor
US20060019327A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20100174158A1 (en) * 2004-07-13 2010-07-08 Dexcom, Inc. Transcutaneous analyte sensor
US8280475B2 (en) 2004-07-13 2012-10-02 Dexcom, Inc. Transcutaneous analyte sensor
US8229534B2 (en) 2004-07-13 2012-07-24 Dexcom, Inc. Transcutaneous analyte sensor
US10932700B2 (en) 2004-07-13 2021-03-02 Dexcom, Inc. Analyte sensor
US10813576B2 (en) 2004-07-13 2020-10-27 Dexcom, Inc. Analyte sensor
US8690775B2 (en) 2004-07-13 2014-04-08 Dexcom, Inc. Transcutaneous analyte sensor
US20110178378A1 (en) * 2004-07-13 2011-07-21 Dexcom, Inc. Transcutaneous analyte sensor
US20060016700A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
EP4122394A1 (en) 2004-07-13 2023-01-25 DexCom, Inc. Transcutaneous analyte sensor
US10799159B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US10980452B2 (en) 2004-07-13 2021-04-20 Dexcom, Inc. Analyte sensor
US9833176B2 (en) 2004-07-13 2017-12-05 Dexcom, Inc. Transcutaneous analyte sensor
US9814414B2 (en) 2004-07-13 2017-11-14 Dexcom, Inc. Transcutaneous analyte sensor
US8721545B2 (en) 2004-07-13 2014-05-13 Dexcom, Inc. Transcutaneous analyte sensor
US8313434B2 (en) 2004-07-13 2012-11-20 Dexcom, Inc. Analyte sensor inserter system
US10799158B2 (en) 2004-07-13 2020-10-13 Dexcom, Inc. Analyte sensor
US20060020187A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US9801572B2 (en) 2004-07-13 2017-10-31 Dexcom, Inc. Transcutaneous analyte sensor
US20060020190A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US9775543B2 (en) 2004-07-13 2017-10-03 Dexcom, Inc. Transcutaneous analyte sensor
US20060036139A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
EP4111962A1 (en) 2004-07-13 2023-01-04 Dexcom, Inc. Transcutaneous analyte sensor
US20100185069A1 (en) * 2004-07-13 2010-07-22 Dexcom, Inc. Transcutaneous analyte sensor
US8731630B2 (en) 2004-07-13 2014-05-20 Dexcom, Inc. Transcutaneous analyte sensor
US10993641B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
US20060036142A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
EP2335587A2 (en) 2004-07-13 2011-06-22 DexCom, Inc. Transcutaneous analyte sensor
US10918314B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US20080275313A1 (en) * 2004-07-13 2008-11-06 Dexcom, Inc. Transcutaneous analyte sensor
US9668677B2 (en) 2004-07-13 2017-06-06 Dexcom, Inc. Analyte sensor
EP2335582A1 (en) 2004-07-13 2011-06-22 DexCom, Inc. Transcutaneous analyte sensor
US20060036140A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
EP2335583A2 (en) 2004-07-13 2011-06-22 DexCom, Inc. Transcutaneous analyte sensor
US9610031B2 (en) 2004-07-13 2017-04-04 Dexcom, Inc. Transcutaneous analyte sensor
EP3718479A1 (en) 2004-07-13 2020-10-07 Dexcom, Inc. Transcutaneous analyte sensor
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US20060036145A1 (en) * 2004-07-13 2006-02-16 Dexcom, Inc. Transcutaneous analyte sensor
US9603557B2 (en) 2004-07-13 2017-03-28 Dexcom, Inc. Transcutaneous analyte sensor
US10827956B2 (en) 2004-07-13 2020-11-10 Dexcom, Inc. Analyte sensor
EP2335581A1 (en) 2004-07-13 2011-06-22 DexCom, Inc. Transcutaneous analyte sensor
EP2335585A2 (en) 2004-07-13 2011-06-22 DexCom, Inc. Transcutaneous analyte sensor
EP2335586A1 (en) 2004-07-13 2011-06-22 DexCom, Inc. Transcutaneous analyte sensor
US8615282B2 (en) 2004-07-13 2013-12-24 Dexcom, Inc. Analyte sensor
US20060142651A1 (en) * 2004-07-13 2006-06-29 Mark Brister Analyte sensor
US10993642B2 (en) 2004-07-13 2021-05-04 Dexcom, Inc. Analyte sensor
EP3718478A1 (en) 2004-07-13 2020-10-07 Dexcom, Inc. Transcutaneous analyte sensor
EP3111832A1 (en) 2004-07-13 2017-01-04 Dexcom, Inc. Transcutaneous analyte sensor
US20060183984A1 (en) * 2004-07-13 2006-08-17 Dobbles J M Analyte sensor
US8750955B2 (en) 2004-07-13 2014-06-10 Dexcom, Inc. Analyte sensor
US10314525B2 (en) 2004-07-13 2019-06-11 Dexcom, Inc. Analyte sensor
EP2332466A1 (en) 2004-07-13 2011-06-15 DexCom, Inc. Transcutaneous analyte sensor
US10918313B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US10722152B2 (en) 2004-07-13 2020-07-28 Dexcom, Inc. Analyte sensor
US20100191082A1 (en) * 2004-07-13 2010-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US20090143660A1 (en) * 2004-07-13 2009-06-04 Dexcom, Inc. Transcutaneous analyte sensor
US20090124879A1 (en) * 2004-07-13 2009-05-14 Dexcom, Inc. Transcutaneous analyte sensor
EP2329771A2 (en) 2004-07-13 2011-06-08 DexCom, Inc. Transcutaneous analyte sensor
EP2329770A1 (en) 2004-07-13 2011-06-08 DexCom, Inc. Transcutaneous analyte sensor
US20080194935A1 (en) * 2004-07-13 2008-08-14 Dexcom, Inc. Transcutaneous analyte sensor
US7949381B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US7946984B2 (en) 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
US20080188731A1 (en) * 2004-07-13 2008-08-07 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US8792954B2 (en) 2004-07-13 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US9414777B2 (en) 2004-07-13 2016-08-16 Dexcom, Inc. Transcutaneous analyte sensor
US8457708B2 (en) 2004-07-13 2013-06-04 Dexcom, Inc. Transcutaneous analyte sensor
US8792953B2 (en) 2004-07-13 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US7713574B2 (en) 2004-07-13 2010-05-11 Dexcom, Inc. Transcutaneous analyte sensor
US8463350B2 (en) 2004-07-13 2013-06-11 Dexcom, Inc. Transcutaneous analyte sensor
US20060270923A1 (en) * 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US10709362B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
EP3001952A1 (en) 2004-07-13 2016-04-06 DexCom, Inc. Transcutaneous analyte sensor
US11026605B1 (en) 2004-07-13 2021-06-08 Dexcom, Inc. Analyte sensor
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
EP2322094A1 (en) 2004-07-13 2011-05-18 DexCom, Inc. Transcutaneous analyte sensor
EP3524142A1 (en) 2004-07-13 2019-08-14 Dexcom, Inc. Transcutaneous analyte sensor
US20100223013A1 (en) * 2004-07-13 2010-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US20060020192A1 (en) * 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US8474397B2 (en) 2004-07-13 2013-07-02 Dexcom, Inc. Transcutaneous analyte sensor
US20100223022A1 (en) * 2004-07-13 2010-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US11045120B2 (en) 2004-07-13 2021-06-29 Dexcom, Inc. Analyte sensor
US10709363B2 (en) 2004-07-13 2020-07-14 Dexcom, Inc. Analyte sensor
EP3524150A1 (en) 2004-07-13 2019-08-14 Dexcom, Inc. Transcutaneous analyte sensor
US11064917B2 (en) 2004-07-13 2021-07-20 Dexcom, Inc. Analyte sensor
US8483791B2 (en) 2004-07-13 2013-07-09 Dexcom, Inc. Transcutaneous analyte sensor
US8801611B2 (en) 2004-07-13 2014-08-12 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US7905833B2 (en) 2004-07-13 2011-03-15 Dexcom, Inc. Transcutaneous analyte sensor
US10918315B2 (en) 2004-07-13 2021-02-16 Dexcom, Inc. Analyte sensor
US8812072B2 (en) 2004-07-13 2014-08-19 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US9078626B2 (en) 2004-07-13 2015-07-14 Dexcom, Inc. Transcutaneous analyte sensor
US20100212583A1 (en) * 2004-07-13 2010-08-26 Dexcom, Inc. Transcutaneous analyte sensor
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20070163880A1 (en) * 2004-07-13 2007-07-19 Dexcom, Inc. Analyte sensor
US8515516B2 (en) 2004-07-13 2013-08-20 Dexcom, Inc. Transcutaneous analyte sensor
US8515519B2 (en) 2004-07-13 2013-08-20 Dexcom, Inc. Transcutaneous analyte sensor
US9060742B2 (en) 2004-07-13 2015-06-23 Dexcom, Inc. Transcutaneous analyte sensor
US9055901B2 (en) 2004-07-13 2015-06-16 Dexcom, Inc. Transcutaneous analyte sensor
EP3524151A1 (en) 2004-07-13 2019-08-14 DexCom, Inc. Transcutaneous analyte sensor
US9044199B2 (en) 2004-07-13 2015-06-02 Dexcom, Inc. Transcutaneous analyte sensor
EP3666187A1 (en) 2004-07-13 2020-06-17 DexCom, Inc. Transcutaneous analyte sensor
US8989833B2 (en) * 2004-07-13 2015-03-24 Dexcom, Inc. Transcutaneous analyte sensor
US10524703B2 (en) 2004-07-13 2020-01-07 Dexcom, Inc. Transcutaneous analyte sensor
US8571625B2 (en) 2004-07-13 2013-10-29 Dexcom, Inc. Transcutaneous analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8825127B2 (en) 2004-07-13 2014-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US8565849B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US20100223023A1 (en) * 2004-07-13 2010-09-02 Dexcom, Inc. Transcutaneous analyte sensor
US8548551B2 (en) 2004-07-13 2013-10-01 Dexcom, Inc. Transcutaneous analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US7885697B2 (en) 2004-07-13 2011-02-08 Dexcom, Inc. Transcutaneous analyte sensor
US20080071156A1 (en) * 2004-07-13 2008-03-20 Dexcom, Inc. Transcutaneous analyte sensor
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US11160475B2 (en) 2004-12-29 2021-11-02 Abbott Diabetes Care Inc. Sensor inserter having introducer
US8223021B2 (en) 2005-02-08 2012-07-17 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US8358210B2 (en) 2005-02-08 2013-01-22 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US8542122B2 (en) 2005-02-08 2013-09-24 Abbott Diabetes Care Inc. Glucose measurement device and methods using RFID
US8390455B2 (en) 2005-02-08 2013-03-05 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US8115635B2 (en) 2005-02-08 2012-02-14 Abbott Diabetes Care Inc. RF tag on test strips, test strip vials and boxes
US10918316B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10743801B2 (en) 2005-03-10 2020-08-18 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10624539B2 (en) 2005-03-10 2020-04-21 Dexcom, Inc. Transcutaneous analyte sensor
EP3797682A1 (en) 2005-03-10 2021-03-31 Dexcom, Inc. Method for processing analyte sensor data for sensor calibration
US9078608B2 (en) 2005-03-10 2015-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8579816B2 (en) 2005-03-10 2013-11-12 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10898114B2 (en) 2005-03-10 2021-01-26 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10709364B2 (en) 2005-03-10 2020-07-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11051726B2 (en) 2005-03-10 2021-07-06 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10918317B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9220449B2 (en) 2005-03-10 2015-12-29 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9314196B2 (en) 2005-03-10 2016-04-19 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
EP3305191A1 (en) 2005-03-10 2018-04-11 DexCom, Inc. System and methods for processing analyte sensor data for sensor calibration
EP2596747A1 (en) 2005-03-10 2013-05-29 DexCom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10617336B2 (en) 2005-03-10 2020-04-14 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8560037B2 (en) 2005-03-10 2013-10-15 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10856787B2 (en) 2005-03-10 2020-12-08 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
EP3821803A1 (en) 2005-03-10 2021-05-19 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10716498B2 (en) 2005-03-10 2020-07-21 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
EP4252649A2 (en) 2005-03-10 2023-10-04 Dexcom, Inc. Method for processing analyte sensor data for sensor calibration
US10610136B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8611978B2 (en) 2005-03-10 2013-12-17 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US11000213B2 (en) 2005-03-10 2021-05-11 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610135B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
EP2561807A1 (en) 2005-03-10 2013-02-27 DexCom, Inc. System and methods for processing analyte sensor data for sensor calibration
EP4248864A2 (en) 2005-03-10 2023-09-27 DexCom, Inc. Method for processing analyte sensor data for sensor calibration
US10918318B2 (en) 2005-03-10 2021-02-16 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
EP3932297A1 (en) 2005-03-10 2022-01-05 Dexcom, Inc. Method for processing analyte sensor data for sensor calibration
US10925524B2 (en) 2005-03-10 2021-02-23 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610102B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. Transcutaneous analyte sensor
US20100168545A1 (en) * 2005-03-10 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20100179402A1 (en) * 2005-03-10 2010-07-15 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US10610137B2 (en) 2005-03-10 2020-04-07 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20100168546A1 (en) * 2005-03-10 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US9918668B2 (en) 2005-03-10 2018-03-20 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8343092B2 (en) 2005-03-21 2013-01-01 Abbott Diabetes Care Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US8029459B2 (en) 2005-03-21 2011-10-04 Abbott Diabetes Care Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US20060224141A1 (en) * 2005-03-21 2006-10-05 Abbott Diabetes Care, Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US8029460B2 (en) 2005-03-21 2011-10-04 Abbott Diabetes Care Inc. Method and system for providing integrated medication infusion and analyte monitoring system
US20070173709A1 (en) * 2005-04-08 2007-07-26 Petisce James R Membranes for an analyte sensor
US7651596B2 (en) 2005-04-08 2010-01-26 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
US10702193B2 (en) 2005-04-15 2020-07-07 Dexcom, Inc. Analyte sensing biointerface
US8060174B2 (en) 2005-04-15 2011-11-15 Dexcom, Inc. Analyte sensing biointerface
US10376188B2 (en) 2005-04-15 2019-08-13 Dexcom, Inc. Analyte sensing biointerface
US9788766B2 (en) 2005-04-15 2017-10-17 Dexcom, Inc. Analyte sensing biointerface
US10667729B2 (en) 2005-04-15 2020-06-02 Dexcom, Inc. Analyte sensing biointerface
US10667730B2 (en) 2005-04-15 2020-06-02 Dexcom, Inc. Analyte sensing biointerface
US20060257996A1 (en) * 2005-04-15 2006-11-16 Simpson Peter C Analyte sensing biointerface
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US20060249381A1 (en) * 2005-05-05 2006-11-09 Petisce James R Cellulosic-based resistance domain for an analyte sensor
US20060252027A1 (en) * 2005-05-05 2006-11-09 Petisce James R Cellulosic-based resistance domain for an analyte sensor
US20140161969A1 (en) * 2005-05-05 2014-06-12 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
US20060253012A1 (en) * 2005-05-05 2006-11-09 Petisce James R Cellulosic-based resistance domain for an analyte sensor
US8744546B2 (en) 2005-05-05 2014-06-03 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
US10300507B2 (en) * 2005-05-05 2019-05-28 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8653977B2 (en) 2005-05-17 2014-02-18 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8471714B2 (en) 2005-05-17 2013-06-25 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US20100298686A1 (en) * 2005-05-17 2010-11-25 Abbott Diabetes Care Inc. Method and System for Providing Data Management in Data Monitoring System
US20090076358A1 (en) * 2005-05-17 2009-03-19 Abbott Diabetes Care, Inc. Method and System for Providing Data Management in Data Monitoring System
US9332944B2 (en) 2005-05-17 2016-05-10 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US10206611B2 (en) 2005-05-17 2019-02-19 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US9750440B2 (en) 2005-05-17 2017-09-05 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US7884729B2 (en) 2005-05-17 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8089363B2 (en) 2005-05-17 2012-01-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US8112138B2 (en) 2005-06-03 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US10709332B2 (en) 2005-06-21 2020-07-14 Dexcom, Inc. Transcutaneous analyte sensor
US10610103B2 (en) 2005-06-21 2020-04-07 Dexcom, Inc. Transcutaneous analyte sensor
EP2532302A1 (en) 2005-06-21 2012-12-12 DexCom, Inc. Analyte sensor
US10813577B2 (en) 2005-06-21 2020-10-27 Dexcom, Inc. Analyte sensor
EP2517623A1 (en) 2005-06-21 2012-10-31 DexCom, Inc. Analyte sensor
EP2499969A1 (en) 2005-06-21 2012-09-19 DexCom, Inc. Analyte sensor
US20070027381A1 (en) * 2005-07-29 2007-02-01 Therasense, Inc. Inserter and methods of use
US20070060814A1 (en) * 2005-08-30 2007-03-15 Abbott Diabetes Care, Inc. Analyte sensor introducer and methods of use
US7731657B2 (en) 2005-08-30 2010-06-08 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US8602991B2 (en) 2005-08-30 2013-12-10 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US20100249565A1 (en) * 2005-08-30 2010-09-30 Abbott Diabetes Care Inc. Analyte Sensor Introducer and Methods of Use
US9775563B2 (en) 2005-09-30 2017-10-03 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
USD979766S1 (en) 2005-09-30 2023-02-28 Abbott Diabetes Care Inc. Analyte sensor device
US11457869B2 (en) 2005-09-30 2022-10-04 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US9480421B2 (en) 2005-09-30 2016-11-01 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US20110144464A1 (en) * 2005-09-30 2011-06-16 Abbott Diabetes Care Inc. Integrated Transmitter Unit and Sensor Introducer Mechanism and Methods of Use
US10194863B2 (en) 2005-09-30 2019-02-05 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US10342489B2 (en) 2005-09-30 2019-07-09 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US20090054746A1 (en) * 2005-09-30 2009-02-26 Abbott Diabetes Care, Inc. Device for channeling fluid and methods of use
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US7756561B2 (en) 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US8638220B2 (en) 2005-10-31 2014-01-28 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US7948370B2 (en) 2005-10-31 2011-05-24 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US20090068954A1 (en) * 2005-10-31 2009-03-12 Abbott Diabetes Care, Inc. Method and apparatus for providing data communication in data monitoring and management systems
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10201301B2 (en) 2005-11-01 2019-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11103165B2 (en) 2005-11-01 2021-08-31 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10231654B2 (en) 2005-11-01 2019-03-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9078607B2 (en) 2005-11-01 2015-07-14 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11399748B2 (en) 2005-11-01 2022-08-02 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11911151B1 (en) 2005-11-01 2024-02-27 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11363975B2 (en) 2005-11-01 2022-06-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US10952652B2 (en) 2005-11-01 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US11272867B2 (en) 2005-11-01 2022-03-15 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9669162B2 (en) 2005-11-04 2017-06-06 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US11538580B2 (en) 2005-11-04 2022-12-27 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8585591B2 (en) 2005-11-04 2013-11-19 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8545403B2 (en) 2005-12-28 2013-10-01 Abbott Diabetes Care Inc. Medical device insertion
US20070249922A1 (en) * 2005-12-28 2007-10-25 Abbott Diabetes Care, Inc. Medical Device Insertion
US8353881B2 (en) 2005-12-28 2013-01-15 Abbott Diabetes Care Inc. Infusion sets for the delivery of a therapeutic substance to a patient
US8515518B2 (en) 2005-12-28 2013-08-20 Abbott Diabetes Care Inc. Analyte monitoring
US11439326B2 (en) 2005-12-28 2022-09-13 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9795331B2 (en) 2005-12-28 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US10219728B2 (en) 2005-12-28 2019-03-05 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US9332933B2 (en) 2005-12-28 2016-05-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US20090105658A1 (en) * 2005-12-28 2009-04-23 Abbott Diabetes Care, Inc. Infusion sets for the delivery of a therapeutic substance to a patient
US20080033268A1 (en) * 2005-12-28 2008-02-07 Abbott Diabetes Care, Inc. Method and Apparatus for Providing Analyte Sensor Insertion
US10307091B2 (en) 2005-12-28 2019-06-04 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8160670B2 (en) 2005-12-28 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US9669156B2 (en) 2005-12-28 2017-06-06 Abbott Diabetes Care Inc. Infusion sets for the delivery of a therapeutic substance to a patient
US8792956B2 (en) 2005-12-28 2014-07-29 Abbott Diabetes Care Inc. Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent
US8852101B2 (en) 2005-12-28 2014-10-07 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
US11191458B2 (en) 2006-01-17 2021-12-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
EP3366201A1 (en) 2006-01-17 2018-08-29 DexCom, Inc. Low oxygen in vivo analyte sensor
US11596332B2 (en) 2006-01-17 2023-03-07 Dexcom, Inc. Low oxygen in vivo analyte sensor
US20170325726A1 (en) * 2006-01-17 2017-11-16 Dexcom, Inc. Low oxygen in vivo analyte sensor
US10265000B2 (en) * 2006-01-17 2019-04-23 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
US7951080B2 (en) 2006-01-30 2011-05-31 Abbott Diabetes Care Inc. On-body medical device securement
US8734344B2 (en) 2006-01-30 2014-05-27 Abbott Diabetes Care Inc. On-body medical device securement
US20090088614A1 (en) * 2006-01-30 2009-04-02 Abbott Diabetes Care, Inc. On-body medical device securement
US9326727B2 (en) 2006-01-30 2016-05-03 Abbott Diabetes Care Inc. On-body medical device securement
US20100049025A1 (en) * 2006-01-30 2010-02-25 Abbott Diabetes Care Inc. On-Body Medical Device Securement
US8095198B2 (en) 2006-01-31 2012-01-10 Warsaw Orthopedic. Inc. Methods for detecting osteolytic conditions in the body
US20070179568A1 (en) * 2006-01-31 2007-08-02 Sdgi Holdings, Inc. Methods for detecting osteolytic conditions in the body
US20070176867A1 (en) * 2006-01-31 2007-08-02 Abbott Diabetes Care, Inc. Method and system for providing a fault tolerant display unit in an electronic device
US8344966B2 (en) 2006-01-31 2013-01-01 Abbott Diabetes Care Inc. Method and system for providing a fault tolerant display unit in an electronic device
EP2407093A1 (en) 2006-02-22 2012-01-18 DexCom, Inc. Analyte sensor
EP4282332A2 (en) 2006-02-22 2023-11-29 DexCom, Inc. Analyte sensor
EP3649925A1 (en) 2006-02-22 2020-05-13 DexCom, Inc. Analyte sensor
EP2407094A1 (en) 2006-02-22 2012-01-18 DexCom, Inc. Analyte sensor
EP3892186A1 (en) 2006-02-22 2021-10-13 DexCom, Inc. Analyte sensor
EP2407095A1 (en) 2006-02-22 2012-01-18 DexCom, Inc. Analyte sensor
US9724028B2 (en) 2006-02-22 2017-08-08 Dexcom, Inc. Analyte sensor
EP3756537A1 (en) 2006-02-22 2020-12-30 DexCom, Inc. Analyte sensor
EP2829224A2 (en) 2006-02-22 2015-01-28 DexCom, Inc. Analyte sensor
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US8506482B2 (en) 2006-02-28 2013-08-13 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US9031630B2 (en) 2006-02-28 2015-05-12 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US10448834B2 (en) 2006-02-28 2019-10-22 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US10117614B2 (en) 2006-02-28 2018-11-06 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US20110046465A1 (en) * 2006-02-28 2011-02-24 Abbott Diabetes Care Inc. Analyte Sensors and Methods of Use
US9844329B2 (en) 2006-02-28 2017-12-19 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US11064916B2 (en) 2006-02-28 2021-07-20 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US10945647B2 (en) 2006-02-28 2021-03-16 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US7822455B2 (en) 2006-02-28 2010-10-26 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US20070203407A1 (en) * 2006-02-28 2007-08-30 Abbott Diabetes Care, Inc. Analyte sensors and methods of use
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US11872039B2 (en) 2006-02-28 2024-01-16 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US20090292188A1 (en) * 2006-02-28 2009-11-26 Abbott Diabetes Care Inc. Analyte Sensors and Methods of Use
US9782076B2 (en) 2006-02-28 2017-10-10 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
US20090102678A1 (en) * 2006-02-28 2009-04-23 Abbott Diabetes Care, Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US10159433B2 (en) 2006-02-28 2018-12-25 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US11179072B2 (en) 2006-02-28 2021-11-23 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9364149B2 (en) 2006-02-28 2016-06-14 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US11179071B2 (en) 2006-02-28 2021-11-23 Abbott Diabetes Care Inc Analyte sensor transmitter unit configuration for a data monitoring and management system
US7981034B2 (en) 2006-02-28 2011-07-19 Abbott Diabetes Care Inc. Smart messages and alerts for an infusion delivery and management system
USD961778S1 (en) 2006-02-28 2022-08-23 Abbott Diabetes Care Inc. Analyte sensor device
EP4218548A1 (en) 2006-03-09 2023-08-02 Dexcom, Inc. Systems and methods for processing analyte sensor data
EP3513708A1 (en) 2006-03-09 2019-07-24 Dexcom, Inc. Systems and methods for processing analyte sensor data
WO2007102842A2 (en) 2006-03-09 2007-09-13 Dexcom, Inc. Systems and methods for processing analyte sensor data
US9625413B2 (en) 2006-03-31 2017-04-18 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US20100099966A1 (en) * 2006-03-31 2010-04-22 Abbott Diabetes Care Inc. Analyte Monitoring and Management System and Methods Therefor
US8597575B2 (en) 2006-03-31 2013-12-03 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US20090076359A1 (en) * 2006-03-31 2009-03-19 Abbott Diabetes Care, Inc. Analyte monitoring and management system and methods therefor
US9743863B2 (en) 2006-03-31 2017-08-29 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8593109B2 (en) 2006-03-31 2013-11-26 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8086292B2 (en) 2006-03-31 2011-12-27 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US9039975B2 (en) 2006-03-31 2015-05-26 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8543183B2 (en) 2006-03-31 2013-09-24 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US7918796B2 (en) 2006-04-11 2011-04-05 Warsaw Orthopedic, Inc. Volumetric measurement and visual feedback of tissues
US8137277B2 (en) 2006-04-11 2012-03-20 Warsaw Orthopedic, Inc. Volumetric measurement and visual feedback of tissues
US20110160587A1 (en) * 2006-04-11 2011-06-30 Warsaw Orthopedic, Inc. Volumetric measurement and visual feedback of tissues
US20070238998A1 (en) * 2006-04-11 2007-10-11 Sdgi Holdings, Inc. Volumetric measurement and visual feedback of tissues
US20090105569A1 (en) * 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US20080071157A1 (en) * 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US20080004601A1 (en) * 2006-06-28 2008-01-03 Abbott Diabetes Care, Inc. Analyte Monitoring and Therapy Management System and Methods Therefor
US20090171269A1 (en) * 2006-06-29 2009-07-02 Abbott Diabetes Care, Inc. Infusion Device and Methods Therefor
US20090105571A1 (en) * 2006-06-30 2009-04-23 Abbott Diabetes Care, Inc. Method and System for Providing Data Communication in Data Management Systems
US9119582B2 (en) 2006-06-30 2015-09-01 Abbott Diabetes Care, Inc. Integrated analyte sensor and infusion device and methods therefor
US8512244B2 (en) 2006-06-30 2013-08-20 Abbott Diabetes Care Inc. Integrated analyte sensor and infusion device and methods therefor
US11432772B2 (en) 2006-08-02 2022-09-06 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US10206629B2 (en) 2006-08-07 2019-02-19 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US9697332B2 (en) 2006-08-07 2017-07-04 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US11445910B2 (en) 2006-08-07 2022-09-20 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US20090054745A1 (en) * 2006-08-07 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Data Management in Integrated Analyte Monitoring and Infusion System
US8932216B2 (en) 2006-08-07 2015-01-13 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US11806110B2 (en) 2006-08-07 2023-11-07 Abbott Diabetes Care Inc. Method and system for providing data management in integrated analyte monitoring and infusion system
US8727982B2 (en) 2006-08-07 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US8206296B2 (en) 2006-08-07 2012-06-26 Abbott Diabetes Care Inc. Method and system for providing integrated analyte monitoring and infusion system therapy management
US20090054750A1 (en) * 2006-08-07 2009-02-26 Abbott Diabetes Care, Inc. Method and System for Providing Integrated Analyte Monitoring and Infusion System Therapy Management
US9833181B2 (en) 2006-08-09 2017-12-05 Abbot Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US9408566B2 (en) 2006-08-09 2016-08-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US10278630B2 (en) 2006-08-09 2019-05-07 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US8376945B2 (en) 2006-08-09 2013-02-19 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US11864894B2 (en) 2006-08-09 2024-01-09 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US20080039702A1 (en) * 2006-08-09 2008-02-14 Abbott Diabetes Care, Inc. Method and System for Providing Calibration of an Analyte Sensor in an Analyte Monitoring System
US8862198B2 (en) 2006-09-10 2014-10-14 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US10362972B2 (en) 2006-09-10 2019-07-30 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US20080097246A1 (en) * 2006-09-10 2008-04-24 Abbott Diabetes Care, Inc Method and System for Providing An Integrated Analyte Sensor Insertion Device and Data Processing Unit
US9808186B2 (en) 2006-09-10 2017-11-07 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9357959B2 (en) 2006-10-02 2016-06-07 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9629578B2 (en) 2006-10-02 2017-04-25 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8515517B2 (en) 2006-10-02 2013-08-20 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US10342469B2 (en) 2006-10-02 2019-07-09 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9839383B2 (en) 2006-10-02 2017-12-12 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US9451908B2 (en) 2006-10-04 2016-09-27 Dexcom, Inc. Analyte sensor
US11399745B2 (en) 2006-10-04 2022-08-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US9504413B2 (en) 2006-10-04 2016-11-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP2796090A1 (en) 2006-10-04 2014-10-29 DexCom, Inc. Analyte sensor
US11382539B2 (en) 2006-10-04 2022-07-12 Dexcom, Inc. Analyte sensor
US20080083617A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10136844B2 (en) 2006-10-04 2018-11-27 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
WO2008041984A1 (en) * 2006-10-04 2008-04-10 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7831287B2 (en) 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10349873B2 (en) 2006-10-04 2019-07-16 Dexcom, Inc. Analyte sensor
US20080214918A1 (en) * 2006-10-04 2008-09-04 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US10070810B2 (en) 2006-10-23 2018-09-11 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US10363363B2 (en) 2006-10-23 2019-07-30 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US11724029B2 (en) 2006-10-23 2023-08-15 Abbott Diabetes Care Inc. Flexible patch for fluid delivery and monitoring body analytes
US11234621B2 (en) 2006-10-23 2022-02-01 Abbott Diabetes Care Inc. Sensor insertion devices and methods of use
US8211016B2 (en) 2006-10-25 2012-07-03 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US20090069649A1 (en) * 2006-10-25 2009-03-12 Abbott Diabetes Care, Inc. Method and System for Providing Analyte Monitoring
US10194868B2 (en) 2006-10-25 2019-02-05 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US9113828B2 (en) 2006-10-25 2015-08-25 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8216137B2 (en) 2006-10-25 2012-07-10 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US20090281407A1 (en) * 2006-10-25 2009-11-12 Abbott Diabetes Care Inc. Method and System for Providing Analyte Monitoring
US11282603B2 (en) 2006-10-25 2022-03-22 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US9814428B2 (en) 2006-10-25 2017-11-14 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US11722229B2 (en) 2006-10-26 2023-08-08 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US20080172205A1 (en) * 2006-10-26 2008-07-17 Abbott Diabetes Care, Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8718958B2 (en) 2006-10-26 2014-05-06 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US8135548B2 (en) 2006-10-26 2012-03-13 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US9882660B2 (en) 2006-10-26 2018-01-30 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US10903914B2 (en) 2006-10-26 2021-01-26 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
US20080119710A1 (en) * 2006-10-31 2008-05-22 Abbott Diabetes Care, Inc. Medical devices and methods of using the same
US10007759B2 (en) 2006-10-31 2018-06-26 Abbott Diabetes Care Inc. Infusion devices and methods
US11043300B2 (en) 2006-10-31 2021-06-22 Abbott Diabetes Care Inc. Infusion devices and methods
US20100317953A1 (en) * 2006-10-31 2010-12-16 Reggiardo Christopher V Medical Devices and Methods of Using the Same
US9064107B2 (en) 2006-10-31 2015-06-23 Abbott Diabetes Care Inc. Infusion devices and methods
US11837358B2 (en) 2006-10-31 2023-12-05 Abbott Diabetes Care Inc. Infusion devices and methods
US11508476B2 (en) 2006-10-31 2022-11-22 Abbott Diabetes Care, Inc. Infusion devices and methods
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
US20080199894A1 (en) * 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8417545B2 (en) 2007-02-15 2013-04-09 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US10022499B2 (en) 2007-02-15 2018-07-17 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8676601B2 (en) 2007-02-15 2014-03-18 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US20080201169A1 (en) * 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US10617823B2 (en) 2007-02-15 2020-04-14 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9801545B2 (en) 2007-03-01 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
EP2796093A1 (en) 2007-03-26 2014-10-29 DexCom, Inc. Analyte sensor
US8149103B2 (en) 2007-04-14 2012-04-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage amplification in a medical device
US10194846B2 (en) 2007-04-14 2019-02-05 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US9743866B2 (en) 2007-04-14 2017-08-29 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US11039767B2 (en) 2007-04-14 2021-06-22 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US7948369B2 (en) 2007-04-14 2011-05-24 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US9204827B2 (en) 2007-04-14 2015-12-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US20110224522A1 (en) * 2007-04-14 2011-09-15 Abbott Diabetes Care Inc. Method and Apparatus for Providing Dynamic Multi-Stage Amplification in a Medical Device
US8140142B2 (en) 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9402584B2 (en) 2007-04-14 2016-08-02 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8937540B2 (en) 2007-04-14 2015-01-20 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US10111608B2 (en) 2007-04-14 2018-10-30 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US20080256048A1 (en) * 2007-04-14 2008-10-16 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
US20080255437A1 (en) * 2007-04-14 2008-10-16 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
US10349877B2 (en) 2007-04-14 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9615780B2 (en) 2007-04-14 2017-04-11 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9008743B2 (en) 2007-04-14 2015-04-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8698615B2 (en) 2007-04-14 2014-04-15 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US8427298B2 (en) 2007-04-14 2013-04-23 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage amplification in a medical device
US7768387B2 (en) 2007-04-14 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8362904B2 (en) 2007-05-08 2013-01-29 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9649057B2 (en) 2007-05-08 2017-05-16 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10653317B2 (en) 2007-05-08 2020-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8593287B2 (en) 2007-05-08 2013-11-26 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10178954B2 (en) 2007-05-08 2019-01-15 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US11696684B2 (en) 2007-05-08 2023-07-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8149117B2 (en) 2007-05-08 2012-04-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US10952611B2 (en) 2007-05-08 2021-03-23 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9949678B2 (en) 2007-05-08 2018-04-24 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US10119956B2 (en) 2007-05-14 2018-11-06 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8571808B2 (en) 2007-05-14 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9737249B2 (en) 2007-05-14 2017-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10991456B2 (en) 2007-05-14 2021-04-27 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10463310B2 (en) 2007-05-14 2019-11-05 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090055149A1 (en) * 2007-05-14 2009-02-26 Abbott Diabetes Care, Inc. Method and system for determining analyte levels
US20090006034A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10261069B2 (en) 2007-05-14 2019-04-16 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9060719B2 (en) 2007-05-14 2015-06-23 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080312842A1 (en) * 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US8612163B2 (en) 2007-05-14 2013-12-17 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11828748B2 (en) 2007-05-14 2023-11-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US8484005B2 (en) 2007-05-14 2013-07-09 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US20080288180A1 (en) * 2007-05-14 2008-11-20 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US10143409B2 (en) 2007-05-14 2018-12-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10634662B2 (en) 2007-05-14 2020-04-28 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10653344B2 (en) 2007-05-14 2020-05-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9797880B2 (en) 2007-05-14 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090005665A1 (en) * 2007-05-14 2009-01-01 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080312845A1 (en) * 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080287762A1 (en) * 2007-05-14 2008-11-20 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US9801571B2 (en) 2007-05-14 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US20080287763A1 (en) * 2007-05-14 2008-11-20 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US10045720B2 (en) 2007-05-14 2018-08-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9804150B2 (en) 2007-05-14 2017-10-31 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8682615B2 (en) 2007-05-14 2014-03-25 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10031002B2 (en) 2007-05-14 2018-07-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10976304B2 (en) 2007-05-14 2021-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11076785B2 (en) 2007-05-14 2021-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9558325B2 (en) 2007-05-14 2017-01-31 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US11300561B2 (en) 2007-05-14 2022-04-12 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10820841B2 (en) 2007-05-14 2020-11-03 Abbot Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080312841A1 (en) * 2007-05-14 2008-12-18 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US11119090B2 (en) 2007-05-14 2021-09-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US11125592B2 (en) 2007-05-14 2021-09-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9483608B2 (en) 2007-05-14 2016-11-01 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10791928B2 (en) 2007-05-18 2020-10-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20080300476A1 (en) * 2007-05-31 2008-12-04 Abbott Diabetes Care, Inc. Insertion devices and methods
US8613703B2 (en) 2007-05-31 2013-12-24 Abbott Diabetes Care Inc. Insertion devices and methods
US9741139B2 (en) 2007-06-08 2017-08-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20080306435A1 (en) * 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8562558B2 (en) 2007-06-08 2013-10-22 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US11373347B2 (en) 2007-06-08 2022-06-28 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US10403012B2 (en) 2007-06-08 2019-09-03 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US8617069B2 (en) 2007-06-21 2013-12-31 Abbott Diabetes Care Inc. Health monitor
US8597188B2 (en) 2007-06-21 2013-12-03 Abbott Diabetes Care Inc. Health management devices and methods
US11276492B2 (en) 2007-06-21 2022-03-15 Abbott Diabetes Care Inc. Health management devices and methods
US20100076293A1 (en) * 2007-06-21 2010-03-25 Abbott Diabetes Care Inc. Health Monitor
US20080319294A1 (en) * 2007-06-21 2008-12-25 Abbott Diabetes Care, Inc. Health management devices and methods
US11264133B2 (en) 2007-06-21 2022-03-01 Abbott Diabetes Care Inc. Health management devices and methods
US8641618B2 (en) 2007-06-27 2014-02-04 Abbott Diabetes Care Inc. Method and structure for securing a monitoring device element
US20090012377A1 (en) * 2007-06-27 2009-01-08 Abbott Diabetes Care, Inc. Method and structure for securing a monitoring device element
US8502682B2 (en) 2007-06-28 2013-08-06 Abbott Diabetes Care Inc. Signal converting cradle for medical condition monitoring and management system
US8085151B2 (en) 2007-06-28 2011-12-27 Abbott Diabetes Care Inc. Signal converting cradle for medical condition monitoring and management system
US20090002179A1 (en) * 2007-06-28 2009-01-01 Abbott Diabetes Care, Inc. Signal converting cradle for medical condition monitoring and management system
US20090143661A1 (en) * 2007-06-29 2009-06-04 Abbott Diabetes Care, Inc Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US10856785B2 (en) 2007-06-29 2020-12-08 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US11678821B2 (en) 2007-06-29 2023-06-20 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US9913600B2 (en) 2007-06-29 2018-03-13 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US7768386B2 (en) 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US9398872B2 (en) 2007-07-31 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US20090036760A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US20090033482A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
US11672422B2 (en) 2007-09-13 2023-06-13 Dexcom, Inc. Transcutaneous analyte sensor
US9668682B2 (en) 2007-09-13 2017-06-06 Dexcom, Inc. Transcutaneous analyte sensor
US9451910B2 (en) 2007-09-13 2016-09-27 Dexcom, Inc. Transcutaneous analyte sensor
US11744943B2 (en) 2007-10-09 2023-09-05 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US11160926B1 (en) 2007-10-09 2021-11-02 Dexcom, Inc. Pre-connected analyte sensors
EP4159114A1 (en) 2007-10-09 2023-04-05 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
EP4098177A1 (en) 2007-10-09 2022-12-07 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US10653835B2 (en) 2007-10-09 2020-05-19 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US9804148B2 (en) 2007-10-23 2017-10-31 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US9332934B2 (en) 2007-10-23 2016-05-10 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US10173007B2 (en) 2007-10-23 2019-01-08 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US20090105568A1 (en) * 2007-10-23 2009-04-23 Abbott Diabetes Care, Inc. Assessing Measures Of Glycemic Variability
US9439586B2 (en) 2007-10-23 2016-09-13 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US11083843B2 (en) 2007-10-23 2021-08-10 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US9743865B2 (en) 2007-10-23 2017-08-29 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US10182751B2 (en) 2007-10-25 2019-01-22 Dexcom, Inc. Systems and methods for processing sensor data
EP4250312A2 (en) 2007-10-25 2023-09-27 DexCom, Inc. Systems and methods for processing sensor data
US11272869B2 (en) 2007-10-25 2022-03-15 Dexcom, Inc. Systems and methods for processing sensor data
US9717449B2 (en) 2007-10-25 2017-08-01 Dexcom, Inc. Systems and methods for processing sensor data
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US20090164190A1 (en) * 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Physiological condition simulation device and method
US20090164239A1 (en) * 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US20090198118A1 (en) * 2008-01-31 2009-08-06 Abbott Diabetes Care, Inc. Analyte Sensor with Time Lag Compensation
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US9770211B2 (en) 2008-01-31 2017-09-26 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US9320468B2 (en) 2008-01-31 2016-04-26 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US20090240193A1 (en) * 2008-02-21 2009-09-24 Dexcom, Inc. Systems and methods for customizing delivery of sensor data
US20090240128A1 (en) * 2008-02-21 2009-09-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
US9143569B2 (en) 2008-02-21 2015-09-22 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US20090240120A1 (en) * 2008-02-21 2009-09-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8591455B2 (en) 2008-02-21 2013-11-26 Dexcom, Inc. Systems and methods for customizing delivery of sensor data
US9020572B2 (en) 2008-02-21 2015-04-28 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US11102306B2 (en) 2008-02-21 2021-08-24 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US11896374B2 (en) 2008-03-25 2024-02-13 Dexcom, Inc. Analyte sensor
US10602968B2 (en) 2008-03-25 2020-03-31 Dexcom, Inc. Analyte sensor
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US20100274107A1 (en) * 2008-03-28 2010-10-28 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US9566026B2 (en) 2008-03-28 2017-02-14 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US20090247857A1 (en) * 2008-03-28 2009-10-01 Abbott Diabetes Care, Inc. Analyte Sensor Calibration Management
US11779248B2 (en) 2008-03-28 2023-10-10 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8954128B2 (en) 2008-03-28 2015-02-10 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US10143410B2 (en) 2008-03-28 2018-12-04 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US9320462B2 (en) 2008-03-28 2016-04-26 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9173607B2 (en) 2008-03-28 2015-11-03 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US9693721B2 (en) 2008-03-28 2017-07-04 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US10463288B2 (en) 2008-03-28 2019-11-05 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8583205B2 (en) 2008-03-28 2013-11-12 Abbott Diabetes Care Inc. Analyte sensor calibration management
US20090247855A1 (en) * 2008-03-28 2009-10-01 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US9173606B2 (en) 2008-03-28 2015-11-03 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US9572523B2 (en) 2008-03-28 2017-02-21 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US11147483B2 (en) 2008-03-28 2021-10-19 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8718739B2 (en) 2008-03-28 2014-05-06 Abbott Diabetes Care Inc. Analyte sensor calibration management
US9549699B2 (en) 2008-03-28 2017-01-24 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US9730623B2 (en) 2008-03-28 2017-08-15 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
EP3387993A2 (en) 2008-03-28 2018-10-17 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US20090259118A1 (en) * 2008-03-31 2009-10-15 Abbott Diabetes Care Inc. Shallow Implantable Analyte Sensor with Rapid Physiological Response
US8802006B2 (en) 2008-04-10 2014-08-12 Abbott Diabetes Care Inc. Method and system for sterilizing an analyte sensor
US20090257911A1 (en) * 2008-04-10 2009-10-15 Abbott Diabetes Care Inc. Method and System for Sterilizing an Analyte Sensor
US8252229B2 (en) 2008-04-10 2012-08-28 Abbott Diabetes Care Inc. Method and system for sterilizing an analyte sensor
US9931075B2 (en) 2008-05-30 2018-04-03 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US20090299151A1 (en) * 2008-05-30 2009-12-03 Abbott Diabetes Care Inc. Method and Apparatus for Providing Glycemic Control
US8509107B2 (en) 2008-05-30 2013-08-13 Abbott Diabetes Care Inc. Close proximity communication device and methods
US9184875B2 (en) 2008-05-30 2015-11-10 Abbott Diabetes Care, Inc. Close proximity communication device and methods
US9795328B2 (en) 2008-05-30 2017-10-24 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US9831985B2 (en) 2008-05-30 2017-11-28 Abbott Diabetes Care Inc. Close proximity communication device and methods
US9541556B2 (en) 2008-05-30 2017-01-10 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US20090300616A1 (en) * 2008-05-30 2009-12-03 Abbott Diabetes Care, Inc. Automated task execution for an analyte monitoring system
US11770210B2 (en) 2008-05-30 2023-09-26 Abbott Diabetes Care Inc. Close proximity communication device and methods
US11735295B2 (en) 2008-05-30 2023-08-22 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US10327682B2 (en) 2008-05-30 2019-06-25 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US8737259B2 (en) 2008-05-30 2014-05-27 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US20090320978A1 (en) * 2008-06-27 2009-12-31 Martinez Johnny C Sound-emitting wallet
US20110213230A1 (en) * 2008-07-02 2011-09-01 Stefan Lindgren On-Line Measuring System of Body Substances
US9101304B2 (en) * 2008-07-02 2015-08-11 Maquet Critical Care Ab On-line measuring system of body substances
US9420966B2 (en) 2008-07-02 2016-08-23 Maquet Critical Care Ab On-line measuring system of body substances
US10328201B2 (en) 2008-07-14 2019-06-25 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US11621073B2 (en) 2008-07-14 2023-04-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US20100027169A1 (en) * 2008-07-30 2010-02-04 Arnold Knott Power distribution arrangement
US20100057057A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Closed Loop Control And Signal Attenuation Detection
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US9572934B2 (en) 2008-08-31 2017-02-21 Abbott DiabetesCare Inc. Robust closed loop control and methods
US20100057040A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US20100057044A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care Inc. Robust Closed Loop Control And Methods
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US8795252B2 (en) 2008-08-31 2014-08-05 Abbott Diabetes Care Inc. Robust closed loop control and methods
US9610046B2 (en) 2008-08-31 2017-04-04 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US20100057041A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Closed Loop Control With Reference Measurement And Methods Thereof
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8560039B2 (en) 2008-09-19 2013-10-15 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
EP3795987A1 (en) 2008-09-19 2021-03-24 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
EP4227675A2 (en) 2008-09-19 2023-08-16 DexCom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10561352B2 (en) 2008-09-19 2020-02-18 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US9339222B2 (en) 2008-09-19 2016-05-17 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10028683B2 (en) 2008-09-19 2018-07-24 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US10028684B2 (en) 2008-09-19 2018-07-24 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US20100076283A1 (en) * 2008-09-19 2010-03-25 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US11202592B2 (en) 2008-09-30 2021-12-21 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US10045739B2 (en) 2008-09-30 2018-08-14 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US20100081909A1 (en) * 2008-09-30 2010-04-01 Abbott Diabetes Care, Inc. Optimizing Analyte Sensor Calibration
US9662056B2 (en) 2008-09-30 2017-05-30 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US11464434B2 (en) 2008-09-30 2022-10-11 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US11484234B2 (en) 2008-09-30 2022-11-01 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US8744547B2 (en) 2008-09-30 2014-06-03 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US20100082364A1 (en) * 2008-09-30 2010-04-01 Abbott Diabetes Care, Inc. Medical Information Management
US11013439B2 (en) 2008-09-30 2021-05-25 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US10980461B2 (en) 2008-11-07 2021-04-20 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US9730650B2 (en) 2008-11-10 2017-08-15 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US11678848B2 (en) 2008-11-10 2023-06-20 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US20100121167A1 (en) * 2008-11-10 2010-05-13 Abbott Diabetes Care Inc. Alarm Characterization for Analyte Monitoring Devices and Systems
US11272890B2 (en) 2008-11-10 2022-03-15 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US10089446B2 (en) 2009-01-29 2018-10-02 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US20100191085A1 (en) * 2009-01-29 2010-07-29 Abbott Diabetes Care, Inc. Method and Device for Providing Offset Model Based Calibration for Analyte Sensor
US8676513B2 (en) 2009-01-29 2014-03-18 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8532935B2 (en) 2009-01-29 2013-09-10 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US9066709B2 (en) 2009-01-29 2015-06-30 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US11464430B2 (en) 2009-01-29 2022-10-11 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8473220B2 (en) 2009-01-29 2013-06-25 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US8560082B2 (en) 2009-01-30 2013-10-15 Abbott Diabetes Care Inc. Computerized determination of insulin pump therapy parameters using real time and retrospective data processing
US11006870B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006871B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US10786190B2 (en) 2009-02-03 2020-09-29 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9993188B2 (en) 2009-02-03 2018-06-12 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD955599S1 (en) 2009-02-03 2022-06-21 Abbott Diabetes Care Inc. Analyte sensor inserter
USD882432S1 (en) 2009-02-03 2020-04-28 Abbott Diabetes Care Inc. Analyte sensor on body unit
US9636068B2 (en) 2009-02-03 2017-05-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11213229B2 (en) 2009-02-03 2022-01-04 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD957642S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor inserter
US11166656B2 (en) 2009-02-03 2021-11-09 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US11006872B2 (en) 2009-02-03 2021-05-18 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
USD957643S1 (en) 2009-02-03 2022-07-12 Abbott Diabetes Care Inc. Analyte sensor device
US11202591B2 (en) 2009-02-03 2021-12-21 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US20100230285A1 (en) * 2009-02-26 2010-09-16 Abbott Diabetes Care Inc. Analyte Sensors and Methods of Making and Using the Same
US10675405B2 (en) 2009-03-27 2020-06-09 Dexcom, Inc. Methods and systems for simulating glucose response to simulated actions
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
US10610642B2 (en) 2009-03-27 2020-04-07 Dexcom, Inc. Methods and systems for promoting glucose management
US10537678B2 (en) 2009-03-27 2020-01-21 Dexcom, Inc. Methods and systems for promoting glucose management
US20100247775A1 (en) * 2009-03-31 2010-09-30 Abbott Diabetes Care Inc. Precise Fluid Dispensing Method and Device
US20100265073A1 (en) * 2009-04-15 2010-10-21 Abbott Diabetes Care Inc. Analyte Monitoring System Having An Alert
US9178752B2 (en) 2009-04-15 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8730058B2 (en) 2009-04-15 2014-05-20 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US10009244B2 (en) 2009-04-15 2018-06-26 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
US20100274515A1 (en) * 2009-04-28 2010-10-28 Abbott Diabetes Care Inc. Dynamic Analyte Sensor Calibration Based On Sensor Stability Profile
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9310230B2 (en) 2009-04-29 2016-04-12 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9088452B2 (en) 2009-04-29 2015-07-21 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10617296B2 (en) 2009-04-29 2020-04-14 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US9693688B2 (en) 2009-04-29 2017-07-04 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US10172518B2 (en) 2009-04-29 2019-01-08 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US9949639B2 (en) 2009-04-29 2018-04-24 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US11872370B2 (en) 2009-05-29 2024-01-16 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US11793936B2 (en) 2009-05-29 2023-10-24 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
US10872102B2 (en) 2009-07-23 2020-12-22 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US9795326B2 (en) 2009-07-23 2017-10-24 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US8798934B2 (en) 2009-07-23 2014-08-05 Abbott Diabetes Care Inc. Real time management of data relating to physiological control of glucose levels
US10827954B2 (en) 2009-07-23 2020-11-10 Abbott Diabetes Care Inc. Continuous analyte measurement systems and systems and methods for implanting them
US10660554B2 (en) 2009-07-31 2020-05-26 Abbott Diabetes Care Inc. Methods and devices for analyte monitoring calibration
US8718965B2 (en) 2009-07-31 2014-05-06 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US8478557B2 (en) 2009-07-31 2013-07-02 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
US11234625B2 (en) 2009-07-31 2022-02-01 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US20110029269A1 (en) * 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and Apparatus for Providing Analyte Monitoring System Calibration Accuracy
US9936910B2 (en) 2009-07-31 2018-04-10 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring and therapy management system accuracy
US8514086B2 (en) 2009-08-31 2013-08-20 Abbott Diabetes Care Inc. Displays for a medical device
US11045147B2 (en) 2009-08-31 2021-06-29 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US10772572B2 (en) 2009-08-31 2020-09-15 Abbott Diabetes Care Inc. Displays for a medical device
US20110193704A1 (en) * 2009-08-31 2011-08-11 Abbott Diabetes Care Inc. Displays for a medical device
US9549694B2 (en) 2009-08-31 2017-01-24 Abbott Diabetes Care Inc. Displays for a medical device
USD962446S1 (en) 2009-08-31 2022-08-30 Abbott Diabetes Care, Inc. Analyte sensor device
US9968302B2 (en) 2009-08-31 2018-05-15 Abbott Diabetes Care Inc. Analyte signal processing device and methods
USD1010133S1 (en) 2009-08-31 2024-01-02 Abbott Diabetes Care Inc. Analyte sensor assembly
US11241175B2 (en) 2009-08-31 2022-02-08 Abbott Diabetes Care Inc. Displays for a medical device
US10881355B2 (en) 2009-08-31 2021-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US10429250B2 (en) 2009-08-31 2019-10-01 Abbott Diabetes Care, Inc. Analyte monitoring system and methods for managing power and noise
US10456091B2 (en) 2009-08-31 2019-10-29 Abbott Diabetes Care Inc. Displays for a medical device
US10123752B2 (en) 2009-08-31 2018-11-13 Abbott Diabetes Care Inc. Displays for a medical device
US10492685B2 (en) 2009-08-31 2019-12-03 Abbott Diabetes Care Inc. Medical devices and methods
US11202586B2 (en) 2009-08-31 2021-12-21 Abbott Diabetes Care Inc. Displays for a medical device
US11635332B2 (en) 2009-08-31 2023-04-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9814416B2 (en) 2009-08-31 2017-11-14 Abbott Diabetes Care Inc. Displays for a medical device
US9226714B2 (en) 2009-08-31 2016-01-05 Abbott Diabetes Care Inc. Displays for a medical device
US10136816B2 (en) 2009-08-31 2018-11-27 Abbott Diabetes Care Inc. Medical devices and methods
US9186113B2 (en) 2009-08-31 2015-11-17 Abbott Diabetes Care Inc. Displays for a medical device
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
USRE47315E1 (en) 2009-08-31 2019-03-26 Abbott Diabetes Care Inc. Displays for a medical device
US11150145B2 (en) 2009-08-31 2021-10-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US11730429B2 (en) 2009-08-31 2023-08-22 Abbott Diabetes Care Inc. Displays for a medical device
US8816862B2 (en) 2009-08-31 2014-08-26 Abbott Diabetes Care Inc. Displays for a medical device
US10918342B1 (en) 2009-08-31 2021-02-16 Abbott Diabetes Care Inc. Displays for a medical device
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US9750439B2 (en) 2009-09-29 2017-09-05 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US10349874B2 (en) 2009-09-29 2019-07-16 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US11259725B2 (en) 2009-09-30 2022-03-01 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US9750444B2 (en) 2009-09-30 2017-09-05 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US10765351B2 (en) 2009-09-30 2020-09-08 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US20110191044A1 (en) * 2009-09-30 2011-08-04 Stafford Gary A Interconnect for on-body analyte monitoring device
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
CN102725629A (en) * 2009-10-01 2012-10-10 美敦力迷你迈德公司 Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
CN102725629B (en) * 2009-10-01 2014-12-10 美敦力迷你迈德公司 Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
US8185181B2 (en) 2009-10-30 2012-05-22 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US11207005B2 (en) 2009-10-30 2021-12-28 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US9050041B2 (en) 2009-10-30 2015-06-09 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US10117606B2 (en) 2009-10-30 2018-11-06 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
US20110184258A1 (en) * 2010-01-28 2011-07-28 Abbott Diabetes Care Inc. Balloon Catheter Analyte Measurement Sensors and Methods for Using the Same
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US20160077036A1 (en) * 2010-03-11 2016-03-17 Roche Diabetes Care, Inc. Method and fuel cell for electrochemical measurement of analyte concentration in vivo
US9709520B2 (en) * 2010-03-11 2017-07-18 Roche Diabetes Care, Inc. Method and fuel cell for electrochemical measurement of analyte concentration in vivo
US11000216B2 (en) 2010-03-24 2021-05-11 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881341B1 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10772547B1 (en) 2010-03-24 2020-09-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9265453B2 (en) 2010-03-24 2016-02-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11064922B1 (en) 2010-03-24 2021-07-20 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD948722S1 (en) 2010-03-24 2022-04-12 Abbott Diabetes Care Inc. Analyte sensor inserter
US11058334B1 (en) 2010-03-24 2021-07-13 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11266335B2 (en) 2010-03-24 2022-03-08 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9215992B2 (en) 2010-03-24 2015-12-22 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9687183B2 (en) 2010-03-24 2017-06-27 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11013440B2 (en) 2010-03-24 2021-05-25 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US9186098B2 (en) 2010-03-24 2015-11-17 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11246519B2 (en) 2010-03-24 2022-02-15 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10881340B2 (en) 2010-03-24 2021-01-05 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10292632B2 (en) 2010-03-24 2019-05-21 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10010280B2 (en) 2010-03-24 2018-07-03 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD987830S1 (en) 2010-03-24 2023-05-30 Abbott Diabetes Care Inc. Analyte sensor inserter
US8764657B2 (en) 2010-03-24 2014-07-01 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
USD997362S1 (en) 2010-03-24 2023-08-29 Abbott Diabetes Care Inc. Analyte sensor inserter
US10945649B2 (en) 2010-03-24 2021-03-16 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10952657B2 (en) 2010-03-24 2021-03-23 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US10959654B2 (en) 2010-03-24 2021-03-30 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10973449B2 (en) 2010-06-29 2021-04-13 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10966644B2 (en) 2010-06-29 2021-04-06 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US10959653B2 (en) 2010-06-29 2021-03-30 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11478173B2 (en) 2010-06-29 2022-10-25 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US10874338B2 (en) 2010-06-29 2020-12-29 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US11213226B2 (en) 2010-10-07 2022-01-04 Abbott Diabetes Care Inc. Analyte monitoring devices and methods
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US11627898B2 (en) 2011-02-28 2023-04-18 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US11534089B2 (en) 2011-02-28 2022-12-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9532737B2 (en) 2011-02-28 2017-01-03 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
EP3536241A1 (en) 2011-04-08 2019-09-11 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP4233718A2 (en) 2011-04-08 2023-08-30 DexCom, Inc. Systems and methods for processing and transmitting sensor data
US10682084B2 (en) 2011-04-15 2020-06-16 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10610141B2 (en) 2011-04-15 2020-04-07 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10561354B2 (en) 2011-04-15 2020-02-18 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10722162B2 (en) 2011-04-15 2020-07-28 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10835162B2 (en) 2011-04-15 2020-11-17 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10555695B2 (en) 2011-04-15 2020-02-11 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US10624568B2 (en) 2011-04-15 2020-04-21 Dexcom, Inc. Advanced analyte sensor calibration and error detection
US20130053666A1 (en) * 2011-08-26 2013-02-28 Dexcom, Inc. Polymer membranes for continuous analyte sensors
EP3505064A1 (en) 2011-09-23 2019-07-03 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP3505065A1 (en) 2011-09-23 2019-07-03 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP3888551A1 (en) 2011-09-23 2021-10-06 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP3092949A1 (en) 2011-09-23 2016-11-16 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US9913619B2 (en) 2011-10-31 2018-03-13 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9465420B2 (en) 2011-10-31 2016-10-11 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US11406331B2 (en) 2011-10-31 2022-08-09 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9069536B2 (en) 2011-10-31 2015-06-30 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
US9980669B2 (en) 2011-11-07 2018-05-29 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9743872B2 (en) 2011-11-23 2017-08-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10136847B2 (en) 2011-11-23 2018-11-27 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9289179B2 (en) 2011-11-23 2016-03-22 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10939859B2 (en) 2011-11-23 2021-03-09 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US10082493B2 (en) 2011-11-25 2018-09-25 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US11391723B2 (en) 2011-11-25 2022-07-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9339217B2 (en) 2011-11-25 2016-05-17 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
WO2013152090A2 (en) 2012-04-04 2013-10-10 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
EP4275598A2 (en) 2012-04-04 2023-11-15 DexCom, Inc. Applicator and method for applying a transcutaneous analyte sensor
WO2013184566A2 (en) 2012-06-05 2013-12-12 Dexcom, Inc. Systems and methods for processing analyte data and generating reports
EP3975192A1 (en) 2012-06-05 2022-03-30 Dexcom, Inc. Systems and methods for processing analyte data and generating reports
US11145410B2 (en) 2012-06-05 2021-10-12 Dexcom, Inc. Dynamic report building
WO2014004460A1 (en) 2012-06-29 2014-01-03 Dexcom, Inc. Use of sensor redundancy to detect sensor failures
EP4018929A1 (en) 2012-06-29 2022-06-29 Dexcom, Inc. Method and system for processing data from a continuous glucose sensor
US11737692B2 (en) 2012-06-29 2023-08-29 Dexcom, Inc. Implantable sensor devices, systems, and methods
US11892426B2 (en) 2012-06-29 2024-02-06 Dexcom, Inc. Devices, systems, and methods to compensate for effects of temperature on implantable sensors
EP3915465A2 (en) 2012-06-29 2021-12-01 Dexcom, Inc. Use of sensor redundancy to detect sensor failures
EP3767633A1 (en) 2012-07-09 2021-01-20 Dexcom, Inc. Systems and methods for leveraging smartphone features in continuous glucose monitoring
EP4075441A1 (en) 2012-07-09 2022-10-19 Dexcom, Inc. Systems and methods for leveraging smartphone features in continuous glucose monitoring
EP4080517A1 (en) 2012-07-09 2022-10-26 Dexcom, Inc. Systems and methods for leveraging smartphone features in continuous glucose monitoring
WO2014011488A2 (en) 2012-07-09 2014-01-16 Dexcom, Inc. Systems and methods for leveraging smartphone features in continuous glucose monitoring
US20140194713A1 (en) * 2012-08-06 2014-07-10 Google Inc. Contact lenses having two-electrode electrochemical sensors
US10942164B2 (en) 2012-08-30 2021-03-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10656139B2 (en) 2012-08-30 2020-05-19 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US10345291B2 (en) 2012-08-30 2019-07-09 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US11612363B2 (en) 2012-09-17 2023-03-28 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US11896371B2 (en) 2012-09-26 2024-02-13 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US10842420B2 (en) 2012-09-26 2020-11-24 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
WO2014052080A1 (en) 2012-09-28 2014-04-03 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
EP3782550A1 (en) 2012-09-28 2021-02-24 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
US11864891B2 (en) 2012-09-28 2024-01-09 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
US11179079B2 (en) 2012-09-28 2021-11-23 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
US9801577B2 (en) 2012-10-30 2017-10-31 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US10188334B2 (en) 2012-10-30 2019-01-29 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
EP3654348A1 (en) 2012-11-07 2020-05-20 Dexcom, Inc. Systems and methods for managing glycemic variability
EP4231309A2 (en) 2012-11-07 2023-08-23 DexCom, Inc. Systems and methods for managing glycemic variability
US10993617B2 (en) 2012-12-31 2021-05-04 Dexcom, Inc. Remote monitoring of analyte measurements
US11213204B2 (en) 2012-12-31 2022-01-04 Dexcom, Inc. Remote monitoring of analyte measurements
US11744463B2 (en) 2012-12-31 2023-09-05 Dexcom, Inc. Remote monitoring of analyte measurements
US11382508B2 (en) 2012-12-31 2022-07-12 Dexcom, Inc. Remote monitoring of analyte measurements
US11160452B2 (en) 2012-12-31 2021-11-02 Dexcom, Inc. Remote monitoring of analyte measurements
US11109757B2 (en) 2012-12-31 2021-09-07 Dexcom, Inc. Remote monitoring of analyte measurements
US11850020B2 (en) 2012-12-31 2023-12-26 Dexcom, Inc. Remote monitoring of analyte measurements
US10869599B2 (en) 2012-12-31 2020-12-22 Dexcom, Inc. Remote monitoring of analyte measurements
US10856736B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
US10860687B2 (en) 2012-12-31 2020-12-08 Dexcom, Inc. Remote monitoring of analyte measurements
EP4220654A1 (en) 2013-03-14 2023-08-02 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP4235684A1 (en) 2013-03-14 2023-08-30 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US11677443B1 (en) 2013-03-14 2023-06-13 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US10985804B2 (en) 2013-03-14 2021-04-20 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP3401818A1 (en) 2013-03-14 2018-11-14 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
WO2014158405A2 (en) 2013-03-14 2014-10-02 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
WO2014158327A2 (en) 2013-03-14 2014-10-02 Dexcom, Inc. Advanced calibration for analyte sensors
EP3806103A1 (en) 2013-03-14 2021-04-14 Dexcom, Inc. Advanced calibration for analyte sensors
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10874336B2 (en) 2013-03-15 2020-12-29 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US11229382B2 (en) 2013-12-31 2022-01-25 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
US11717225B2 (en) 2014-03-30 2023-08-08 Abbott Diabetes Care Inc. Method and apparatus for determining meal start and peak events in analyte monitoring systems
WO2015156966A1 (en) 2014-04-10 2015-10-15 Dexcom, Inc. Sensors for continuous analyte monitoring, and related methods
EP4257044A2 (en) 2014-04-10 2023-10-11 DexCom, Inc. Sensor for continuous analyte monitoring
USD980986S1 (en) 2015-05-14 2023-03-14 Abbott Diabetes Care Inc. Analyte sensor inserter
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
US11439351B2 (en) 2015-09-02 2022-09-13 Metronom Health, Inc. Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor
US11553879B2 (en) 2015-09-02 2023-01-17 Metronom Health, Inc. Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor
EP4046571A1 (en) 2015-10-21 2022-08-24 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US10932672B2 (en) 2015-12-28 2021-03-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US11399721B2 (en) 2015-12-28 2022-08-02 Dexcom, Inc. Systems and methods for remote and host monitoring communications
US11112377B2 (en) 2015-12-30 2021-09-07 Dexcom, Inc. Enzyme immobilized adhesive layer for analyte sensors
EP4324921A2 (en) 2015-12-30 2024-02-21 Dexcom, Inc. Biointerface layer for analyte sensors
EP3895614A1 (en) 2015-12-30 2021-10-20 Dexcom, Inc. Enzyme immobilized adhesive layer for analyte sensors
EP4292528A1 (en) 2015-12-30 2023-12-20 Dexcom, Inc. Membrane layers for analyte sensors
EP4253536A2 (en) 2015-12-30 2023-10-04 DexCom, Inc. Diffusion resistance layer for analyte sensors
US10881335B2 (en) 2016-03-31 2021-01-05 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10799157B2 (en) 2016-03-31 2020-10-13 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10980451B2 (en) 2016-03-31 2021-04-20 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10568552B2 (en) 2016-03-31 2020-02-25 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10561349B2 (en) 2016-03-31 2020-02-18 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10980450B2 (en) 2016-03-31 2021-04-20 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US10980453B2 (en) 2016-03-31 2021-04-20 Dexcom, Inc. Systems and methods for display device and sensor electronics unit communication
US11596330B2 (en) 2017-03-21 2023-03-07 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
EP4008240A1 (en) 2017-06-23 2022-06-08 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11395631B2 (en) 2017-06-23 2022-07-26 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11311241B2 (en) 2017-06-23 2022-04-26 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
EP3925522A1 (en) 2017-06-23 2021-12-22 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US11510625B2 (en) 2017-06-23 2022-11-29 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
CN111278356A (en) * 2017-06-23 2020-06-12 博卡赛恩斯公司 Analyte sensor
EP4111949A1 (en) 2017-06-23 2023-01-04 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and needle hub comprising anti-rotation feature
US11504063B2 (en) 2017-06-23 2022-11-22 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
EP3928688A1 (en) 2017-06-23 2021-12-29 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US20190090797A1 (en) * 2017-09-28 2019-03-28 California Institute Of Technology Switchable low voltage electrochemical sensing for interfering species rejection
US11903708B2 (en) * 2017-09-28 2024-02-20 California Institute Of Technology Switchable low voltage electrochemical sensing for interfering species rejection
US11706876B2 (en) 2017-10-24 2023-07-18 Dexcom, Inc. Pre-connected analyte sensors
US11350862B2 (en) 2017-10-24 2022-06-07 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11382540B2 (en) 2017-10-24 2022-07-12 Dexcom, Inc. Pre-connected analyte sensors
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
CN112294323A (en) * 2019-08-02 2021-02-02 华广生技股份有限公司 Miniature biosensor and measuring method thereof
US11918354B2 (en) 2019-12-31 2024-03-05 Dexcom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
USD1006235S1 (en) 2020-12-21 2023-11-28 Abbott Diabetes Care Inc. Analyte sensor inserter
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
USD982762S1 (en) 2020-12-21 2023-04-04 Abbott Diabetes Care Inc. Analyte sensor inserter

Also Published As

Publication number Publication date
DE60213096D1 (en) 2006-08-24
US9328371B2 (en) 2016-05-03
EP1669022A3 (en) 2006-06-21
WO2003011131A3 (en) 2003-08-21
JP4295615B2 (en) 2009-07-15
US20090045055A1 (en) 2009-02-19
US20130299350A1 (en) 2013-11-14
EP1669022A2 (en) 2006-06-14
ATE332666T1 (en) 2006-08-15
US20160178558A1 (en) 2016-06-23
US7471972B2 (en) 2008-12-30
US8509871B2 (en) 2013-08-13
EP1411823A2 (en) 2004-04-28
US20050103625A1 (en) 2005-05-19
AU2002317584A1 (en) 2003-02-17
US9804114B2 (en) 2017-10-31
JP2005525834A (en) 2005-09-02
EP1411823B1 (en) 2006-07-12
WO2003011131A2 (en) 2003-02-13
US20180024086A1 (en) 2018-01-25

Similar Documents

Publication Publication Date Title
US9804114B2 (en) Sensor head for use with implantable devices
US9931067B2 (en) Device and method for determining analyte levels
US6405066B1 (en) Implantable analyte sensor
US7136689B2 (en) Device and method for determining analyte levels
ES2324804T3 (en) A GLUCOSE SENSOR.
US5914026A (en) Implantable sensor employing an auxiliary electrode
Guerrieri et al. Electrosynthesized non-conducting polymers as permselective membranes in amperometric enzyme electrodes: a glucose biosensor based on a co-crosslinked glucose oxidase/overoxidized polypyrrole bilayer
US8527025B1 (en) Device and method for determining analyte levels
US20040045879A1 (en) Device and method for determining analyte levels
CA2406814A1 (en) Implantable analyte sensor
Churchouse et al. Needle enzyme electrodes for biological studies
US20170290538A1 (en) Amperometric sensor and method for its manufacturing
JP2019170701A (en) Protection film for preventing outward flow of specimen responsive enzyme and biosensor probe having same formed thereon
WO2004060297A2 (en) Hydrophilic cross-linking agents for use in enzymatic sensors
US20220338768A1 (en) Hexamethyldisiloxane membranes for analyte sensors
JP2020156911A (en) Biosensor probe and method for producing the same

Legal Events

Date Code Title Description
AS Assignment

Owner name: DEXCOM, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RHODES, RATHBUN;SHULTS, MARK C.;TAPSAK, MARK A.;AND OTHERS;REEL/FRAME:012265/0884;SIGNING DATES FROM 20010917 TO 20011001

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION